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ABSTRACT 
 
 
With the advent of effective antiretroviral medication and increased expectancy of 
life span among HIV-infected individuals has lead to an increase in the at-risk population 
of uninfected children living with their HIV-infected parent(s). The purpose of this study 
was to investigate the impact of parent’s HIV status on their child’s access to healthcare 
resources, healthcare utilization and health outcomes. 
 
This was a cross-sectional study in which the information on the children of HIV 
seropositive parent(s) was collected through a face-to-face interview of the HIV-infected 
parents having children currently residing with them. The comparative group comprising 
of children of HIV seronegative parents was obtained from the Medical Expenditure 
Panel Survey (MEPS) 2006 database. HIV seronegative children aged between 2 yrs and 
15 yrs of HIV seropositive as well as HIV seronegative parent(s) were included in this 
study. A parent was identified as HIV seropositive if they had a prior diagnosis of 
HIV/AIDS (ICD-9-CM 042, 043, V08) by a physician and had at least one record of a 
HIV positive serological test result in the past 6 months in their medical records. A parent 
was defined HIV seronegative if there were no diagnosis of HIV/AIDS (ICD-9-CM 042, 
043, V08) in their medical records in MEPS 2006 database. Each child of HIV 
seropositive parent (primary group) was matched with two children of HIV seronegative 
parents (comparative group) using the Mahalanobis Distance Metric matching including 
the propensity score technique. Bivariate and two step multivariable logistic and negative 
binomial regression analysis was conducted to assess the relationship between the 
parent’s HIV status and potential variables of interest. 
 
Upon matching, 89 children of HIV seropositive parent(s) matched with 178 
children of HIV seronegative parents (1:2 ratio), thus making the final study sample of 
267 participants. No differences were observed between the groups in terms of their mean 
age (8.47 vs 8.94 yrs, p=0.6265), parent’s age (33.57 vs 34.21 yrs, p=0.9464) and other 
socio-economic and parent’s health insurance variables. This study found no difference 
between the children in terms of their access to health insurance (97.75% vs 96.63%, 
p=0.7227) and access to regular source of medical care (87.64% vs 86.68%, p=0.4453). 
However, a larger number of children of HIV seropositive parent(s) had prescription 
insurance (95.51% vs 16.29%, p=<0.0001) compared to children of HIV seronegative 
parents. Also, children of HIV seropositive parent(s) took more time and expressed 
having difficulty in getting to a healthcare provider compared to children of HIV 
seronegative parents. Children of HIV seropositive parent(s) were 1.682 times (95% CI: 
1.115-6.453) more likely to have a physician visit and had 49% (p=0.0206) more visits to 
a doctor than the children of HIV seronegative parents. No differences were observed in 
the likelihood of the children in having a hospital visit or an emergency room visit. 
However, among children who had a hospital visit and among those who had an 
emergency room visit, children living with their HIV seropositive parent had 3.0 times 
more hospital visits (p=0.0244) and 86% more emergency room visits (p=0.0464) 
compared to children living with HIV seronegative parents, respectively. No relationship 
was noted between the parent’s HIV status and the child’s absenteeism in school/daycare 
vi  
due to illness (OR: 0.938, 95% CI: 0.425-2.069). However, children of HIV seropositive 
parent were 4.041 times more likely (95% CI: 1.887-13.471) to be overweight. Though 
no difference in the likelihood of these children being currently on prescription 
medication was observed (OR: 0.918, 95% CI: 0.413-2.042), among those who were 
currently on any medication, children of HIV seropositive parent(s) were more likely to 
be on a medication for a mental health problem (OR: 5.520, 95% CI: 1.503-20.276). 
 
This study concluded that HIV status of the parent has significant impact on the 
child’s access in getting to a healthcare provider. It was also found that children of HIV-
infected parent(s) had higher utilization of physician’s visits. Higher incidences of 
obesity and consumption of psychotropic medications among children of HIV 
seropositive parent(s) signify serious impact of the parent’s HIV status on the nutrition 
and psychological growth of the child. Further studies are recommended to investigate 
the exact cause and long term impacts of the findings observed in this study. 
vii  
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CHAPTER 1: INTRODUCTION 
 
 
“Let us sacrifice our today so that our children can have a better tomorrow.” 
- Dr. A.P.J. Abdul Kalam  
(11th President of India, President's Speech to the Nation, August 14, 2003) 
 
Human Immunodeficiency Virus, known to the world as HIV, has been a menace 
disease to the human race since its detection. With the disease now attaining the status of 
a chronic illness, the impact of HIV has stretched itself through time. The world, which 
still wrestles the virus in form of infected people, now has to organize itself to deal with a 
new populace of individuals affected by this disease. With the increase in the survival 
span of the HIV-infected individuals, a new generation comprising children has emerged 
that faces the far reaching consequence of the disease.  Children are one of the silent 
recipients of the indirect effects of the disease. Children of HIV-infected parent(s) face 
severe community discrimination, emotional deprivation, psychological trauma, 
economic hardships, abuse and a bunch of superfluous and harmful circumstances that 
hinders their natural growth. By impacting these children HIV has now found its way to 
lay its spawn into the next generation. 
 
 
1.1 Background 
 
Studies show more than a quarter of women younger than 30 years conceived 
despite the knowledge of their HIV positive status.1 Current estimates suggest that nearly 
28% of HIV-infected adults under medical care have one or more children less than 18 
years, and many of these children currently stay with their HIV-infected parent(s).2 
Reports claim an alarming fourfold increase, from 6.5% in 1985 to 26% in 2005, in the 
population of women among the newly infected HIV cases in the past 20 years.3 Seventy 
nine percent of the newly infected HIV women, between 2000 and 2005, were in the 
childbearing ages of 20 to 44 years old.4 Strong desire and commitment for bearing a 
child was observed among  HIV positive women in their child bearing age, very similar 
to uninfected women.5,6 With the advent of the highly active antiretroviral therapy 
(HAART) the life expectancy among the people living with HIV/AIDS (PLWHA) has 
increased tremendously in the past decade.7,8 Appropriate treatment adherence decreases 
the risk of mother to child transmission of the infection. This has been identified as a 
significant factor for the current surge in the parenthood status among PLHWA.1  
 
Conceptually health of parent(s) is a significant predictor of the health of a child.9 
According to Grossman’s human health capital model every person produces their 
health.10 An extended theory of this concept, which took family as a unit, found the 
health status of the parents to be an important determinant in the child’s production of 
health.9 Children of parents suffering from somatic illness have high probability of 
developing behavioral and psychological problems.11 This fact may be true for HIV-
infected population and the HIV status of parent(s) can have a significant impact on the 
health of the child. It is true that the state of mental health of the uninfected child has 
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been found to be significantly dependent on the health status of the HIV-infected 
parent.12 A recent study has also shown that school age children of mothers suffering 
from late stage HIV/AIDS suffer from significant psychiatric and/or behavioral 
symptoms.16 High risk of incidence of traumatic and unexpected, noninfectious deaths in 
children born to HIV-infected parents has also been documented.13 It is postulated that 
the viability of home care relies greatly on the willingness and ability of the caregiver, 
predominantly women, to provide adequate care and upbringing of their children.14  
 
HIV-infected families face severe economic hardship and this can mean long term 
detrimental consequences for their children. In the initial stages of the disease the impact 
of the disease is minimal, however as the health of the parent deteriorates the care 
demands of the person increases. Disability in performing routine household work and 
physical impairments is commonly observed in late stage HIV/AIDS patients and 
meeting the expectation of their family becomes difficult.15 This then has a direct impact 
on the economic productivity of the person. At the same time the household faces an 
increased cost of treatment. Literature identifies loss of household income, possibility of 
migration, loss of formal education, impact on nutrition, emotional deprivation, social 
abuse and exploitation and even rapes and exposure to domestic violence, as a few of the 
long term consequences faced by children in HIV-infected families.16   
 
Contrary to these observations, being infected with HIV, some parents have been 
seen to be more judicious and efficient in their caregiver’s role, something which the 
literature identifies as ‘defensive mothering’.17 A study has also shown that one third of 
the HIV-infected parents had proper guardianship planning for their children, less than 
seen in the general population.18 Ross et al., in their study found that the HIV status of 
mothers does not adversely affect the physical growth of the child in the first 3 years 
from birth.19 A similar study that followed children up to the age of 10 yrs showed a 
lower growth rate among children born to HIV-infected mothers.20 However, literature 
lacks studies on the healthcare utilization among these children, especially among US 
population. The current literature acknowledges the growing population of children living 
with their HIV-infected parents but lacks adequate information concerning its impact on 
healthcare utilization and health outcomes of these children. This virus (HIV) has been 
known to erode the productive capacity of the current generation. Due to the increase in 
the newly emerging HIV-affected children, this disease seems to be eroding the health of 
the next generation.  
 
The most comprehensive government policy catering to the HIV-infected as well 
as affected population in the Unites States has been the ‘Title XXVI of the PHS Act’, 
previous known as ‘Ryan White Care Act’.21 Authorized in 1990, this act initiated the 
Ryan White  HIV/AIDS program executed by the Health Resources and Services 
Administration (HRSA) and estimated to benefit more than half a million people 
annually.22 The program aims to provide health care coverage and financial assistance to 
those coping with HIV/AIDS disease. After Medicare and Medicaid, this program is the 
third largest funding source of the government for HIV/AIDS care in the United States.23 
Policy analysts have repeatedly felt the deficiency of having a family-centric approach 
instead of the current individual-centric dogma in the policy.24,25 Also the policies do not 
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address the disease associated issues of social stigma which still hinders the effectiveness 
of the program especially in children and youth affected by HIV.25 
 
 
1.2 Statement of Problem 
 
The current increase in the numbers of uninfected children living with HIV-
infected parents has given rise to a population that has been scarcely studied.7 Little has 
been known about the healthcare utilization and health outcomes of these children. Low 
income, low level of education and unemployment has been associated with the 
prevalence of HIV.26 Prevalence of food insecurity is almost five(5) times greater among 
HIV/AIDS-infected individuals than observed in the general population.27 Reduced 
ability to perform work related activities and decreased productivity erodes the financial 
stability of the family. Evidence of severe disparity among the infected population is well 
document in the literature.15,28,29 African Americans who make up 13% of the total US 
population actually make up 49% of the new HIV-infected population, an increase from 
25% in the past two decades.34 Reduction in income, deterioration of physical and mental 
health, regular incidences of discrimination, lack of access to healthcare resources and a 
constant fear of parental loss makes the children vulnerable to numerous health related 
consequences. Current health investments of a child are a strong determinant of the 
child’s future healthcare needs. It is pertinent to understand the impact of the disease 
(HIV) on the health and healthcare utilization of the children living in HIV-infected 
families. Lack of adequate public policy undermines the attention required by the 
growing vulnerable population. 
 
 
1.3 Research Question 
 
What is the impact of parent(s) HIV seropositive status on the health healthcare 
access, healthcare utilization and health outcomes of their children? This study aims to 
investigate the healthcare access, healthcare utilization, and health outcomes of 
uninfected children living with their HIV seropositive parents.  
 
 
1.4 Purpose of the Study 
 
? The primary purpose of this research was to determine whether the health 
outcomes of uninfected children living with their HIV seropositive parent(s) 
differed significantly from the health outcomes of uninfected children living with 
their HIV seronegative parent(s). 
? The secondary purpose included investigating differences in the healthcare 
utilization and access to healthcare between uninfected children living with HIV 
seropositive and seronegative parent(s). 
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1.5 Conceptual Model 
 
The conceptual model for this study was based upon two pivotal models found in 
the healthcare study literature - The Andersen’s Healthcare Utilization Behavioral 
Model30 and the Grossman’s concept of Human Capital & Demand for Health Model.31 
 
 
1.5.1 Andersen’s Behavioral Model for Health Service Utilization 
 
Healthcare utilization has been addressed in many studies in the past couple of 
decades. One of the pivotal studies explaining the determinants of healthcare utilization 
has been the conceptual model proposed by Ronald Anderson in 1968.32 At that time the 
model explained the utilization of healthcare services taking ‘family’ as a measure of 
study since the consumption of these services by any individual was a function of the 
family’s demographic, social and economic parameters. However, the rising complexity 
of defining and measuring family attributes that determined individual’s behavior 
towards use of healthcare services lead to redesigning of the model based  on the 
‘individual’ as the unit of analysis and incorporating additional variables into the original 
model.33-36 
 
According to this revised model the healthcare utilization outcomes of an 
individual was determined by various factors which can be categorized into three major 
areas: Population characteristics, Environment, and Health behavior (Figure 1-1). 
 
 
1.5.1.1 Population Characteristics 
 
The population characteristics can be further grouped into predisposing, enabling 
and need factors. The predisposing factors are the individual’s demographic, socio-
structural and attitudinal-belief variables. The demographic variables such as age and 
gender determine the likelihood that the individual would require a service. The socio-
structural variables define the status of the individual in the society as a determinant of 
healthcare utilization and include factors such as ethnicity, race, occupation and level of 
education. Individual’s health beliefs about the healthcare environment and health 
services drive the need for health and healthcare services, and constitute the attitudinal-
belief component of the predisposing factors. In order for an individual to utilize these 
services, apart from the desire to consume, is its availability and accessibility. The factors 
that facilitate the individual to consume the desired quantity of services, that is make it 
available and access it, are termed as ‘enabling factors. These enabling factors can be at a 
community or personal level and includes variables such as income, health insurance 
status, regular source of care, access to prescription drugs, adequate transportation, 
community and social support, etc. Though the predisposing factors and the enabling 
factors drive the individual’s degree of healthcare service utilization the ‘need’ factor 
regulates the initiation of the individual’s requirement of healthcare services. It comprises 
of the biologically driven variables such as individual’s perceived general and functional  
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Figure 1-1: Andersen Healthcare Utilization Behavioral Model 
(Reprinted with permission from American Sociological Association. Andersen, RM. 
Revisiting the behavioral model and access to medical care: does it matter? J Health Soc 
Behav. 1995;36:1-10.)30 
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self-health status, severity of disease and symptoms, and the perceived need to seek for 
medical attention. 
 
 
1.5.1.2 Environment 
 
The importance of healthcare system and policies became crucial in driving 
healthcare utilization both at micro and macro level. This component was developed and 
added to the original model by Aday et al.33,36 Factors such as the type of healthcare 
system, resources and their organizations in the healthcare system, national health and 
educational policies, etc, represent the environmental factors. 
 
 
1.5.1.3 Health Behavior 
 
Increase in the health awareness among the population and self-education health 
initiatives by individuals are newly emerging determinant of healthcare services in recent 
years. Factors such as the individuals effort to improve and maintain its own health status, 
personal health practices such as diet, exercise and self care, constitute the health 
behavior variable. 
 
 
1.5.2 Grossman’s Human Capital and Demand for Health Model 
 
Michael Grossman, in 1972, conceptualized “good health” as a human capital and 
developed a model for the demand for “good health” as a product of human consumption. 
In his concept Grossman proposed that individuals not only consume services that add to 
their health but also produce “good health” using the resources available in the form of 
healthcare and medical services. According to Grossman, every individual is born with an 
initial stock of health and this stock depreciates with time. The concept further reinstates 
that individuals can increase their health stock by investing in the production of their 
“good health”. These investments can be in the form of human capital (health and 
education) and/or as market goods to enhance their health outcomes in both, market 
(work) as well as in the non-market (household) regions.31 So every human being 
produces “good health” with the help of healthcare services/products and their own time. 
The amount of time invested and quantity of healthcare services consumed depends upon 
the individual’s stock of health. One more key variable of interest expressed by 
Grossman that drives the production (market and non-market) is the individual’s amount 
of knowledge. Knowledge increases the person’s productivity with respect to time and 
hence augments the rate of production of “good health”. At the same time, knowledge 
also increases the person’s market value and hence strengthens the individual’s financial 
ability to consume more healthcare services. The time spent on production of “good 
health” is a function of the marginal utility derived from this commodity. Individuals 
keep producing “good health” only till the point where the marginal utility gained from it 
equals the marginal utility gained from using the same time in other non-health producing 
activities such as work or leisure. Hence individuals with a good health stock (healthy) 
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have a lower marginal utility in producing further health in comparison to the individuals 
with a lower health stock (sick). And this is the reason why sick individuals tend to have 
a higher utilization of healthcare services in comparison to healthy ones. And since 
healthcare services are consumed to produce “good health” hence lower consumption 
may lead to lower production, and is identified as inadequate investment in health. 
Individual with a high degree of knowledge is more efficient in producing “good health” 
and can make right health decisions for themselves and their families leading to a healthy 
life. In his concept Grossman identified ‘education’ as a key determinant in the 
production of health.10,37 
 
 
1.5.2.1 Individual as a Producer of “Good Health” 
 
Grossman’s model can be represented by the following mathematical equations. 
Since individuals derive its utility from their current health stock ‘Ht’ and from the other 
commodities Zt, the equation for the derived utility ‘Ut’ in period ‘t’ is given by, 
 
Ut = u(Ht, Zt) 
 
This concept assumes that the health stock of every individual depreciates with 
time and this depreciation can be recovered with further production of health, hence the 
“good health” created over time is the difference between the production of additional 
health stock ‘It’ and the depletion of current stock ‘δt Ht’ and is given by the following 
equation: 
 
δHt / δt = It - δt Ht 
 
The individual creates total health investment ‘It’, and consumes other 
commodities, ‘Zt’, using the following inputs, 
 
It = (Mt, ht,H; Et,H), and 
 
Zt = (Xt, ht,Z; Et,Z), 
 
where Mt and Zt are market goods, and ht,H and ht,Z are the time periods of individuals 
consumed in the production of “good health” and other commodities, respectively. Et,H 
and Et,Z are efficiency parameters. 
 
 
1.5.2.2 Family as a Producer of “Good Health” 
 
An extension of the Grossman model, which actually focused on individual’s 
health was derived using family as a unit of measure by Lena Jacobson.9 In this model a 
family comprising of husband, wife and a child was considered as a unit in production 
“good health.”9 The mathematical representation of the utility derived by Grossman was 
modified to include the family members as below, 
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Ut = u(Hm, Hf, Hc, Zt), 
 
where, Hm, Hf and Hc are the health of the male parent (father), female parent (mother) 
and that of the child, respectively. 
 
In the family, as a producer of health of each member, the parents not only 
produce health for themselves but are also involved in the process of their child’s 
production of health. This includes using their time, healthcare resources and knowledge 
as input variables in their child’s production of health. Hence parent’s individual health 
stock, commonly known as health status, and production efficiency or knowledge, 
commonly known as level of education,  are two pivotal determinants of the child’s 
production of “good health.” 
 
In this framework the child has been taken as the unit of measure but since the 
child is an integral part of the family and most the health related decisions are taken by 
the parents on behalf of the child hence family (parents) was identified as a key variable 
in the conceptual model. The health outcome, which is a function of the health status of a 
child, is dependent on the amount of health investments done by their parents. These 
health investments are in the form of utilization of healthcare and medical services, diet, 
environment the child lives in, time, and attention shared by the parents with the child, in 
order to generate “good health” for the child. 
 
The efficiency of the health production is greatly dependent on the age and 
education level of the parents and hence is termed as the ‘Efficiency parameters.’ 
Efficiency decreases with the increase in age and increases with increase in the level of 
education of the parents. Younger parents are healthier and have higher health stock 
hence can invest more to produce “good health” for themselves and for their children in 
comparison to older parents. Increase in level of education not only increases the market 
productivity value of the parents leading to increase in their income but also increases the 
quality of health related choices made by the parents for themselves and for their children. 
The healthcare utilization of the child is determined by the parent’s health status, child’s 
predisposing factors (age, gender, ethnicity, race, education and parent’s genetic 
contribution), child’s need factors (presence of disease and any special health needs), and 
the child’s enabling factors (family income, regular source of care, access to health and 
prescription insurance, and access to transportation). Similarly, the parent’s health status 
is determined by their own health inputs which are a function of their predisposing, 
enabling and need factors.  
 
If we assume that the child is completely dependent on their parents for their 
health investment then the child’s production of health is primarily the function of the 
parent’s health status and the parent’s healthcare utilization, that is parent’s predisposing, 
enabling and need factors. Hence, if the parent has a low stock of health then it will have 
a negative impact on the amount of health inputs invested in the child and will hamper 
adequate production of health in the child. So the child will have a lower health status 
and hence have compromised health outcomes. Low health outcomes make the child 
medically compromised and hence utilizes medical services like medicines, 
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hospitalization or emergency room visits, in order to compensate for the compromised 
health stock. Good health results in better production of “good health” and hence lower 
use of prescription drugs, lower rate of hospitalization and emergency room visits. 
 
In this study the hypothesis states that since the parent is suffering from 
HIV/AIDS infection hence they have a compromised health status. This impact the health 
investments made in their child leading to low health stock in comparison to the children 
of seronegative parents. Low health stock makes the child sicker and requires greater 
medical attention. This leads to higher utilization of healthcare and medical services in 
comparison to the uninfected children of seronegative parents. 
 
 
1.5.3 Parent-Child Healthcare Behavior Model 
 
Based on the concepts of the Anderson Model and the Grossman Model this study 
aimed to develop a combined model that would include the health status of the parent as a 
crucial predictor of the child’s healthcare investments and health outcomes. A ‘Parent-
Child Healthcare Behavior Model’ was developed that included all the variables and 
predictors identified by Anderson’s Model and Grossman’s Model (Figure 1-2). 
 
 
1.6 Specific Aims and Hypotheses 
 
The study aims and the related hypotheses were as follows: 
 
• Aim 1: To determine whether HIV seronegative children living with HIV 
seropositive parent(s) have lower healthcare access in comparison to the HIV 
seronegative children living with HIV seronegative parent(s). 
 
? Hypothesis 1: Lower proportion of children living with HIV seropositive 
parents have a health insurance compared to children living with HIV 
seronegative parent(s). 
? Hypothesis 2: Lower proportion of children living with HIV seropositive 
parents have a regular source of care compared to children living with HIV 
seronegative parent(s). 
? Hypothesis 3: Lower proportion of children living with HIV seropositive 
parents have a prescription drug insurance compared to children living with 
HIV seronegative parent(s). 
? Hypothesis 4: Higher proportion of children living with HIV seropositive 
parents take more than 15 minutes to get to a healthcare provider compared to 
children living with HIV seronegative parent(s). 
? Hypothesis 5: Higher proportion of children living with HIV seropositive 
parents indicate having difficulty in getting to a healthcare provider compared 
to children living with HIV seronegative parent(s). 
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Figure 1-2: Parent-Child Healthcare Behavior Model 
Combining factors from *Andersen Healthcare Utilization Behavioral Model (Andersen 
RM. Revisiting the behavioral model and access to medical care: does it matter? J Health 
Soc Behav. 1995;36:1-10)30 and #Grossman Human Capital Model (Grossman M. The 
demand for health: a theoritical and emperical investigation. NBER Occasional Paper 
119, New York. 1972.)31 
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• Aim 2: To determine if HIV seronegative children living with HIV seropositive 
parents have higher healthcare utilization in comparison to the HIV seronegative 
children living with HIV seronegative parent(s). 
 
? Hypothesis 6: Children of HIV seropositive parents have higher likelihood for 
a doctor’s visits compared to children of HIV seronegative parent(s). 
? Hypothesis 7: Children of HIV seropositive parents have higher likelihood for 
a hospital visit compared to children of HIV seronegative parent(s). 
? Hypothesis 8: Children of HIV seropositive parents have higher likelihood for 
an emergency room visit compared to children of HIV seronegative parent(s). 
 
• Aim 3: To determine the healthcare outcomes of the HIV seronegative children 
living with HIV seropositive parents in comparison to HIV seronegative children 
living with HIV seronegative parent(s). 
 
? Hypothesis 9: Children of HIV seropositive parents have higher likelihood to 
have a school/daycare day missed due to ill health compared to children of 
HIV seronegative parent(s). 
? Hypothesis 10: Children of seropositive parents have a higher likelihood to be 
overweight compared to children of HIV seronegative parent(s). 
? Hypothesis 11: Children of seropositive parents have a higher likelihood of 
being currently on a prescription medication for any health condition 
compared to children of HIV seronegative parent(s). 
? Hypothesis 12: Children of seropositive parents have a higher likelihood to 
being currently on a prescription medication for mental health condition 
compared to children of HIV seronegative parent(s). 
 
 
1.7 Terms and Definitions 
 
? HIV — Human Immunodeficiency Virus (HIV) is a surveillance definition of a 
disease based on signs, symptoms, infections, and cancers associated with the 
deficiency of the immune system that stems from infection with HIV.46 It is a type 
of virus known as ‘retrovirus’ which infects the cells of the body’s immune 
system, mainly the CD4 positive T cells and the macrophages thereby impairing 
the cellular immune system of the body. 
? AIDS — Acquired Immunodeficiency Syndrome (AIDS) applies to the most 
advanced stages of HIV infection, defined by the occurrence of any of more than 
20 opportunistic infections or HIV-related cancers. In addition, the UNAIDS and 
CDC defines AIDS on the basis of a CD4 positive T cell count of less than 200 
per mm3 of blood.38,39 
? HIV Seropositive — Patients who are diagnosed as HIV positive using an official 
serology test. In a non-HIV-infected person the CD4 count ranges from 700 – 
1000 in a single drop of blood. A HIV-infected person is said to be normal if the 
CD4 count is above 500 and as it drops below 200 the person is classified as 
HIV/AIDS patient. 
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? HIV Seronegative — Patients who have a diagnosis of HIV negative or have no 
previous record for a medical diagnosis of HIV/AIDS. 
? Uninfected Children — Children who have a diagnosis of HIV negative or have 
no previous record for a medical diagnosis of HIV/AIDS, and are currently living 
with their parent(s). 
? Primary Group — Uninfected children of HIV seropositive parent(s) who are 
currently residing with their HIV-infected parent(s). 
? Comparative Group — Uninfected children of HIV seronegative parent(s) who 
are currently residing with their parent(s). 
 
 
1.8 Assumptions 
 
? Since the study included interviews of individuals, it was assumed that the study 
participants were truthful and as accurate as possible in responding to the study 
questionnaire. 
? It was assumed that the respondents had adequate and complete knowledge about 
their children to answer the questions pertaining to them. 
? The investigator was allowed to access the medical records and reports of the 
study participants by the physician after receiving proper authorization from the 
study participants. 
 
 
1.9 Limitations 
 
In this study, convenient sampling technique was used to identify the study 
population. This population may lack generalizability to represent the complete HIV / 
AIDS population in the United States; however this study aimed to generate pertinent 
information that will assist in addressing similar issues evident in the general population. 
The study results are also a stepping stone for future research. Much of the health status 
of the child was assessed by information gathered from the parent. This may not have 
reflected the exact health status of the child. However, the investigator expected to collect 
enough information to reach certain logical conclusions. HIV negative parents were 
defined as those who did not have a prior diagnosis of a HIV infection by a physician. 
Literature cites that almost 25% of the HIV-infected individuals are not aware of their 
HIV positive status.39 The absence of a confirmatory serological test to identify HIV 
negative parents may limit the study results. Since the data collected was based on self-
reported events, therefore the results may also be subjected to recall bias. 
 
 
1.10 Relevance 
 
The economic impact of HIV/AIDS has been recognized and studied in depth and 
it is no surprise that poverty seems to be the most significant variable impacting the 
spread of this disease. Lack of adequate knowledge coupled with limited education and 
health related information leads to improper decision making by the parents and exposes 
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their family members, especially children, to a plethora of health related ailments. This 
study would provide some insight as to the health status of the HIV-affected children and 
whether these children need immediate attention. 
 
 Understanding and identifying the healthcare needs of this at-risk population will 
assist in designing health policies both at the micro as well as at the macro level. This 
study will be a resource for policy makers, social workers, researchers, physicians, 
healthcare professional and to the society as a whole. The results of this study will aid the 
healthcare professionals in identifying and acknowledging the facts and design 
interventions needed. This study will also provide valuable information to social workers 
and public health workers dealing with the HIV-affected families at the micro level to 
identify the healthcare needs of the children in these families. 
 
Finally, this research adds to the body of literature and is a resource for future 
researchers and projects. This study generated numerous research questions and 
hypothesis that will promulgate better understanding of the impact of parent’s HIV status 
on their uninfected children. 
 
 
1.11 Organization of the Study 
 
The complete study has been organized into five chapters. Chapter 1 provides the 
introduction and the purpose of the study. Chapter 2 comprises a review of current 
literature and provides an overview of the body of research studies conducted on the 
prevalence, spread and the socio-economic impact of HIV/AIDS as a disease on the 
children of infected parents. In the chapter 3, a detailed description of the research design, 
study population, methodology, study variables, study instruments, data collection 
method and the analysis techniques are presented. This section also provides insight on 
the various economic theories and concepts relating to health and healthcare in terms of 
investment, access, utilization and outcomes. Chapter 4 highlights the study results and 
the analysis of the data. Chapter 5 includes the interpretations and conclusions deduced 
from the analysis of the data, provide health policy recommendations, and identify future 
research topics. 
 15
CHAPTER 2:  REVIEW OF LITERATURE 
 
 
The purpose of this study was to analyze the variation in the healthcare utilization 
and healthcare access of the uninfected children staying with their HIV seropositive 
parent(s) compared to those staying with their HIV seronegative parent(s). The study also 
proposed a model that will illustrate the impact of parent’s health HIV status on the 
healthcare utilization and health outcomes of their children. The review of the literature 
for this research study has been divided in to two major sections. The first section 
highlights various issues relating to parenthood among HIV/AIDS-infected individuals 
and the related studies. And the second section presents a synopsis of the studies 
investigating the impact of HIV/AIDS on the uninfected children/families of infected 
individuals. A critical review of literature on the impact of parent’s illness on the 
healthcare utilization of the child has also been discussed in the final section. 
 
As this study deals with the HIV disease it is pertinent to provide the readers with 
adequate information on the history, etiology and the prevalence of the virus in the 
human population. This information has been summarized in the Appendix A of the 
dissertation. 
 
 
2.1 Section I: Impact on HIV/AIDS-Infected Individuals 
 
 
2.1.1 Non-Disclosure of HIV Status among HIV-Infected Individuals 
 
A desire to have a child is a cultural norm and a socially accepted phenomenon in 
the United States irrespective of the HIV status of the individual.40,41 Despite clinical 
reasons that hinder parenthood, lack of desire for children is often viewed as a serious 
violation of this cultural norm.42 The HIV/AIDS virus has been a socially stigmatized 
disease and is the reason for delaying treatment and accessing medical care.43,44 
Disclosure of the HIV status to the sexual partner is also low, despite the fact that 
concealing the fact to the other partner before a sexual act is a criminal offense in almost 
31 states in the United States.45 A study by Ciccarone et al. reported significantly high 
rates of non-disclosure of the HIV status to the sexual partner among HIV-infected 
individuals.46 The study also reported that the non-disclosure rates were higher among 
gay or bisexual men (42%), followed by heterosexual men (19%) and women (17%). 
Across all the groups nearly 13% of the sexual encounters involved unprotected anal or 
vaginal sex.46 Non-disclosure and prevalence of unprotected sex among the infected 
population augment the possibility of the pregnancy among HIV-infected women. 
 
A meta-analysis of factors influencing disclosure of the HIV status among HIV-
infected males showed that 68% to 88% of the primary sex partner being aware of the 
HIV status of the infected male where as only 25%-58% of the partner other than the 
primary partner was aware of the HIV status. The likelihood of disclosure reduced 
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significantly with increase in the number of partners having sex with the infected 
individual.47  
 
Disclosure of the HIV status by infected parents to their children (5-17 years) has 
been estimated to be around 44% in a study done on a nationally representative sample. 
Parents with high income, high CD4 counts, greater social isolation and those with 
younger children were less likely to disclose their HIV positive status to their children 
than other infected individuals. Most parents cited unwanted emotional consequences 
(67%), fear that child may disclose to other people (36%), and lack of knowledge on how 
to disclose (28%) as prime reasons for their decision to not disclosure their HIV positive 
status to their children.48 
 
 
2.1.2 Pregnancy among HIV-Infected Mothers 
 
Trends in pregnancy among HIV mothers in the United States from 1990 to 1994 
was studied by Chu et al. (1996) and then later from 1992 through 2001 by Blair et al. 
(2004).49,50 Chu et al. reported that 14% of the infected women were pregnant whereas 
the study by Blair reported it to be 16%. The HAART guidelines and recommendations51 
were effectively used in clinical practice since 1996 and therefore the impact of the 
HAART treatment on the pregnancy rates among HIV-infected women was evidently 
visible. Similar results were observed among perinatally HIV-infected children. In 
comparison to the children born in between 1980-1995 the birth cohort of 1996-1997 
(Hazard ratio: 0.39, 95% CI: 0.15-0.96) and 1996-1997 (Hazard ratio: 0.65, 95% CI: 
0.45-0.95) had higher survival rates unadjusted for maternal antiretroviral treatment 
during pregnancy and clinical condition at time of delivery, gestational age, and birth 
weight.52 
 
Blair et al., 2004, based findings on the analysis of HIV-infected women aged 15- 
44 years participating in the Adult/Adolescent Spectrum of HIV Disease Project Study. 
On an average 5.5% of the HIV-infected women became pregnant each year. The study 
reported that women aged 15 to 24 years (RR: 9.2, 95% CI: 7.4-11.3) and between 25 to 
34 years (RR: 4.0, 95% CI: 3.3-4.9) had a higher likelihood to become pregnant 
compared to women aged 35 to 44 years. Women undergoing HAART treatment had 
higher rates of pregnancy (RR: 1.3, 95% CI: 1.0-1.6) than those who were on other 
regimens of ARVs. 
 
The risk of vertical transmission (mother to child) has reduced tremendously over 
the years. This has been the single most reason for the increase in the number of children 
born to HIV-infected individuals. With the advent of the HAART treatment has further 
augmented the likelihood of the HIV-infected parent to be pregnant. Studies suggest less 
than 2% of the children get infected if the mother had started the HIV treatment early in 
the pregnancy, 12-13% of the children get infected if the mother had not started the 
treatment until labor, delivery or after birth, and 25% of the children get infected if their 
mothers did not receive any preventive treatment.53 It has also been reported that HIV-
infected women who become pregnant even after the knowledge of their HIV status are 
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generally younger, less educated, have stayed longer with their HIV infection, had more 
previous history of pregnancies, miscarriages and abortion than those infected women 
who do not.54 
 
Researchers have associated the desire to have child as a significant predictor in 
the pregnancy decision making process in addition to the fear of transmitting the 
infection to their child, and personal health related concerns.55,56 Other external 
explanatory variables that influence pregnancy decisions among HIV-infected women 
found in the literature are husband and sex partner,54 attitudes of family members,4 
medical provider4 and significant others with HIV.4,54,57 
 
 
2.1.3 Child Bearing Desires among HIV-Infected Individuals 
 
Chen et al. (2001) interviewed 1,421 HIV-infected adults who were a part of the 
HIV Cost and Services Utilization Study to investigate the relationship between the 
socio-demographic and health factors that influence child bearing desired among the 
HIV-infected population in the United States.58 The study reported that almost 28% of the 
HIV-infected population, 28% among infected men and 29% among infected women, 
expressed their desire to have a child in future. The proportion of women desiring a child 
in the future was higher (69%) compared to those among men (59%). The study also 
found that HIV-infected women desiring a child were younger (27% were >30 yrs versus 
5%, p=0.0014), had fewer children (37% had no children versus 11%, p=0.0020), less 
likely to be married (19% married versus 29%, p<0.0001) and had scored higher on the 
overall health (80.5% versus 70.2%, p=0.0002) than their counterparts who declined to 
have a child in future. HIV-infected women who already have a child were less likely to 
expect children in future than the HIV-infected women who have no children. The desire 
to have child among black non-Hispanics (51%) HIV-infected individuals were higher 
than those expressed by white non-Hispanics (32%).  
 
 
2.2 Section II: Impact on HIV/AIDS-Affected Individuals 
 
 
2.2.1 Growing Population of Children Living in HIV-Infected Households 
 
It is estimated that around 62,800 HIV-infected families in the United States have 
children living with them. The number of these children less than 18 years of age in 2000 
was estimated to be 120,300 children.1 This number has been growing due to early HIV 
detection and increasing life expectancy of HIV-infected individuals. Rising proportion 
of women among the HIV-infected population, especially in the child bearing age, has 
also been attributed as one of the reason. Effective treatment decreases the transmission 
of the infection from mother to child resulting in decreased incidences of vertically 
transmitted HIV infection to a large extent.59,60 
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Schuster et al. (2000), studied the number, characteristic, and the living situation 
of children of HIV-infected adults.1 In this study the researchers used the HIV Cost and 
Health Utilization Study database. This database was created from a multistage national 
probability sampling that selected HIV-infected adults through random sampling who had 
at least one healthcare visit at a facility other than a military, prison, or emergency 
department facility within a 2-month population definition period in early 1996.61 The 
study was conducted in 1996 and 2864 HIV-infected adults were interviewed for 
information related to their socio-demographic information, current physical and mental 
health status, number of offspring, HIV status of their offspring and primary caregiver of 
the offspring. Out of the 2864 respondents interviews, 2803 (98%) had completed their 
survey. From these reports of 3138 offspring were collected and out these 1644 reports 
were of children younger than 18 years. Sample weights were used to represent the data 
to the entire HIV-infected population. This study found that 28% of the HIV-infected 
adults (62,800) have children, aged less than 18 years and 52% of these children currently 
live with their infected parent(s). Women have a higher likelihood of having a child (60% 
vs 18%, p<.001). Among the parent living with at least one of their children, 76% were 
women. Almost 26% of the HIV-infected women younger than 30 years reported to have 
conceived after being diagnosed for the infection. 21% of these infected parent reported 
to have been hospitalized in the past 6 months, 18% reported to have required home 
health care in the past 6 months, 45% had mental health needs, 10% showed probable 
signs of drug dependence and 10% reported to have received a drug or alcohol treatment 
in the past 6 months. Out of the total 3138 children considered in this study, 49% had a 
HIV test prior to the survey and among these 4% of the children were tested positive. 
Since 3% of the respondents were dropped due to incomplete responses hence the study 
findings may be underestimating the actual numbers. More than 25% of the HIV 
population is unaware of the disease and this can significantly add to the current estimate 
of the number of children affected by the disease.39 
 
 
2.2.2 Impact of Parent’s Illness on Children 
 
Parents, by nature, are responsible for governing and nurturing their children. 
Therefore, numerous factors related to the parents have an impact on the child’s health, 
healthcare access and healthcare resource utilization. Parents have always acted as the 
‘gatekeepers’ for their child’s healthcare access and utilization. Parent’s emotional 
functioning and perception about their child’s health, especially those of the mothers, are 
significant predictors of child’s healthcare utilization.62  Also parent’s health condition, 
health beliefs and health literacy have been positively associated with the child’s access 
and utilization of healthcare resources. 
 
Altman et al. used the 1987 National Medical Expenditure Survey (now called as 
Medical Expenditure Panel Survey) to investigate the healthcare utilization of family 
members of individuals with disability and found that the mean medical expenditure and 
the number of physician visits were higher for members having a disabled family 
member compared to members without a disabled family member.63 Upon adjusting for 
various demographic and socioeconomic variables showed that children living in a family 
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with a disabled members have a 7.5 percentage points greater probability of having a 
physician visit (p>0.1).  
 
Lipstein et al. (2009) used the National Health Interview Survey (NHIS) to study 
the impact of the parent’s health status on the health outcomes and healthcare utilization 
in children with asthma.64 The parent’s health status was measured by the presence or 
absence of at least one chronic illness (coronary heart disease or any other heart disease, 
emphysema, asthma, diabetes, kidney dysfunction, any kind of liver related disease, 
arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia, or if the parents reported some 
limitations of activity because of chronic illness). The study concluded that no significant 
differences (p=0.47) in the number of emergency visits or the outpatient visits between 
children of parents with and without chronic illness. However, significant differences 
were observed in the average number of school days missed in a year for children of 
parents with chronic illness versus children of parents without chronic illness (6.6 versus 
4.9, p=<0.01). Also 74.4% of the children of parents without chronic disease reported to 
have excellent/good health compared to 62.3% of the children of parent having a chronic 
disease (p=0.01). 
 
A 10 year follow-up study of children reported a significant association between 
the parental depression status and the risk for medical problems and hospitalization 
among children.65 Similarly, Weissman et al. (2006) followed the offspring of depressed 
and non-depressed parents for a period of 20 years to explore the magnitude of the risk it 
poised on their children’s health.66 Weissman et al. found a threefold increase in the 
incidents of anxiety disorders, major depression, and substance abuse among children of 
depressed parents compared to the children of non-depressed parents. The study also 
observed emergence of increased rates of medical problems and mortality in the offspring 
of depressed parents. These risks were higher in female child compared to male child. 
Flynn et al. (2004) studied the children (less than 7 years of age) visiting the pediatric 
emergency department and found that 31% of the mothers were screened positive for risk 
of depression and 78% among those were not currently receiving any form of treatment 
for depression.67 Higher emergency department visits (OR: 2.91; 95% CI: 1.01-8.40) 
were observed among children of mothers with depression, and that these children also 
were more likely to miss a doctor’s appointment (OR: 2.90; 95% CI: 1.18-8.70), 
compared to children with non-depressed mothers. 
 
Visser et al. (2005) focused their study on the emotional and behavioral functions 
of children living with parents having cancer.68 They measured the emotional and 
behavioral functioning of the children who had both or either of their parents diagnosed 
for cancer using the Child Behavior Checklist (CBCL) and the Youth Self Report (YSR) 
instruments.69,70 The study observed age and gender of the child as significant factor in 
determining the magnitude of the impact of parent’s illness on the child. Male children 
aged 4-11 years were found to have higher emotional problems (7.1% versus 4.8%, 
p≤0.05) compared to group of children of parents without cancer. Adolescent (12-18 
years) daughters were having higher proportions of emotional and behavioral problems 
compared to the adolescent sons among parents suffering from cancer (7.2% versus 5.4%, 
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p≤0.001). Higher proportions of behavioral problems were observed among daughter and 
sons when the parent suffering from cancer was the father (p≤0.01). 
 
A study by Olfson et al. (2003) reviewed in to the association of the presence of 
depression among parents and the child’s mental health problems and their healthcare 
utilization.71 They used the Medical Expenditure Panel Survey (MEPS) 1997 data and 
concluded that children of parents diagnosed with depression are twice as likely (95% CI: 
1.4-2.9) as the children of parents without depression to have a psychological problem, 
and 2.8 times (95% CI: 1.9-4.2) more likely to use mental health services. This study 
found no differences (39% versus 36.6%, p value=0.63) in the occurrence of 
psychological problems in children of parents receiving treatment for their depression 
and parents not receiving treatment, however the difference in the utilization of mental 
health services were significant (15.1% versus 4.0%, p=<0.0001) among children whose 
parents received treatment for depression. Olfon et al. (2003) also found that among the 
parental depression group, 77% of parent having depression were mothers of the children.  
 
Recent studies based on the National Maternal and Infant Health Survey 
(NMIHS) data showed that mothers suffering from depression exhibit lower use of injury 
prevention strategies such as proper handling of children, proper use of car seats, safe 
guarding electrical outlets in home, and safe keeping of poisonous or hazardous 
substance in home.72,73  Using nationally representative data from the National Institute 
of Child Health and Human Development (NICHD) Study of Early Child Care, Schwebel 
et al. (2008) examined the relationship between chronic maternal depression and child 
injury over a period of birth to 3 years and from 3 year to Grade I.74 The study reported 
that the children from birth to age 3 years of severely depressed mothers had an injury 
rate three times higher than the children whose mothers did not have depression. The 
adjusted univariate model identified severe maternal depression as a significant predictor 
of child injury (t=4.52; p<0.01; 95% CI: 0.61-1.54). 
 
 
2.2.3 Defensive Mothering among HIV-Infected Mothers 
 
Motherhood imbibes a feeling of pride, social recognition, source of love in a 
woman and ensured legacy for future.75,76 However this concept among HIV-infected 
mothers also include fear, isolation and abuse. Some researchers have identified 
mothering among HIV-infected women to be more of survival rather than source of self 
esteem and social identity.77-81 Ingram and Hutchinson (1999) studied the mothering 
experience of HIV-infected women.17 The investigators conducted focused interviews of 
18 HIV positive mothers aged between 18-44 years. The study took a qualitative 
approach and used the grounded theory to analyze the study findings. The researchers 
found a high degree of fear and uncertainty among the mothers in regards to the future of 
their children, in terms of health and social acceptability. Three fundamental themes were 
observed: preventing the spread of HIV and stigma, preparing the children for a 
motherless future, and protecting themselves through thought control. Mother felt the 
need to over protect their children and took more care of their children. No doubt, this 
sense of defensive mothering among HIV-infected mothers did help them to combat the 
 21
threats associated with the disease, however such an attitude may also lead to over 
utilization of healthcare resources. This particular phenomenon was also reported by 
Gulhati and Minty (1998). They studied the association between the parental illness and 
health attitudes, and the referrals of children to medical specialists. The study findings 
suggested that mothers with a medical and psychiatric history perceived the medical 
condition of their children to be more adverse, made higher referrals to specialists, and 
expressed less willingness to accept medical reassurances. Numerous studies have 
reported the relationship between factors and resilience among children in HIV- infected 
families. Dutra et al. (2000) found significant correlation between resilience in children 
and parent-child relationship, parental monitoring and parental structure. Resilience was 
found to increase coping skills and self efficacy among children living in HIV-infected 
families.82 
 
 
2.2.4 Impact of Parent’s HIV Status on Children 
 
Depleting health of the infected individual depletes the financial, social and 
emotional resources of the family and this has a detrimental short and long term impacts 
on the children living within the family. Poverty is one of the major factor that the HIV-
infected families go through.83 Deteriorating health of the earning member not only 
decreases individual’s earning capacity but also increases the cost of treatment. Social 
stigma attached to the disease weakens the social support system for the entire family. 
Death of the HIV-infected parent does not put an end to plight of the children. Early loss 
of a parent, sometimes both parents, exposes the child to loss of parental love, grief, 
hardship, insecurity and lack of value based upbringing.  
 
 
 2.2.4.1 Child’s Physical Health 
 
A study conducted by Starc et al. (1999), reported unexpected non-HIV-related 
deaths in children born to mothers with HIV infection.13 This study reviewed the 121 
deaths among the 805 children enrolled in the Pediatric Pulmonary and Cardiac 
Complications of Vertically Transmitted HIV Infection study. This study suggested that 
the infants born to HIV-infected mothers have a high risk for traumatic and accidental 
deaths (standardized mortality ratio: 7.35; 95% CI: 2.0-18.7). And that the risk is highest 
during the first few months of life. 
 
Ross et al. (1995) studied the impact of the maternal HIV infection and drug use 
during pregnancy on the growth of the infected child.19 The study focused on the weight 
and height of the child in their first 3 years. The study participants were identified from 
the healthcare setting in Edinburg, Scotland, between 1983 and 1992. Two hundred and 
fifty three uninfected children born to 43 HIV-infected mothers with a history of drug use 
were retrospectively followed for a period of 3 years from the birth of the child. For each 
child two controls were matched for parity, age (within 5 years), year of birth, smoking 
status of mother, hospital, delivery complications (twins or if any other) and ethnic  group. 
The height and weight of the child was taken from the child health surveillance records 
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measured during the predefined window periods 5-12 weeks, 7-18 months, and 2-4 years. 
The sex adjusted weights and heights were used to calculate the body mass index (BMI) 
using the standard formula (weight in kg/square of height in meters). The study 
concluded that there was no significant affects of the HIV status on the growth of the 
child upon 3 years. Though children of mothers who smoked has low birth weight at birth 
but this difference were negligible by 3 years. The major drawback of this study was in 
the sample selection as it only included children who made to their third year and could 
have excluded those children deceased before the 3 year time period. 
 
A similar study done among the European population compared the growth rates 
of uninfected children versus infected children born to HIV-infected mothers. The 
children were followed from the birth to 10 years of age.20 The study showed normal 
growth among the uninfected children but the infected children had a lower height and 
weight, especially after the 2nd and the 4th year, in comparison to the uninfected children. 
The general HIV population in Europe is less socio-economically disadvantaged than the 
HIV-infected population in the United States and also the healthcare system in Europe is 
different in terms of reimbursement structure, hence the studies done on European 
population may not represent the population in the United States. Also disparity in health 
outcomes is larger in the United States in comparison to the other developed European 
countries.84,85 
 
 
2.2.4.2 Child’s Mental Health 
 
The mental health needs of children living in HIV-infected families have been 
studied in depth. With increase in the survival expectancy the HIV-infected parent(s) are 
living longer with the disease. This longer association with the disease results in 
numerous psychological disorders among the infected parents. Recent studies have found 
alarming proportions of psychological symptoms among the infected population. Bing et 
al. (2001) conducted a study that estimated the national prevalence of psychiatric 
disorders (major depression, dysthymia, generalized anxiety disorders and panic attacks) 
and use of illicit drugs among the HIV-infected adults in the United States.86 The HIV 
Cost and Service Utilization Study (HCSUS) was used and a nationally representative 
sample comprising of 2864 HIV-infected adults receiving care was sampled. The study 
reported that nearly half (47.9%), weighted to represent national estimates, of the HIV-
infected adult population had screening of at least one of the predefined psychiatric 
disorder in the past 12 months. And, nearly 40% of them were screened positive for drug 
use within the past 12 months. The prevalence of major depression among the HIV-
infected adults was found to be 5 times (36.0% versus 7.6%) to the findings of the 
National Household Survey on Drug Abuse (NHSDA), which surveyed the presence of 
major depression, generalized anxiety disorder and panic attacks among the general 
population in 1994. The prevalence of generalized anxiety disorder among the HIV-
infected adults was found to be nearly 8 times higher (15.6% versus 2.1%) and the panic 
disorders were found to be 4 times higher (10.5% versus 2.5%) than the general adult 
population in the United States. The NGSDA survey interviewed 22,181 adults and used 
the screening technique similar to the one used by Bing et al. (2001). 
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A longitudinal follow up study of the psychological well-being of the children, 
aged 6-11 years, of mothers having HIV was done by Murphy et al. (2006).11 HIV-
infected mothers were recruited from 14 sites in Los Angeles County, between 1997 and 
1999. The investigators in this study followed the children for approximately 6 years and 
reported the relationship between the mental health of the children and the mother’s 
physical illness over time. Presence of depression, anxiety and aggression were the 
variable measured to ascertain the mental health status of the child while viral load, 
CD4+ T cell count and Short Form 36 (SF-36) score on physical functioning were taken 
as measures for mother’s physical illness. The study found a strong association between 
the children’s depression, anxiety and aggressiveness, and the lower levels of physical 
functioning of the mothers. However, this association weakened over time and this 
decline was higher in mothers who had a better health status at the base line (time of 
entry in to the study) in comparison to children whose mothers who entered the study 
with a poor health. This study highlighted the coping skills among children to adjust to 
the situation they live in. Stability of the disease progression and length of time a person 
is with the disease are crucial factors in determining the impact of the parent’s illness on 
the child’s health. 
 
A high proportion of HIV-infected population has been a past or a current victim 
of drug abuse. Bing et al. (2001) estimated that 40% of national HIV population in 
United States had been a drug user in the past 12 months.86 With such a high population 
of injection drug users (IDU) among this population it is very likely that a HIV positive 
parent having children may also be a IDU victim, and this can have more detrimental 
effects in the child’s physical and mental development. The current literature cites 
numerous studies that looked in to the impact of the HIV infection of parents on the 
mental health of the child among IDU population. One such study was conducted by 
Pilowsky et al. (2001).87 They recruited IDU individuals from 1997 to 1998 and 
categorized them as HIV seropositive or HIV seronegative based on their medical records. 
Parental health status was measured by two variables: presence of a medical condition 
(diabetes, cirrhosis, hepatitis, sepsis, pneumonia, pulmonary tuberculosis, cancer, and 
endocarditis), and reported difficulty in performing activities of daily living 
(housework/housecleaning, shopping for food, cooking/preparing food, doing laundry 
and using public transport). The child’s mental health status was measured using the 
Child Behavior Check List (CBCL) that provides a score on the child’s emotional and 
behavioral status.69 The CBCL also provides separate score for the internalizing as well 
as externalizing behavioral symptoms. Internalizing behaviors include symptoms such as 
anxiety and depression while externalizing behaviors include attention-deficit 
hyperactivity, aggressive conduct, defiant and disruptive behaviors, etc. Such behaviors 
can have serious long term consequences such as academic failure, severe psychiatric 
disorder, and criminal involvement.88 This study did not find any significant relationship 
between the HIV status of the IDU parent with the internalizing (OR: 1.10; 95% CI: 0.37-
3.27) and externalizing (OR: 1.17; 95% CI: 0.43-3.14) behaviors of the children. One of 
the reasons provided by the investigators for this finding was the possibility that the 
parents may not have disclosed their HIV status to their children. But the parent’s 
medical illness (OR: 4.67; 95% CI: 1.21-18.05) and presence of depression (OR: 4.58; 
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95% CI: 1.45-14.50) were found to be significantly associated with internalizing behavior 
symptoms only. 
 
In another study Pilowsky et al. (2003) repeated the study among the same 
population, which was the intravenous drug users and took the parental disclosure of their 
HIV status to their children in to consideration.89 The study found that children of HIV-
infected parent were almost 8 times as likely (OR: 7.80; 95% CI: 1.56-39.09) to have a 
disruptive behavior disorder compared to children of HIV negative parent among those 
parents who had disclosed their HIV status to their children. It also reported that parental 
depression was associated with more than 3 fold increase in the prevalence of disruptive 
behavior disorder among their children (OR: 3.49; 95% CI: 1.11-11.04). 
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CHAPTER 3: METHODOLOGY 
 
 
This chapter provides a detailed description of the concepts used to design, 
operationalize and analyze the study hypotheses. The chapter also explores the various 
other concepts and models present in the current literature that has been used to build the 
conceptual framework for this study. 
 
 
3.1 Designing of Conceptual Framework 
 
The conceptual model for this study is based upon two pivotal models found in 
the healthcare study literature - The Andersen’s healthcare utilization behavioral model30 
and Grossman’s human capital and demand for health model.31 
 
With the understanding of the concepts illustrated in Chapter 1 a proposed model 
for the child’s health outcomes was derived. The fundamental basis of the model was that 
the child’s health outcome is a function of the parent’s health investment in them and that 
the degree of health investment was a function of the parent’s health status. Further, the 
health investments are determined by the child’s predisposing factors, need factors 
(parent’s health status), and enabling factors. The health status of the parent was also a 
function of their predisposing factors, enabling factors, need factors and other health 
related inputs. Predisposing factors such as race and ethnicity of the child was considered 
to be same as that of the parent and represented the parent’s genetic contribution to an 
extent. The age and education level of the child were included as predisposing factors in 
to the model. The presence of a physical or a behavior related disease in the child formed 
the child’s need factors. 
 
Child’s enabling factors incorporated their regular source of care, access to health 
insurance, access to prescription and dental insurance and access to adequate means of 
transportation. Since children have limited or no source of income hence parent’s income 
replaced the child’s income variable. Age and level of education of the parent were 
included in the model as efficiency parameters. Since this model considers family as the 
unit of operation marital status of the parent and number of siblings in the family was 
also included in the model. For the purpose of this study a modified version of the Parent-
Child Healthcare Behavior Model discussed in Chapter 1 was used. 
 
This version was named as Modified Parent-Child Healthcare Behavior Model and 
has been illustrated in Figure 3-1. The child’s health outcome parameters considered for 
the purpose of this study were body mass index, physical and mental health status and 
performance of the child in the school which was measured as number of school/daycare 
days missed due to illness. 
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Figure 3-1: Modified Parent-Child Healthcare Behavior Model 
Adapted with permission from Andersen Healthcare Utilization Behavioral Model 
(Andersen RM. Revisiting the behavioral model and access to medical care: does it 
matter? J Health Soc Behav. 1995;36:1-10)30 and Grossman Human Capital Model 
(Grossman M. The demand for health: a theoritical and emperical investigation. NBER 
Occasional Paper 119, New York. 1972.)31 
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3.2 Research Design 
 
 
3.2.1 Study Design 
 
This study is a cross-sectional comparative analysis of the variables of interest 
between HIV seronegative children living with their HIV seropositive parent(s) and HIV 
seronegative parents.  
 
 
3.2.2 Study Population 
 
The population for this study was the uninfected children living with their HIV 
seropositive parents. However, in order to make a reasonable interpretation of the results 
a benchmark or a comparable population was eminent. In this study, the uninfected 
children living with HIV seronegative population in the US was taken as the comparative 
group. For the purpose of clarity all uninfected children of HIV seropositive parents will 
be referred as the ‘primary group’, where as uninfected children of HIV seronegative 
parents will be referred to as ‘comparative group.’ 
 
The information regarding the uninfected children of HIV-infected parents was 
collected through a primary data collection conducted at the study settings. Due to limited 
resources available for the study the information on the uninfected children of HIV 
uninfected parents were taken from the 2006 Medical Expenditure Panel Survey (MEPS) 
database. MEPS is a nationally represented healthcare utilization survey of the non-
institutionalized US population. The Agency of Healthcare Research and Quality 
(AHRQ), an agency within US Department of Health and Human Services (HHS), has 
been conducting this survey since 1996. MEPS database consists of annual estimates of 
the national health expenditures, healthcare utilization and access, and health insurance 
information for non-institutionalized US population.90  
 
 
3.2.2.1 Inclusion Criteria 
 
 HIV seronegative children aged between 2 yrs and 15 yrs of HIV seropositive as 
well as HIV seronegative parent(s) were included in this study. A parent was identified as 
HIV seropositive if they had a prior diagnosis of HIV/AIDS (ICD-9-CM 042, 043, V08) 
by a physician and has at least one record of a HIV positive serological test result in the 
past 6 months in their medical records. A parent was defined HIV seronegative if there 
were no diagnosis of HIV/AIDS (ICD-9-CM 042, 043, V08) in their medical records at 
the point of entry into the study. Only those parents who provided their informed consent 
to voluntarily participate in the study were included. Since the comparative group 
(children of HIV seronegative parents) was identified from the MEPS data the inclusion 
criteria to obtain an informed consent was not applicable. 
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3.2.2.2 Exclusion Criteria 
 
Children born before the detection of the HIV status of the parent were excluded 
from the study. Parents who refused or for any reason did not want to continue with the 
interview process were excluded from the study. All respondents of incomplete 
questionnaires were excluded from the study. Children of HIV seropositive parents 
currently not residing with their infected parent were excluded from the study. Also if the 
respondent was already interviewed in any of the other sites designated as study settings 
in this study were excluded to avoid duplication. 
 
 
3.2.3 Study Setting 
 
For this study three locations were identified as study sites to recruit potential 
participants. And these were - The Adult Special Care clinic, Friends for Life and Hope 
House Daycare. 
 
 
3.2.3.1 The Adult Special Care Clinic 
 
The Regional Medical Center, Memphis, has a dedicated outpatient clinic for 
HIV/AIDS-infected patients. This clinic is called the ‘Adult Special Care Clinic’ and it 
provides treatment to almost 2000 patients a year. The site being a government-run health 
center is a point of care for majority of the HIV-infected population in Memphis. 
 
 
3.2.3.2 Friends for Life 
 
Friends for life specifically provide psychological counseling, basic needs, and 
critical services to HIV-infected individuals, and also coordinate outreach programs in 
order to improve the mortality and morbidity associated with the infected. They organize 
free food distribution activities on selected days of the week, conduct health related 
seminars and regular self-motivational activities, and even conduct free HIV screening 
tests. They have more than 500 patients enrolled as members who regularly attend the 
activities organized by the organization. (www.friendsforlifecorp.org) 
 
 
3.2.3.3 Hope House Daycare 
 
Hope House is the only agency in the state of Tennessee that provides a day care 
for children and social service to families affected by HIV. Though HIV-infected 
children were not the study population for this research parents of these children were 
potential respondents. (www.hopedaycare.org) 
 
The investigator had a few initial meetings with the management of these 
organizations and discussed the feasibility of approaching the study population and the 
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approval procedure required by the respective organizations to access this group. For all 
these organizations the approval from the institutional review board (IRB) was the main 
document required along with a copy of the research proposal explaining the purpose, 
methodology and study instruments to be used.  
 
 
3.2.4 Study Sample  
 
Sample size estimation using statistical methods require the standard deviation, 
type I and type II error estimates, and the effect size of the study population. The level of 
significance (type 1 error) for this study was at 0.05 level and a power of 0.80 (type II 
error) were defined in order to test the hypothesis. The standard deviation and the effect 
size was calculated from a small pilot study that was conducted by the investigator using 
the MEPS 2001-2006 database on the difference in the healthcare utilization among 
uninfected children of HIV seropositive and seronegative parents.91 The required sample 
size for a one-tail hypothesis was then calculated using the following formulae: 
 
  N > 2{(z2α + z2β)σ / δ1  }2 
     
where,  N = sample size 
 z2α = 1.64 
 z2β = 0.842 
 σ = standard deviation 
 δ1 = effect size (absolute difference between means) 
 
The main variables of interest in the study were number of physician visits, 
hospital visits, emergency room visits and number of days missed school/daycare due to 
illness. Following minimum sample size requirement for the various variables were 
estimated (Table 3-1). 
 
Among the various sample size estimates the largest sample size was found to be 
≈70 in a group, hence this number was taken as the minimum sample size of participants 
in each of the groups in order to have the required statistical power for the tests. 
 
 
Table 3-1: Estimating the sample size for the study 
 
Variable SD (σ) Mean 1 Mean 2 Effect size (δ1) N pairs
      
ER visits 0.420 0.22 0.083 0.137 57.90 
Physician visits 5.700 3.440 1.2 2.24 39.89 
Inpatient visits 0.460 0.07 0.24 0.17 45.10 
Zero nights hospital stays 3.290 2.29 3.5 1.21 45.54 
Number of days missed school 0.010 0.003 0 0.003 68.45 
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3.2.5 Operationalization of Determinants  
 
 
3.2.5.1 Child’s Predisposing Factors 
 
The predisposing factors of the children include their age, gender, race and 
ethnicity.32 Since most of the health related decisions are taken the parent on behalf of 
their children hence education level of the child was not considered as an efficiency 
parameter.32 By including the factors such as race and ethnicity the effects of parent’s 
genetic contribution was captured to a large extent. Other effects of the parent’s genetic 
constitution have not been considered for the sake of the operationalization and hence 
were beyond the scope of the study. 
 
? Age: Age was computed from the date of birth information of the child. Number 
of years completed as of January 1st, 2009, was taken as the age of the child. 
? Gender: The variable was categorized into male and female. 
? G40 
? Race: The race of the study respondents were categorized into White, Black, 
Asian, Native Hawaiian/Pacific Islander, American Indian/Alaska Native, and 
Others. Post data collection analysis showed that the study population consisted of 
only whites and blacks. 
? Ethnicity: This variable was categorized as Hispanic and Non-Hispanic. Post data 
collection showed 98% of the study participants to be Hispanics. Therefore, due 
to lack of variability of this factor in the study population, the ethnicity variable 
was dropped from the model. 
 
 
3.2.5.2 Child’s Need Factors 
 
The child’s health status was determined from the parent reported child’s 
perceived health status. Each parent was asked the question “My child seems less healthy 
than other that I know?” The parents had to select one of the five options: 1) Definitely 
true 2) Mostly true 3) I don’t know 4) Mostly false and 5) Definitely false. Options 1 and 
2 were considered as worst/bad health and options 4 and 5 were taken as good/excellent 
health.92,93 
 
 
3.2.5.3 Child’s Enabling Factors 
 
Access to healthcare resources enables the child to avail and utilize inputs which 
are crucial in the production of ‘good health’. Variables considered as enabling factors in 
this study included access to health insurance, access to prescription and dental insurance, 
having a regular source of care and access to transportation. Income is a key variable, 
however most children have no defined annual income. Since the parents have the 
responsibility to cater to the financial requirements of the child, income of the parents 
was considered in place of income of the child. 
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? Access to health insurance: In the current healthcare system in the United States 
the health insurance status of an individual is a prime factor that governs access to 
the healthcare resources. A child was categorized as ‘insured’ if the child had 
health insurance, else marked as ‘uninsured’. Insured children were further 
categorized as ‘public’ and ‘private’ based on the source of funding for the 
insurance program they were enrolled in. For statistical reasons, i.e. low cell 
counts, categories ‘public’ and ‘private’ were combined together. Therefore in the 
regression analysis the groups were dichotomized as ‘insured’ and ‘uninsured’. 
? Regular source of care: The parents were asked whether there was a particular 
doctor’s office, clinic, health center, or other place that their child usually goes if 
he/she was sick or if the parent required any advice regarding their child’s health. 
If the child had a particular provider/clinic/health center then the regular source of 
care was marked as ‘present’, else marked ‘absent’.  
? Access to healthcare provider: Parents were asked to rate their child’s access to 
get to their healthcare provider from the following options: very difficult, 
somewhat difficult, not too difficult and not at all difficult. For the purpose of 
analysis and interpretation categories ‘very difficult’ and ‘somewhat difficult’ 
were combined in to a single variable as ‘very/somewhat difficult’. 
? Access to transportation: This was measured using two variables: 
? Mode of transportation: Parents were asked about the mode of transportation 
generally required to get to their healthcare provider. This variable was 
categorized as drives, is driven, uses a taxi, public transport, or has to walk. 
? Transportation time: The parents were asked to approximately estimate the 
time taken by the child, taking in to consideration the mode of transportation 
used, to get to the healthcare provider. The time span was categorized as less 
than 15 minutes, 15-30 minutes, 31-60 minutes, 61-90 minutes, 91-120 
minutes, and more than 120 minutes (2 hours). For statistical reasons, i.e. zero 
cell counts, last four categories were combined to for a common category of 
‘More than 30 minutes’. 
 
 
3.2.5.4 Parental Factors 
 
Parent’s age, gender, level of education, marital status, family size, and parent’s 
perception of their child’s health were included as the parental factors in this study.  
 
? Age: Age was computed from the date of birth of the parent. Number of years 
completed as of January 1st, 2009, was taken as the age of the parent. 
? Gender: The variable was categorized into male and female. 
? Level of education: This variable was calculated in two ways. One was the 
number of years of education completed by the parent. And second variable was 
based on the highest degree attained by the parent and this was categorized as no 
degree, GED, high school diploma, bachelor’s degree, master’s degree, or any 
other. In the analysis number of years of education was taken as the variable for 
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age of the parent and it was dichotomized as ‘less than 12 years’ and ’12 years or 
more’. 
? Marital status: The parent was asked to select one of options that best described 
their marital status – single, married or divorced. Widowed and divorced parent 
were categorized as ‘single’ for the purpose of analysis in this study.  
? Income: The cumulative income of the family provided by the parent was taken as 
the measure of the family income in this study. For analysis purpose, it was 
categorized in to ‘less than $10,000’ per year, ‘$10,000 - $20,000’ per year and 
‘above $20,000’ per year. 
? Access to health insurance: Parents were categorized as ‘insured’ if they had any 
health insurance, else marked as ‘uninsured’. Insured parents were further 
categorized as ‘public’ and ‘private’ based on the source of funding for the 
insurance program they were enrolled in. For statistical reasons, i.e. low cell 
counts, categories ‘public’ and ‘private’ were combined together. Therefore in the 
analysis the groups were dichotomized as ‘insured’ and ‘uninsured’. 
? Access to prescription drug insurance: If the health insurance had a prescription 
coverage as a part of the insurance policy then the parent was marked ‘yes’, else 
marked as ‘no’. 
? Family size is represented by the number of dependents in the family. Number of 
dependents was defined as number of children less than 18yrs living in household 
plus the spouse (if any). 
? Perception of child’s health: MEPS documents the use of 5 questions from the 
General Health Subscale of the Child Health Questionnaire (CHQ) that captures 
the parent’s perception of their child’s health.94 Parents were asked to rate the 
questions on a 5 point scale ranging from “Definitely True” (1), “Mostly True” 
(2), ”I don’t know” (3), “Mostly False” (4) to “Definitely False” (5).  
 
 
3.2.5.5 Health Status of the Parent 
 
Health status of the parent is the key determinant of the healthcare investments 
and health outcomes of a child. The health status of parent in this study is defined in 
terms of their HIV/AIDS status (positive or negative). In case of HIV seropositive parents, 
severity of HIV infection was identified as an important variable that would dictate the 
physical functionality of the parent. 
 
One of the pivotal markers for the severity of HIV infection is the CD4 count of 
the person. Human immune system has numerous types of cells that fight diseases. CD4 
lymphocyte T cells are one such disease fighting cells in the body. HIV virus attacks 
these cells and thereby affects the body’s immune system, thus making the infected 
person prone to other disease attacks and illnesses. In a non-HIV-infected person the CD4 
count ranges from 700 – 1000 in a single drop of blood. A HIV-infected person is said to 
be normal if the CD4 count is above 500 and as it drops below 200 the person is 
classified as HIV/AIDS patient. The transition from HIV to AIDS may take few months 
to several years depending upon the person’s previous health and immune system. Hence 
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CD4 count and the number of years since HIV-infected is a good measure of the HIV 
patient’s severity of disease and also their health status. 
 
 
3.2.5.6 Healthcare Utilization 
 
? Number of times the child has made a visit to a doctor for any medical reason in 
the past 12 months. A dichotomous variable was created if the child had a doctor 
visit in the past 12 months for any medical reason. 
? Number of times the child has made a visit to a hospital for any medical reason in 
the past 12 months. A dichotomous variable was created if the child had a hospital 
visit in the past 12 months for any medical reason. 
? Number of times the child has made a visit to an emergency room for any medical 
reason in the past 12 months. A dichotomous variable was created if the child had 
an emergency room visit in the past 12 months for any medical reason. 
 
 
3.2.5.7 Health Outcomes 
 
Number of days of school/daycare missed due to sickness and the Body Mass 
Index (BMI) of the child were taken as the measure of the child’s health outcomes. 
 
? Number of school/daycare days missed due to illness was taken as one of the 
measures for the health outcomes of the child. The justification is that children 
with lower health status will have higher number of school days or daycare days 
missed because of sickness compared to healthier children. The variable was 
dichotomized as ‘have missed’ and ‘have not missed’ a school/daycare day due to 
illness in the past 12 months. 
? Body Mass Index: BMI has been a measure of child’s growth for various clinical 
purposes. The BMI standards based on height/weight and age developed by the 
World Health Organization (WHO) depicts the child’s normal growth among 
children irrespective of ethnicity, socio-economics status as type of feeding.95 The 
BMI is calculated by dividing weight in pounds (lbs) by height in inches (in) 
squared and multiplying by a conversion factor of 703.96 
 
BMI = weight (lb) / [height (in)]2 x 703 
 
 Interpreting BMI among children has been debated and lacks consensus.97 
However, researchers have used various methods to interpret the BMI figures in 
the pediatric population.98 The International Obesity Task Force suggests the 
percentile system in which the children over the 80th percentile are overweight, as 
this corresponds to a body mass index of 25 in men as well as in women at the age 
of 18 yrs.99,100 The Center for Disease Control and Prevention (CDC) 
recommends above 85th percentile as a cut-off point for a child to be categorized 
as ‘overweight’.101 In this study, children with BMI above the 85th percentile were 
grouped as ‘overweight’, those below the 5th percentile were grouped as 
 34
‘underweight’ and those children with BMI falling in between the 5th and the 85th 
percentile were grouped as ‘normal’. For the purpose of analysis, the variable was 
dichotomized in to ‘normal weight’ and ‘not normal (under/over) weight’. 
 
After BMI is calculated for children and teens, the BMI number was 
plotted on the CDC BMI-for-age growth charts (for either girls or boys) to obtain 
a percentile ranking. Percentiles are the most commonly used indicator to assess 
the size and growth patterns of individual children in the United States. The 
percentile indicates the relative position of the child's BMI number among 
children of the same sex and age. The growth charts show the weight status 
categories used with children and teens (underweight, healthy weight, overweight, 
and obese). The BMI charts for boys (2-20yrs) please refer to Appendix B.1 and 
for the BMI charts for girls (2-20yrs) please refer to Appendix B.2. 
? Prescription drug status: This includes the child’s physical or behavioral 
conditions. Presence of a medical or a mental health need was determined from 
the medications the child has been currently prescribed. Parents were asked, 
whether the child was on any kind of prescription medications currently, apart 
from vitamins, and if yes, then whether the medication was for a medical/physical, 
behavioral or any other reason. Literature provides enough evidences which 
speaks about significant correlation between perceived health status and the 
occurrence of chronic illnesses and physician’s ratings of health status in cross-
sectional observational studies.92,93,102,103 
 
 
3.2.6 Study Instrument  
 
Information was collected from parents using structured questionnaires with 
proven validity and reliability scores. For measuring the access, utilization and health 
outcomes standardized questionnaires are available in the current literature. The 
questionnaires used in this study were taken from the standardized questionnaires used by 
Agency for Healthcare Research and Quality (AHRQ) for collecting Medical Expenditure 
Panel Survey (MEPS) data. MEPS is a nationally represented sample population on US 
healthcare utilization and medical expenses, and are reliable as well as validated.104 Two 
different questionnaires were developed in order to get the information on both parents as 
well as the children.  
 
 
3.2.6.1 Questionnaire for Parental Factors 
 
The first questionnaire collected the socio-demographic, health insurance related 
and health related information of the HIV-infected parent (Appendix B.3). 
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3.2.6.2 Questionnaire for Child Factors 
 
The second questionnaire was designed to collect data on the variables of interest 
(health investments, access, healthcare utilization, and health outcomes) of the children 
(Appendix B.4). All the information regarding the child was obtained from the parent 
(parent reported information). 
 
 
3.2.7 Study Data Collection Plan 
 
Though the study aimed to find the health and healthcare related information of 
children, all the information required to test the hypothesis was taken from the HIV 
seropositive parent (parent reported information). Such a design protected the privacy of 
the patient population who may not appreciate any attempt from the investigator to 
directly question their children. Also studies suggest that less than half of the parents 
actually inform their children about their HIV status.48 Hence, it was necessary to avoid 
any direct interaction with the HIV-affected children. Such an attempt may hinder free 
participation of the patient population in the study and may negatively impact the sample 
size. MEPS also followed similar data collection procedure for their Child Health and 
Preventive Care section. Questions were asked about each child (under the age of 18 
excluding deceased children) to the applicable respondent.  
 
In the study a convenient sampling technique was used to collect information of 
uninfected children living with HIV seropositive parent. In the primary data collection 
the initial recruitment of the participants were done by the case managers (in Adult 
Special Care Clinic) or by the social workers (in Friends for Life and in Hope House 
Daycare). The HIV seropositive parents had their walk-in as well as scheduled visits to 
the Adult Special Care Clinic and at the Friends for Life study sites. During their visit the 
case managers/social workers approached each visitor to identify parents who have 
children (aged 2-15 yrs) and were currently living with them. Once identified, they were 
then directed to the principal investigator for a detailed explanation of the study objective 
and agreed participants were interviewed upon informed consent. At the Hope House 
Daycare, recruiting was done at the front office when each parent came in to pick their 
children back home. As the Friends for Life and Hope House had a social orientation 
hence the investigator was advised by the social workers to wear a casual dress. However, 
the Adult Special Care Clinic has a profession/clinical orientation; hence the investigator 
was advised by the case managers to wear a formal dress along with a white coat that 
displayed the name (Arijit Ganguli) and designation (Graduate PhD Student). 
 
All HIV/AIDS seropositive patients having a child (2-15yrs) living with them 
were approached as per the pre-designed script (Appendix C.3). The study objectives 
and the procedure were explained to each and every participant before asking them the 
study questions. The answering of the questions by a parent was considered as their 
permission (informed consent) to use their responses to the survey questions in the study. 
During the survey the study participants were asked to provide information related to 
their child’s healthcare utilization, access to healthcare services and their health 
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outcomes. The study participants (HIV seropositive parent) were asked questions (refer 
to Questionnaire Parent) regarding their demographic information (age, gender, race, 
and ethnicity), socio-economic status (level of education and family income), and 
certain basic questions on their current health status (length of HIV seropositive status 
and CD4 counts, as a measure of their severity of disease). Then each participant was 
asked questions regarding the healthcare access, insurance status, healthcare utilization, 
and health outcomes of their child/children (refer to Questionnaire Child). In case of 
more than one child, parents were required to fill separate questionnaires for each child. 
 
No monetary or non-monetary benefits of any kind were provided to the study 
participants to enroll in the study. To maintain anonymity all the study participants, data 
was encrypted and each participant was given a ‘participant identification number’ as a 
form of identity. No information regarding the name, address or any other form of contact 
information of the study respondents or their children was collected. Since this was a 
cross sectional study hence such a study plan ensured that no reported information could 
be traced back to the actual respondent for any follow up information.  
 
The information of the comparative group (uninfected children of HIV 
seronegative parent) was taken from the Medical Expenditure Panel Survey (MEPS) 
2006 database, a nationally representative survey conducted by AHRQ. 
 
 
3.2.8 Required Approvals and Documentations 
 
All necessary documentation was done to obtain complete authorization from the 
University of Tennessee Institutional Review Board (UT-IRB), and the management of 
Adult Specialty Clinic, Friends for life and Hope House to conduct the study (Appendix 
C). This study was exempted from continuing oversight from the UT- IRB because the 
data collected from the survey cannot be linked back to any particular study subjects. No 
information identifying the study participants (HIB seropositive parents) name, address 
or contact details will be taken. This study was a cross sectional study and no follow up 
of the study participants was required. And it would be impossible to contact the subjects 
selected from the MEPS database in order to get their informed consent. Additionally, a 
waiver of the requirement of assigned consent form was obtained and the willingness of 
the respondent to answer the survey questions was taken as the informed consent of the 
respondent. 
 
Since the study deals with socially marginalized population all the data collected 
were encrypted and stored in a password protected computer. No data was sent or 
received through emails. All completed questionnaires were kept in a lock and key 
cabinet. Only the principal investigator had the authorization to access these data. 
 
 
3.2.9 Study Analysis 
 
As the data on both the groups (study and comparative group) was taken from two 
different sources, the possibility of the observed as well as unobserved variables being 
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similar was questionable. Hence, to minimize the bias during interpretation both the 
groups were matched based on their propensity scores or likelihood to be in a particular 
group. 
 
 
3.2.9.1 Propensity Score Based Matching 
 
This research is an observational study comparing various variables of interest 
between two groups. One of the major limitations of an observational study design is the 
lack of randomization in the assigning of individuals to either the group of interest 
(treatment) or the comparative group (control). Randomization ensures that each 
individual in a study has equal probability of being in a particular group (treatment versus 
control) therefore reduces the differences in the measured an unmeasured variables. Such 
a design guarantees that only one difference exists in assigned group status, and this 
difference is the likely cause for any observed difference in the outcomes.105 In the 
absence of randomization, the differences in the observed and unobserved covariates 
between the groups induce bias in the estimation of the variables. As a solution to 
minimize the confounding effects of these covariates propensity score matching 
technique is advised.106 Some other techniques available in the literature and used 
frequently in observational studies are stratification and regression adjustments based on 
various covariates. 
 
Propensity score is defined as the “conditional probability” of an individual being 
in a particular group (treatment / control). Rosenbaum and Rubin proposed the matching 
based on propensity scores in observation studies reduces this bias.107 The logical 
justification behind this concept is that individuals with equal propensity scores have 
equal probability of being assigned to either the treatment or the control group, very 
similar to a randomized study design. In this technique every individual in the treatment 
group is matched with an individual in the control group based in their propensity scores. 
Propensity score techniques use a logistic regression method to predict the probability of 
being assigned to a group (treatment versus control) based on a set of predictors such as 
pretreatment demographic, socioeconomic and clinical characteristics. The matching of 
the propensity scores, as outlined by Rosenbaum and Rubin, can be done in three ways: 
(1) nearest available matching on the estimated propensity scores; (2) Mahalanobis 
metric matching including the propensity scores; and (3) nearest available Mahalanobis 
metric matching within calipers defined by the propensity scores.108 All the three 
techniques have been used extensively in the statistical as well as medical literatures. 
However, the third technique produces the best balance for the covariates between the 
two groups.106 This study uses the third technique to match the individuals hence will 
only be discussed. Mahalanobis Distance109 (MD) is an estimate of the distance between 
two dimensional points measured by the statistical variations in each component of the 
point.110 The Mahalanobis distance is calculated using the following expression, 
 
D(X,Y) = (X-Y)t C-1(X-Y) 
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where, X and Y are two points obtained from similar distribution with covariance matrix 
C and D(X,Y) denoting the Mahalanobis distance between points X and Y.111 
 
 
3.2.9.2 Method for Matching 
 
Based on the demographic factors (age, gender, race and ethnicity), 
socioeconomic factors (family income, parent’s level of education, parent’s marital status, 
number of dependents and the geographical region) and parent’s insurance status, a 
propensity score and the Mahalanobis distance of all study participants were calculated. 
Then the children who were living with their HIV seropositive parent(s) were randomly 
ordered, and the first child was selected. Based on the propensity of this child (living with 
HIV seropositive parent), all children from the comparative group (children living with 
HIV seronegative parents) with a propensity score with in a caliper of ±0.001 were 
selected and grouped as potential matched individuals. Then based on the Mahalanobis 
distances, calculated previously, two children were selected from the potential matched 
individuals using a caliper of a quarter (0.25) of a standard deviation of the logit of the 
propensity score.105 Similarly, each child in the first group (uninfected children of HIV 
seropositive parents) was matched with two children from the comparative group. 
 
In the absence of specific ZIP codes of the respondents matching was done base 
on geographical region as defined in MEPS. In MEPS, respondents are categorized in to 
four major geographical zones – Northeast, Midwest, South and West.104 Since the 
primary collection was done in Memphis, Tennessee, the comparative group meeting the 
inclusion criteria consisted of respondents from the ‘south’ region only. 
 
The values and states for each region in the MEPS 2006 database include the 
following:  
 
? Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, 
New York, Pennsylvania, Rhode Island, and Vermont. 
? Midwest: Indiana, Illinois, Iowa, Kansas, Michigan, Minnesota, Missouri, 
Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. 
? South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, 
Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South 
Carolina, Tennessee, Texas, Virginia, and West Virginia 
? West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, 
New Mexico, Oregon, Utah, Washington, and Wyoming. 
 
 
3.2.9.3 Analysis for Differences Post-Matching 
 
A chi squared test was conducted to analyze to ascertain that no differences 
existed between the two groups post-matching in terms of the various demographic, 
socioeconomic and health status variables. The only difference was the HIV health status 
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of the parent and hence any differences observed during the hypothesis testing can be 
attributed to the parent’s HIV status. 
 
 
3.2.9.4 Descriptive Statistics 
 
Frequency distribution of the sample population was done to describe the 
distribution in terms of the demographic, socioeconomic and health factors for the child 
as well as the parent. All the results of the frequency distributions were reported as 
numbers and percentages in a tabular form. 
 
 
3.2.9.5 Inferential Statistics 
 
For the inferential statistics bivariate and multivariate models were used to test the 
study hypothesis. Depending upon the hypothesis, two different multivariate models were 
used in alignment went the Parent-Child Healthcare Behavior model (refer to Figure 3-1) 
 
 
3.2.9.5.1 Model I 
 
In this model the dependent variable was the healthcare utilization variables such 
as doctor visits, hospital visits and the emergency room visits. According to the Parent-
Child Healthcare Behavior Model, the healthcare utilization of an individual is a function 
of the child’s predisposing, need and enabling factors, and the parent’s health status, and 
their predisposing and enabling factors. 
 
Y(Utilization) =  f(parent HIV status, child’s predisposing, need & enabling factors, 
parent’s predisposing and enabling factors) 
 
 
3.2.9.5.2 Model II 
 
In Model II, the dependent variable was the health outcome variables. In 
accordance with the conceptual framework of this study the health outcomes of the child 
was the function of the child’s predisposing, need and enabling factors, efficiency 
parameters, healthcare utilization variables of the child and the health status of the parent. 
The conceptual framework showed that the health of the parent impacts health outcomes 
in two different ways. According to Grossman’s Human Capital Model, every child is 
born with an initial stock of health and this initial stock is highly driven by the health 
stock of the parent. Therefore, parent’s health influences the child’s health and hence the 
health outcomes directly. Subsequently, parents also make healthcare decisions on behalf 
of the child and decide the quality and quantity of the healthcare resources used by the 
child. Thereby controlling the use of healthcare resources the parent indirectly influence 
the child’s health outcomes, as both Andersen as well as Grossman model signifies the 
importance of use of healthcare resources as predictors/inputs of health outcomes. In 
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order to incorporate the healthcare utilization variable as a function of the parent and 
child’s predisposing, need and enabling factors, the predicted value of the utilization 
variables were used in place of the observed values in this model. The predicted values 
were calculated using the Model I. 
Y(Health Outcomes) = f(parent HIV status, child’s predisposing, need & enabling factors, 
efficiency parameters, predicted value of utilization) 
 
 
3.2.9.5.3 Hypothesis Testing Using Bivariate Analysis 
 
For categorical variables a chi-square (χ2) analysis was preformed and for 
continuous variables the difference between the means among the groups were performed 
using the student ‘t’ test statistical method. For all statistical inferences the level of 
significance was at 0.05. The null hypothesis for these tests was:  
 
H0: No differences exist between the groups 
HA: Differences exist between the groups 
 
 
3.2.9.5.4 Hypothesis Testing Using Multivariate Logistic Regression Model 
 
A logistic regression was performed on binary dependent variables with the HIV 
status of the parent (HIV seropositive versus HIV seronegative parent) as the independent 
variable adjusting for factors in accordance with Model I or II. 
 
Y(Utilization) =  b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 ‘race’ 
+ b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 ‘parent’s 
gender’ + b9 parent’s marital’ + b10 ‘parent’s education’ + b11 ‘parent’s 
insurance’ + b12 ‘dependents’ + b13 ‘child’s health’ + b14‘access’ + b15 
‘source’ + ε  
 
Y(Outcomes) =  b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 ‘race’ 
+ b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 ‘parent’s 
education’ +  b9 ‘child’s health’ + b10 ‘access’ + b11 ‘source’ + b12 
‘predicted doctor visit +  b13 ‘predicted hospital visits +  b14 ‘predicted 
ER visits’ + ε 
 
 
3.2.9.5.5 Hypothesis Testing Using Multivariate Negative Binomial Regression 
Model 
 
In order to quantify the differences in the utilization of healthcare resources by the 
children living with seropositive and seronegative parent(s), a negative binomial 
regression model was used. Negative binomial is a general distribution often used as an 
alternative to the Poisson distribution. This approach ensures inclusion of a random 
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component that takes in to consideration the uncertainty about the actual rates at which 
events occurs for individual cases.112 Negative binomial accommodates the phenomenon 
of over dispersion which is generally found to count data when assumption of equality of 
mean and the variance is violated.113,114 The Poisson model also assumes that all 
differences among the individuals to use resources were explained by the variables 
expressed in the model equation. However, in real life cases, such an assumption is 
violated as several unobserved variations may not be explained by all the variables 
measured in the study. Negative binomial model address this constrain of the Poisson 
model.112 The model fit statistic for negative binomial regression is the dispersion 
parameter ‘α’ using a maximum likelihood-ratio test. If the confidence interval window 
of the dispersion parameter does not include one, then the negative binomial model fits 
the data. (Note: As the data is log transformed in the SAS analysis, the confidence 
intervals are actually in the log form and therefore needs to be converted in to its 
exponential form before interpretation). In case the confidence interval consists α=1, then 
the data fits a Poisson distribution and a Poisson regression model needs to be used for 
analyzing the quantity differences.115 Interpretation of the coefficients of the negative 
binomial regression using the log transformed data was done by taking the natural 
exponential value [exp(β1)] of the regression coefficients. 
 
A multivariable model was developed to fit the Poisson/Negative Binomial model 
and is as follows: 
 
Log(Utilization) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 
‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 
‘parent’s gender’ + b9 parent’s marital’ + b10 ‘parent’s education’ + 
b11 ‘parent’s insurance’ + b12 ‘dependents’ + b13 ‘child’s health’ + 
b14‘access’ + b15 ‘source’ + ε  
 
Log(Outcomes) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 
‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 
‘parent’s education’ +  b9 ‘child’s health’ + b10 ‘access’ + b11 
‘source’ + b12 ‘predicted doctor visit +  b13 ‘predicted hospital visits +  
b14 ‘predicted ER visits’ + ε 
 
Hypothesis 1: A smaller proportion of children living with HIV seropositive parent(s) 
have a health insurance compared to children living with HIV seronegative parent(s). 
 
H0: Differences does not exist between the two groups. 
HA: Differences exists in the proportion of insured children between the two 
groups. 
 
Hypothesis 2: A smaller proportion of children living with HIV seropositive parent(s) 
have a regular source of care compared to children living with HIV seronegative 
parent(s). 
 
H0: Differences does not exist between the two groups. 
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HA: Differences exists in the proportion of children with regular source of care 
between the two groups. 
 
Hypothesis 3: A smaller proportion of children living with HIV seropositive parent(s) 
have a prescription drug insurance compared to children living with HIV seronegative 
parent(s). 
 
H0: Differences does not exist between the two groups. 
HA: Differences exists in the proportion of children with prescription drug 
insurance between the two groups. 
 
Hypothesis 4: Higher proportion of children living with HIV seropositive parent(s) take 
more than 30 minutes to get to a healthcare provider compared to children living with 
HIV seronegative parent(s). 
 
H0: Differences does not exist between the two groups. 
HA: Differences exists in the proportion of children who take more than 30 
minutes to get to a health provider between the two groups. 
 
Hypothesis 5: Higher proportion of children living with HIV seropositive parent(s) 
indicate having difficulty in getting to a healthcare provider compared to children living 
with HIV seronegative parent(s). 
 
H0: Differences does not exist between the two groups. 
HA: Differences exists in the proportion of children indicating difficulty in getting 
to a healthcare provider between the two groups. 
 
Hypothesis 6: Children of HIV seropositive parent(s) have lower likelihood for a doctor 
visit compared to children of HIV seronegative parent(s). 
 
Y(Doctor’s visit) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 
‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 
‘parent’s gender’ + b9 parent’s marital’ + b10 ‘parent’s education’ + 
b11 ‘parent’s insurance’ + b12 ‘dependents’ + b13 ‘child’s health’ + 
b14‘access’ + b15 ‘source’ + ε 
 
Log(Number of doctors visit) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s 
gender’ + b4 ‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 
parent’s age’ + b8 ‘parent’s gender’ + b9 parent’s marital’ + b10 
‘parent’s education’ + b11 ‘parent’s insurance’ + b12 ‘dependents’ + 
b13 ‘child’s health’ + b14‘access’ + b15 ‘source’ + ε 
 
Hypothesis 7: Children of HIV seropositive parent(s) have higher likelihood for a 
hospital visit compared to children of HIV seronegative parent(s). 
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Y(Hospital visit) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 
‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 
‘parent’s gender’ + b9 parent’s marital’ + b10 ‘parent’s education’ + 
b11 ‘parent’s insurance’ + b12 ‘dependents’ + b13 ‘child’s health’ + 
b14‘access’ + b15 ‘source’ + ε 
 
Log(Number of hospital visit) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s 
gender’ + b4 ‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 
parent’s age’ + b8 ‘parent’s gender’ + b9 parent’s marital’ + b10 
‘parent’s education’ + b11 ‘parent’s insurance’ + b12 ‘dependents’ + 
b13 ‘child’s health’ + b14‘access’ + b15 ‘source’ + ε 
 
Hypothesis 8: Children of HIV seropositive parent(s) have higher likelihood for an 
emergency room visit compared to children of HIV seronegative parent(s). 
 
Y(ER visit) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 ‘race’ + 
b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 ‘parent’s 
gender’ + b9 parent’s marital’ + b10 ‘parent’s education’ + b11 
‘parent’s insurance’ + b12 ‘dependents’ + b13 ‘child’s health’ + 
b14‘access’ + b15 ‘source’ + ε 
 
Log(Number of ER visit) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ 
+ b4 ‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ 
+ b8 ‘parent’s gender’ + b9 parent’s marital’ + b10 ‘parent’s 
education’ + b11 ‘parent’s insurance’ + b12 ‘dependents’ + b13 
‘child’s health’ + b14‘access’ + b15 ‘source’ + ε 
 
Hypothesis 9: Children of HIV seropositive parent(s) have higher likelihood for a missed 
school/daycare day due to ill health compared to children of HIV seronegative parent(s). 
 
Y(School days missed) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + 
b4 ‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + 
b8 ‘parent’s education’ +  b9 ‘child’s health’ + b10 ‘access’ + b11 
‘source’ + b12 ‘predicted doctor visit +  b13 ‘predicted hospital visits 
+  b14 ‘predicted ER visits’ + ε 
 
Log(Number of school days missed) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 
‘child’s gender’ + b4 ‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + 
b7 parent’s age’ + b8 ‘parent’s education’ +  b9 ‘child’s health’ + b10 
‘access’ + b11 ‘source’ + b12 ‘predicted doctor visit +  b13 ‘predicted 
hospital visits +  b14 ‘predicted ER visits’ + ε 
 
Hypothesis 10: Children of seropositive parent(s) have a higher likelihood to be 
overweight compared to children of HIV seronegative parent(s). 
 
 44
Y(BMI overweight) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 
‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 
‘parent’s education’ +  b9 ‘child’s health’ + b10 ‘access’ + b11 
‘source’ + b12 ‘predicted doctor visit +  b13 ‘predicted hospital visits 
+  b14 ‘predicted ER visits’ + ε 
 
Hypothesis 11: Children of seropositive parent(s) have a higher likelihood of being 
currently on a prescription medication for any health condition compared to children of 
HIV seronegative parent(s). 
 
Y(Rx medication) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 
‘race’ + b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 
‘parent’s education’ +  b9 ‘child’s health’ + b10 ‘access’ + b11 
‘source’ + b12 ‘predicted doctor visit +  b13 ‘predicted hospital visits 
+  b14 ‘predicted ER visits’ + ε 
 
Hypothesis 12: Children of seropositive parent(s) have a higher likelihood to being 
currently on a prescription medication for mental health condition compared to children 
of HIV seronegative parent(s). 
 
Y(Rx mental) = b0 + b1 ‘HIV parent’ + b2 ‘child’s age’ + b3 ‘child’s gender’ + b4 ‘race’ 
+ b5 ‘income’ + b6 ‘child’s insurance’ + b7 parent’s age’ + b8 
‘parent’s education’ +  b9 ‘child’s health’ + b10 ‘access’ + b11 
‘source’ + b12 ‘predicted doctor visit +  b13 ‘predicted hospital visits 
+  b14 ‘predicted ER visits’ + ε  
 
 
3.2.9.6  Sensitivity Analysis 
 
A sensitivity analysis was carried out incorporating the data that was missed out 
during the propensity matching scores. In the matching process 9 children did not have a 
matched pair. The purpose of this step was to see whether the exclusion of this data 
affected the results significantly. A multivariate logistic regression was carried out for the 
utilization and health outcome variables and the coefficients and p values were compared 
with that of the regression results of data conducted without these 9 children. 
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CHAPTER 4: RESULTS 
 
 
This chapter summarizes the descriptive, bivariate and the multivariate analysis in 
order to analyze the study hypothesis and illustrate the impact of the HIV status of the 
parents on the health outcomes, healthcare utilization and access to healthcare resources 
of their children residing with them. The results have been presented in two different 
sections: descriptive statistic of the sample population and the inferential statistic for 
bivariate and multivariate hypothesis testing. 
 
 
4.1 Descriptive Statistics 
 
 
4.1.1 Study Sample 
 
The data for the primary group (uninfected children living with their HIV 
seropositive parents) in this study was collected from three study sites and the 
comparative group (uninfected children living with HIV seronegative parents) was teased 
out from the 2006 MEPS data. The data for the primary group was collected between 
January 2009 and March 2009, and the data represented the healthcare utilization of the 
respondents for the year 2008. 
 
Figure 4-1 provides a schematic representation of the data mining process to get 
the study sample. For the primary data collection phase, a total of 92 HIV seropositive 
parents were recruited by the various case managers and social workers. Out of these, 90 
parents agreed to participate in the study and 2 denied participation, thereby giving a 
response rate of 97.82%. These 90 parents provided information on their HIV 
seronegative (uninfected) children through a survey questionnaire session. In all, 
information on 98 uninfected children was obtained who met the inclusion-exclusion 
criteria of the study. 
 
The MEPS Household component of the Medical Expenditure Panel Survey 
dataset of 2006 consisted to 34,145 participants, and the MEPS Medical condition file, 
which is an event level data, had 105,116 records. Out of the 2006 MEPS respondents, 
34,091 participants had no medical record of HIV/AIDS. Among these HIV seronegative 
respondents 5,745 respondents belonged to the age group of 2-15 yrs. Four children from 
this had HIV seropositive parents hence were excluded from the group, thus we had a 
group of 5,741 uninfected children living with HIV seronegative parent(s). Since we had 
collected the primary data from Memphis, Tennessee, respondents in the MEPS database 
who belong to the southern region was considered. From the 5,741 respondents, 2,194 
children belonged to the southern region of US as defined by MEPS. 
 
Propensity score matching was done with 98 participants in the primary group and 
2,194 participants in the comparative group. Upon matching, 89 participants from the 
primary group matched with 178 participants in the comparative groups (1:2 ratio), thus  
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Figure 4-1: Schematic representation of the data collection and data mining 
process 
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making the final study sample of 267 participants. Nine participants were did not had a 
match hence were excluded from the study analysis. 
 
 
4.1.2 Demographic and Socioeconomic Characteristics 
 
After matching, 89 children (33.33%) who live with their HIV seropositive 
parent(s) and 178 children (66.66%) who live with their HIV seronegative parent(s) made 
up the final study population for analysis. 
 
Table 4-1 summarizes the age, gender, race, ethnicity, annual family income and 
insurance status of the children considered for final analysis. Table 4-1 also provides 
information on the parent’s age and gender, parent’s educational status, and parent’s 
marital as well as insurance status of each child included in the study analysis. 
 
 
4.1.2.1 Child Related Factors 
 
The mean age for the children with HIV seropositive parent(s) was 8.47yrs (SD 
4.45). Among them, 24.72% (n=22) were aged less than 5yrs, 34.83% (n=31) were aged 
between 5-9yrs, and 40.45% (n=36) were aged between 10-15yrs. The mean age for the 
children with HIV seronegative parent was 8.94yrs (SD 4.74) and 25.84% (n=46), 
29.21% (n=52), and 44.94% (n=80) belonged to the age groups less than 5yrs, 5-9yrs, 10-
15yrs, respectively. Among the children with HIV seropositive parent(s), 57.30% (n=51) 
were males, while 47.19% (n=84) of the children with HIV seronegative parent(s) were 
males. In terms of race, 91.01% (n=81) of the children with HIV seropositive parent(s) 
and 85.96% (n=153) were African American, while the rest in both the groups were 
Caucasian whites. Almost 97.75% (n=87) and 93.26% (n=172) of the children with HIV 
seropositive and seronegative parent(s) were non-Hispanics, respectively. Analysis of the 
annual family income of the study participants between the children with HIV 
seropositive and HIV seronegative showed that 59.55% (n=53) versus 45.51% (n=81) 
had income less than $10,000, 23.60% (n=21) versus 36.52% (n=65) had income 
between $10,000 - $20,000, and 16.85% (n=15) versus 17.98% (n=32) has income more 
than $20,000, respectively. Among these children, 78.65% (n=70) of those living with a 
HIV seropositive parent(s) and 85.39% (n=152) of those living with a HIV seronegative 
parents belong to single parent family. 
 
 
4.1.2.2 Parent Related Factors 
 
The mean age for the HIV seropositive parents were 33.57yrs (SD 7.78). Among 
them, 10.11% (n=9) were aged less than 25yrs, 80.90% (n=72) were aged between 25-
44yrs, and 8.99% (n=8) were aged above 44yrs. The mean age for the HIV seronegative 
parents were 34.21yrs (SD 9.13) and 11.24% (n=20), 29.21% (n=52), 79.21% (n=141) 
and 9.55% (n=17) belonged to the age groups less than 25yrs, 55-44yrs, and above 44yrs, 
respectively. Among the children with HIV seropositive parent(s), 92.13% (n=82) had a 
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Table 4-1: Baseline characteristics of the study population (children of HIV 
seropositive versus seronegative parents) 
 
Variables Children of HIV seropositive parent 
Children of HIV 
seronegative parent P value 
 Numbers % Numbers %  
      
Study Population 98 4.27 2197 95.72  
      
Matched Population 89 33.33 178 66.66  
      
Age     0.6265 
Less than 5 yrs 22 24.72 46 25.84  
5 - 9 yrs 31 34.83 52 29.21  
10 - 15 yrs 36 40.45 80 44.94  
      
Mean (SD) 8.47 (4.45)  8.94 (4.74)   
Minimum 2yrs  2yrs   
Maximum 15 yrs  15 yrs   
      
Sex     0.1192 
Male 51 57.30 84 47.19  
      
Race     0.2367 
Black 81 91.01 153 85.96  
White 8 8.99 25 14.04  
      
Ethnicity     0.1204 
Non-Hispanics 87 97.75 166 93.26  
      
      
Parent's Age     0.9464 
Less than 25 years 9 10.11 20 11.24  
25 - 44 years 72 80.90 141 79.21  
Above 44 years 8 8.99 17 9.55  
      
Mean (SD) 33.57 (7.78)  34.21 (9.13)   
Minimum 21yrs  19yrs   
Maximum 62yrs  67yrs   
      
Parent's Sex     0.6499 
Females 82 92.13 161 90.45  
      
Parent's Marital 
Status     0.1654 
Single 70 78.65 152 85.39  
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Table 4-1 (Continued) 
 
Variables Children of HIV seropositive parent 
Children of HIV 
seronegative parent P value 
 Numbers % Numbers %  
      
Annual Family Income     0.0655 
Less than $10,000 53 59.55 81 45.51  
$10,000 - $20,000 21 23.60 65 36.52  
Above $20,000 15 16.85 32 17.98  
      
Parent's Insurance 
Status     0.7227* 
Insured 87 97.75 172 96.63  
      
Parent's Educational 
Status     0.3854 
Less than 12 years 74 83.15 140 78.65  
      
Doctor Visits     0.0486 
Mean (SD) 2.337 (2.39)  1.707 (2.52)   
Minimum 0  0   
Maximum 12  21   
      
Hospital Visits     0.0460 
Mean (SD) 0.168 (0.54)  0.044 (0.25)   
Minimum 0  0   
Maximum 4  2   
      
ER Visits     0.2221 
Mean (SD) 0.404 (0.80)  0.286 (0.58)   
Minimum 0  0   
Maximum 6  3   
      
School/Daycare Days 
Missed      
Mean (SD) 3.078 (3.58)  2.606 (4.91)  0.3734 
Minimum 0  0   
Maximum 15  29   
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
* Fisher Exact Test Two-sided Probability 
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seropositive mother, while 90.45% (n=161) of the children with HIV seronegative 
parents had a seropositive mother. Almost 97.75% (n=87) of the children with HIV 
seropositive parent had a parent with health insurance, while 96.63% (n=172) of the 
children with HIV seronegative parent(s) has a parent with health insurance. In terms of 
the level of education of the parent, 83.15% (n=74) and 78.65% (n=140) of the children 
with HIV seropositive and seronegative parent(s) had an education of less than 12 yrs, 
respectively. 
  
 
4.1.2.3 Statistical Differences between Groups at Baseline 
 
The Chi Square analysis showed that both the groups of children has no statistical 
difference in terms of age (p=0.6265), gender (p=0.1192), race (p=0.2367), ethnicity 
(p=0.1204), parent’s age (p=0.9464), parent’s gender (p=0.6499), parent’s marital status 
(p=0.1654), family’s annual income (p=0.0655), parent’s insurance (p=0.6117) and 
parent’s level of education (p=0.3854). 
 
 
4.2 Inferential Statistics 
 
 
4.2.1 Results for Aim 1 
 
To determine whether HIV seronegative children living with HIV seropositive 
parent(s) have lower healthcare access in comparison to the HIV seronegative children 
living with HIV seronegative parent(s). 
 
 
4.2.1.1 Hypothesis 1 
 
Smaller proportion of children living with HIV seropositive parent(s) have a 
health insurance compared to children living with HIV seronegative parent(s). 
 
Upon analysis, 97.75% (n=87) of the children living with a HIV seropositive 
parent(s) had health insurance. Out these 87 children, 84 (96.55%) children had a 
publicly funded insurance. Among the children living with a HIV seronegative parent(s), 
96.63% (n=172) had health insurance and 77.9% (n=134) children of these had a publicly 
funded insurance. Fischer Exact Test analysis showed no statistical differences in the 
insurance status of the children in the two groups (p=0.6117). However, the proportional 
of children with a public insurance was significantly higher among those living with a 
HIV seropositive parent(s) (p=0.001). 
 
The health insurance status of the children in the study population is summarized 
in Table 4-2. 
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Table 4-2: Insurance status of the study population (children of HIV seropositive 
versus seronegative parents) 
 
Variables 
Children of HIV 
seropositive parent(s) 
Children of HIV 
seronegative parent(s) P value 
  Numbers % Numbers %  
      
Insurance Status      
Insured 87 97.75 172 96.63 0.7227* 
      
Type of Insurance      
Publicly insured 84 96.55 134 77.91 <0.0001*
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
* Fisher Exact Test Two-sided Probability 
 
 
4.2.1.2 Hypothesis 2 
 
Smaller proportion of children living with HIV seropositive parent(s) have a 
regular source of care compared to children living with HIV seronegative parent(s). 
 
Almost 87.64% (n=78) of children, according to their HIV seropositive parent, 
reported to have a regular source of care (particular doctor’s office) where the child is 
taken whenever the child is sick or when the parents need a medical advice, 3.37% (n=3) 
said they had more than one place, while 8.99% (n=8) children had no regular source of 
care. Responding to the same question, 86.68% (n=154) of the children with HIV 
seronegative parent confirmed having a regular source of care. None of children in the 
comparative group had more than one regular source of care. However, 12.36% (n=22) 
had no regular source of care. Chi Square analysis indicated no statistical differences 
between the groups (p=0.4453). 
 
The responses of the study participants to the question on whether they had a 
regular source of care for the children are summarized in Table 4-3. 
 
 
4.2.1.3 Hypothesis 3 
 
Smaller proportion of children living with HIV seropositive parent(s) have a 
prescription drug insurance compared to children living with HIV seronegative parent(s) 
 
As per the respondent, 95.51% (n=85) of the children with HIV seropositive 
parent(s) had a prescription drug insurance compared to 16.29% (=29) of the children 
with HIV seronegative parent(s).  
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Table 4-3: Regular source of care among the study population (children of HIV 
seropositive versus seronegative parents) 
 
Variable 
Children of HIV 
seropositive parent(s)
Children of HIV 
seronegative parent(s) P value 
  Numbers % Numbers %  
      
Regular Source of Care     0.4453 
Yes 78 87.64 154 86.68  
No 8 8.99 22 12.36  
More than one place 3 3.37 0 -  
Missing - - 2 1.12  
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
 
 
The Fischer Exact Test indicate a significant difference between the two groups 
(p=<0.0001). Refer to Table 4-4 for a summary of the children having a prescription drug 
insurance coverage as a part of their health insurance plan. 
 
 
4.2.1.4 Hypothesis 4 
 
Higher proportion of children living with HIV seropositive parent(s) take more 
than 15 minutes to get to a healthcare provider compared to children living with HIV 
seronegative parent(s). 
 
Only 14.61% (n=13) children living with a HIV seropositive parent(s) took less 
than 15 minutes to get to a healthcare provider versus 45.51% (n=81) of the children 
living with a HIV seronegative parent(s). Among children with HIV seropositive and 
seronegative parent(s), 53.93% (n=48) versus 34.27% (n=61), 26.97% (n=24) versus 
6.74% (n=12) and 4.49% (n=4) versus 0% (n=0) took 15-30 minutes, 31-60 minutes, and 
more than 60 minutes, respectively, to get to their healthcare provider. Therefore, 
significantly more time is taken by the children of seropositive parent(s) to reach to their 
provider compared to the children of seronegative parents (p=<0.0001). 
 
Majority of the children of seropositive as well as seronegative parent(s) are 
driven (72.28% versus 82.59%) or use a taxi (5.62% versus 3.93%) to get to their 
healthcare provider. However, 16.85% (n=15) of the children living with HIV 
seropositive parent(s) use public transport (bus or train), while 2.25% (n=2) had to walk 
to reach their healthcare providers. Also, both groups were significantly different in terms 
of their mode of transportation (p=<0.0001). 
 
Table 4-5 summarizes the frequency distribution of time taken and the mode of 
transportation by the study participants to get to their healthcare provider. 
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Table 4-4: Prescription drug insurance of the study population (children of HIV 
seropositive versus and seronegative parents) 
 
Variable 
Children of HIV 
seropositive parent(s)
Children of HIV 
seronegative parent(s) P value 
  Numbers % Numbers %  
            
Prescription Drug 
Insurance     <0.0001*
Yes 85 95.51 29 16.29  
No 4 4.49 149 83.71  
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
* Fisher Exact Test Two-sided Probability 
 
 
Table 4-5: Time and mode of transport taken to get to a provider among the study 
population (children of HIV seropositive versus seronegative parents) 
 
Variable 
Children of HIV 
seropositive parent(s)
Children of HIV 
seronegative parent(s) P value 
  Numbers % Numbers %  
      
Time Taken     <0.0001 
Less than 15 minutes 13 14.61 81 45.51  
15 - 30 minutes 48 53.93 61 34.27  
31 - 60 minutes 24 26.97 12 6.74  
60 - 90 minutes 4 4.49 0 0  
91-120 minutes 0 0 0 0  
More than 120 minutes 0 0 0 0  
Missing - - 24 13.48  
      
Mode of Transport     <0.0001 
Drives 0 0 0 0  
Is driven 67 72.28 147 82.59  
Taxi 5 5.62 7 3.93  
Public transport 15 16.85 0 0  
Walks 2 2.25 0 0  
Missing - - 24 13.48  
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
* Fisher Exact Test Two-sided Probability 
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4.2.1.5 Hypothesis 5 
 
Higher proportion of children living with HIV seropositive parent(s) indicate 
having difficulty in getting to a healthcare provider compared to children living with HIV 
seronegative parent(s). 
 
According to parent reported information, 4.49% of the children living with a 
HIV positive parent(s) found it very difficult (n=4) and 23.6% (n=21) found it somewhat 
difficult to get to a provider compared to 2.25% (n=4) and 2.25% (n=4) of the children 
who live with their HIV seronegative parent(s). Also, between the children of HIV 
seropositive and seronegative parents, respectively, 32.58% (n=29) versus 19.66% (n=35) 
found it not too difficult, while 39.33% (n=35) versus 61.8% (n=110) found getting to 
their provider was not at all difficult. The Chi Square analysis showed significant 
differences between the two groups in terms of their degree of difficulty faced to get to 
their provider (p=<0.0001). 
 
Table 4-6 summarizes the responses of the study participants on the level of 
difficulty to get to a healthcare provider. 
 
 
4.2.2 Results for Aim 2 
 
 To determine if HIV seronegative children living with HIV seropositive parent(s) 
have higher healthcare utilization in comparison to the HIV seronegative children living 
with HIV seronegative parent(s). 
 
A logistic regression was performed to test the various hypothesis using a 
dichotomous dependent variable, respective to the hypothesis, and the child’s HIV status 
of the parent as the independent variable adjusting for all the child and parent’s 
predisposing, need and enabling factors, such as age, gender, race, ethnicity and 
insurance status of the child and the parent, annual family income, marital status of the 
parent, level of parent’s education, number of dependents, health condition of the child, 
level of difficulty and time taken in getting to a healthcare provider, and usual source of 
care status. 
 
A generalized linear regression using a negative binomial model was used to 
analyze the difference in the annual number of times the healthcare resource (doctor, 
hospital and emergency room visit) was utilized. 
 
 
4.2.2.1 Hypothesis 6 
 
Children of HIV seropositive parent(s) have lower likelihood for a doctor visit 
compared to children of HIV seronegative parent(s).  
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Table 4-6: Difficulty in getting to a provider among the study population (children 
of HIV seropositive versus seronegative parents) 
 
Variable 
Children of HIV 
seropositive parent(s)
Children of HIV 
seronegative parent(s) P value 
  Numbers % Numbers %  
      
Difficulty in Getting to 
a Provider     <0.0001 
Very difficult 4 4.49 4 2.25  
Somewhat difficult 21 23.6 4 2.25  
Not too difficult 29 32.58 35 19.66  
Not at all difficult 35 39.33 110 61.8  
Missing - - 25 14.14  
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
* Fisher Exact Test Two-sided Probability 
 
 
4.2.2.1.1  Results of Bivariate Analysis 
 
Children of HIV seropositive parent have a mean number of doctor visits of 2.337, 
while the children of HIV seronegative parent have a mean of 1.707 numbers of visits to 
a doctor in the past 12 months (Table 4-7). The bivariate chi square analysis showed both 
these means to be significantly different (p=0.0486). 
 
 
4.2.2.1.2  Results of Logistic Regression Model 
 
The dependent variable for analyzing this hypothesis was whether the child had a 
doctor/physician visit in the past 12 months. The variable was dichotomized as ‘yes’ and 
‘no’. Logistic regression estimates showed that children living with a HIV seropositive 
parent(s) were 1.682 times (95% CI: 1.115 – 6.453) more likely to have a doctor visit 
than the children living with a HIV seronegative parent after adjusting for all the child 
and parental predisposing, need and enabling factors. All the other factors were 
statistically insignificant except the age of the child. With every one year increase in the 
child’s age the likelihood of having a doctor visit decreased by 0.902 times (95% CI: 
0.820 – 0.992).  
 
The regular source of care (OR: 6.479; 95% CI: 0.979 – 42.861) was marginally 
significant (p<0.10). Please refer to Table 4-8 for the complete result of the logistic 
regression. The Max-rescaled R-square statistics for this model was 16.32% and the 
Hosmer and Lemeshow Goodness-of-fit test was 0.6832, which meant we failed to reject 
the null hypothesis and concluded that the model fits the data. The C statistics was 0.722 
which means that for 72.20% of all possible pairs of children (one being those who had a  
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Table 4-7: Bivariate chi-square analysis of the number of doctor visits in the past 12 
months for the study population (children of HIV seropositive versus seronegative 
parents) 
 
Variable Children of HIV seropositive parent(s) 
Children of HIV 
seronegative parents P value
    
Doctor Visits   0.0486 
Mean (SD) 2.337 (2.39) 1.707 (2.52)  
Minimum 0 0  
Maximum 12 21  
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
 
 
Table 4-8: Odd ratios from the logistic regression of the visit to a doctor/physician’s 
office as the dependent variable 
 
Variables Doctor visit 
 Odd ratio 95% CI P value 
    
Children of HIV Parent 2.682 1.115 – 6.453 0.0276 
    
Child's Age 0.902 0.820 – 0.992 0.0340 
    
Parent's Age 1.015 0.965 – 1.068 0.5605 
    
Child's Gender    
Male 0.640 0.338 – 1.211 0.1700 
    
Parent's Gender    
Male 2.992 0.650 – 13.768 0.1593 
    
Race    
Black 0.415 0.123 – 1.403 0.1570 
    
Annual Family Income    
Less than $10,000 Reference - - 
$10,000 - $20,000 2.021 0.924 – 4.423 0.0782 
More than $20,000 0.962 0.359 – 2.575 0.9386 
    
Marital Status    
Single Reference - - 
Married 1.748 0.628 – 4.869 0.2853 
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Table 4-8 (Continued) 
 
Variables Doctor visit 
 Odd ratio 95% CI P value 
    
Level of Education    
12 years or less Reference - - 
More than 12 years 0.967 0.407 – 2.295 0.9386 
    
Child's Insurance Status    
Uninsured Reference - - 
Insured 1.047 0.082 – 13.304 0.9717 
    
Parent's Insurance Status    
Uninsured Reference - - 
Insured 0.378 0.042 – 3.423 0.3872 
    
No. of Dependents 0.940 0.612 – 1.444 0.7766 
    
Health Condition    
Excellent/Good health Reference - - 
Worst/Bad health 2.051 0.733 – 5.742 0.1713 
    
Access to Health Provider    
Not difficult at all Reference - - 
Not too difficult 1.339 0.596 – 3.011 0.4796 
Somewhat or very difficult 0.528 0.184 – 1.513 0.2342 
    
Time to Reach the Provider    
Less than 15 minutes Reference - - 
15 - 30 minutes 1.037 0.500 – 2.150 0.9220 
More than 30 minutes 1.749 0.562 – 5.439 0.3341 
    
Having a Usual Source of 
Care    
No Reference - - 
Yes 6.479 0.979 – 42.861 0.0526 
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
 
 58
doctor/physician visit in the past 12 months and the other with no doctor visits) the model 
correctly assigned a higher probability to those who made a doctor visit in the past 12 
months. 
 
 
4.2.2.1.3 Results of Negative Binomial Regression Model 
 
The dispersion parameter for this model was 1.693 (95% CI: 1.389 – 2.071), 
hence the data fits the negative binomial model. 
 
The dependent variable was a count variable consisting of number of times the 
child has made a visit to a doctor/physician’s clinic in the past 12 months. The regression 
model estimated that children living with HIV seropositive parent(s) have 49% 
(p=0.0206) more visits to a doctor than the children living with HIV seronegative 
parent(s). Also, children with an annual family income between $10,000 and $20,000 
visit the doctor 72% (p=0.0008) more than the children who have a family income of less 
than $10,000 per year. Children with perceived worst/bad health condition visited the 
doctor 87% more than the number of visits made by children with an excellent/good 
perceived health condition. Children who found it not too difficult to get to their 
healthcare provider made 44% more visits to their provider than the number of visits 
made by the children who found it not at all difficult to get to their healthcare provider. 
And children who reported to take 15 – 30 minutes to reach to their healthcare provider 
visited a doctor 0.10 times more compared to the children who took less than 15 minutes 
to get to their provider. Table 4-9 summarizes the results of the negative binomial 
regression with doctor visits as the dependent variable. 
 
The marital status of the parent (Rate Ratio: 1.4767; p=0.0639), number of 
dependents (Rate Ratio: 0.8368; p=0.0603) and regular source of care (Rate Ratio: 2.685; 
p=0.0691) were marginally significant (p<0.10). 
 
 
4.2.2.2 Hypothesis 7 
 
Children of HIV seropositive parent(s) have higher likelihood for a hospital visit 
compared to children of HIV seronegative parent(s). 
 
 
4.2.2.2.1 Results of the Bivariate Analysis 
 
The bivariate analysis showed that the mean number of hospital visits made by 
the children of HIV seropositive parent was significantly higher than that of the mean 
number of hospital visits observed among children of HIV seronegative parent (0.168 
versus 0.044, p=0.0460), see Table 4-10. 
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Table 4-9: Rate ratios from the negative binomial regression of the visit to a 
doctor/physician’s office as the dependent variable 
 
Variables Doctor visit 
 Rate ratio P value 
   
Children of HIV Parent 1.4920 0.0206 
   
Child's Age 0.9707 0.1264 
   
Parent's Age 1.0111 0.3004 
   
Child's Gender   
Male 0.9385 0.6631 
   
Parent's Gender   
Male 0.9804 0.9446 
   
Race   
Black 0.7533 0.1829 
   
Annual Family Income   
Less than $10,000 Reference - 
$10,000 - $20,000 1.7281 0.0008 
More than $20,000 1.1849 0.4340 
   
Marital Status   
Single Reference - 
Married 1.4767 0.0639 
   
Level of Education   
12 years or less Reference - 
More than 12 years 0.7755 0.1858 
   
Child's Insurance Status   
Uninsured Reference - 
Insured 1.3200 0.6449 
   
Parent's Insurance Status   
Uninsured Reference - 
Insured 0.6889 0.2822 
   
No. of Dependents 0.8368 0.0603 
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Table 4-9 (Continued) 
 
Variables Doctor visits 
 Rate ratio P value 
 
Health Condition   
Excellent/Good health Reference - 
Worst/Bad health 1.8752 0.0010 
   
Access to Health Provider   
Not difficult at all Reference - 
Not too difficult 1.4454 0.0346 
Somewhat or very difficult 0.9288 0.7715 
   
Time to Reach the Provider   
Less than 15 minutes Reference - 
15 - 30 minutes 1.1035 0.5569 
More than 30 minutes 1.2614 0.3432 
   
Having a Usual Source of Care   
No Reference - 
Yes 2.6185 0.0691 
   
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable. 
 
 
Table 4-10: Bivariate chi-square analysis of the number of hospital visits in the past 
12 months for the study population (children of HIV seropositive versus 
seronegative parents) 
 
Variable 
Children of HIV 
seropositive parent(s) 
Children of HIV 
seronegative parents P value
    
Hospital Visits   0.0460 
Mean (SD) 0.168 (0.54) 0.044 (0.25)  
Minimum 0 0  
Maximum 4 2  
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
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4.2.2.2.2 Results of Logistic Regression Model 
 
The dependent variable for analyzing this hypothesis was whether the child had a 
hospital visit in the past 12 months. The variable was dichotomized as ‘yes’ and ‘no’. 
Logistic regression estimates showed that children living with a HIV seropositive 
parent(s) had a higher likelihood (OR: 4.027; 95% CI: 0.811 – 20.00) of having a hospital 
visit than the children living with a HIV seronegative parent(s) after adjusting for all the 
child and parent’s predisposing, need and enabling factors. However, this relationship 
was statistically insignificant with a p value of 0.0885. All the other factors were 
statistically insignificant except for those who felt not too difficult to get to their 
healthcare provider. Child whose parents indicated that they did not find it too difficult to 
get to a provider were 6.588 times (95% CI: 1.143 – 37.969) more likely to have a 
hospital visit compared to those children whose parents indicated they did not find it 
difficult at all to reach a healthcare provider. Refer to Table 4-11 for the complete output 
of the logistic regression using the hospital visits as the dependent variable. 
 
The Max-rescaled R-square statistics for this model was 34.47% and the Hosmer 
and Lemeshow Goodness-of-fit test was 0.8386, which meant we failed to reject the null 
hypothesis and concluded that the model fits the data. The C statistics was 0.879 which 
means that for 87.90% of all possible pairs of children (one being those who had a 
hospital visit in the past 12 months and other with no hospital visit) the model correctly 
assigned a higher probability for those who made a hospital visit in the past 12 months. 
  
 
4.2.2.2.3 Results of Negative Binomial Regression Model 
 
The dispersion parameter for this model was 0.778 (95% CI: 0.778 – 0.778), 
hence the data fits the negative binomial model. 
 
The dependent variable was a count variable consisting of number of times the 
child has made a visit to a hospital in the past 12 months. The regression model estimated 
that children living with HIV seropositive parent(s) have 3.0 times (p =0.0244) more 
hospital visits than the children living with HIV seronegative parent(s). Also, children 
with an annual family income between $10,000 and $20,000 visit the hospital 2.2 times 
(p=0.0391) more than the children who have a family income of less than $10,000 per 
year. The analysis also showed that with every one additional increase in the number of 
dependents the number of hospital visits decreased by almost 63% (p=0.0129). And those 
who indicated that they had somewhat or very difficulty in getting to a healthcare 
provider has a thrice (p=0.0270) the number of hospital visits compared to those children 
whose parents found it not at all difficult in getting to a healthcare provider. 
 
Table 4-12 summarizes the complete results of the negative binomial regression 
model for the number of hospital visits. 
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Table 4-11: Odd ratios from the logistic regression of the visit to a hospital as the 
dependent variable 
 
Variables Hospital visit 
 Odd ratio 95% CI P value 
    
Children of HIV Parent 4.383 0.818 – 23.447 0.0844 
    
Child's Age 1.107 0.919 – 1.333 0.2841 
    
Parent's Age 0.953 0.863 – 1.053 0.3432 
    
Child's Gender    
Male 3.295 0.777 – 13.976 0.1058 
    
Parent's Gender    
Male 4.819 0.383 – 60.571 0.2253 
    
Race    
Black 1.421 0.094 – 21.527 0.8000 
    
Annual Family Income    
Less than $10,000 Reference - - 
$10,000 - $20,000 1.448 0.318 – 6.599 0.6322 
More than $20,000 1.619 0.222 – 11.794 0.6344 
    
Marital Status    
Single Reference - - 
Married 3.207 0.324 – 31.727 0.3190 
    
Level of Education    
12 years or less Reference -  
More than 12 years 0.073 0.003 – 1.564 0.0941 
    
Child's Insurance Status    
Uninsured Reference - - 
Insured >999.9 - 0.9867 
    
Parent's Insurance Status    
Uninsured Reference - - 
Insured >999.9 - 0.9802 
    
No. of Dependents 0.306 0.105 – 0.886 0.0290 
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Table 4-11 (Continued) 
 
Variables Hospital visit 
 Odd ratio 95% CI P value 
    
Health Condition    
Excellent/Good health Reference - - 
Worst/Bad health 0.508 0.037 – 6.909 0.6107 
    
Access to Health Provider    
Not difficult at all Reference - - 
Not too difficult 9.388 1.372 – 64.232 0.0225 
Somewhat or very difficult 8.923 1.005 – 79.233 0.0495 
    
Time to Reach the Provider    
Less than 15 minutes Reference - - 
15 - 30 minutes 0.78 0.127 – 4.795 0.7883 
More than 30 minutes 1.047 0.140 – 7.850 0.9647 
    
Having a Usual Source of 
Care    
No Reference - - 
Yes 1.093 0.050 – 23.705 0.9549 
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
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Table 4-12: Rate ratios from the negative binomial regression of the visit to a 
hospital as the dependent variable 
 
Variables Hospital visit 
 Rate ratio P value 
   
Children of HIV Parent 4.0305 0.0244 
   
Child's Age 1.0047 0.9453 
   
Parent's Age 0.9842 0.6440 
   
Child's Gender   
Male 0.9042 0.8436 
   
Parent's Gender   
Male 1.7480 0.5935 
   
Race   
Black 1.1735 0.8697 
   
Annual Family Income   
Less than $10,000 Reference - 
$10,000 - $20,000 3.2424 0.0391 
More than $20,000 2.1027 0.3905 
   
Marital Status   
Single Reference - 
Married 2.1231 0.3628 
   
Level of Education   
12 years or less Reference - 
More than 12 years 0.4117 0.3193 
   
Child's Insurance Status   
Uninsured Reference - 
Insured 4.8303 0.5595 
   
Parent's Insurance Status   
Uninsured Reference - 
Insured 3.5113 0.5108 
   
No. of Dependents 0.3722 0.0129 
   
 65
Table 4-12 (Continued) 
 
Variables Hospital visit 
 Rate ratio P value 
   
Health Condition   
Excellent/Good health Reference - 
Worst/Bad health 0.7136 0.7227 
   
Access to Health Provider   
Not difficult at all Reference - 
Not too difficult 2.5961 0.1845 
Somewhat or very difficult 3.2233 0.0270 
   
Time to Reach the Provider   
Less than 15 minutes Reference - 
15 - 30 minutes 1.4614 0.5947 
More than 30 minutes 0.9101 0.9060 
   
Having a Usual Source of Care   
No Reference - 
Yes 0.9399 0.9588 
   
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable 
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4.2.2.3 Hypothesis 8 
 
Children of HIV seropositive parent(s) have higher likelihood for an emergency 
room visit compared to children of HIV seronegative parent(s). 
 
 
4.2.2.3.1 Results of Bivariate Analysis 
 
The results of the bivariate analysis of the number of ER visits made during the 
last 12 months showed no significant differences in the mean number of ER visits 
between the children of HIV seropositive and seronegative parent (0.404 versus 0.286, 
p=0.2221), see Table 4-13. 
 
 
4.2.2.3.2 Results of Logistic Regression Model 
 
The dependent variable for analyzing this hypothesis was whether the child had 
an emergency room visit in the past 12 months. The variable was dichotomized as ‘yes’ 
and ‘no’. Logistic regression estimates showed that children living with a HIV 
seropositive parent(s) had a higher likelihood (OR: 2.007; 95% CI: 0.900 – 4.476) for an 
emergency room visit in the past 12 months than the children living with a HIV 
seronegative parent(s) after adjusting for all the child’s and parent’s predisposing, need 
and enabling factors. However, this relationship was statistically insignificant with a p 
value of 0.0887. All the other factors were statistically insignificant, except the parent’s 
insurance status. Children of insured parents were 0.185 less likely to visited an 
emergency room in the past 12 months compared to those children whose parents are not 
insured. For the summarized results of the logistic regression model for the emergency 
visits as the dependable variable please refer to Table 4-14. 
 
 
Table 4-13: Bivariate chi-square analysis of the number of emergency room (ER) 
visits in the past 12 months for the study population (children of HIV seropositive 
versus seronegative parents) 
 
Variable Children of HIV seropositive parent(s) 
Children of HIV 
seronegative parents P value 
    
ER Visits   0.2221 
Mean (SD) 0.404 (0.80) 0.286 (0.58)  
Minimum 0 0  
Maximum 6 3  
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
* Fisher Exact Test Two-sided Probability 
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Table 4-14: Odd ratios from the logistic regression of the visit to an emergency room 
as the dependent variable 
 
Variables Emergency room visit 
 Odd ratio 95% CI P value 
    
Children of HIV Parent 2.007 0.900 – 4.476 0.8691 
    
Child's Age 0.953 0.868 – 1.046 0.0887 
    
Parent's Age 1.002 0.953 – 1.054 0.3060 
    
Child's Gender    
Male 1.747 0.908 – 3.359 0.9360 
    
Parent's Gender    
Male 0.900 0.238 – 3.400 0.0947 
    
Race    
Black 0.863 0.316 – 2.258 0.8760 
    
Annual Family Income    
Less than $10,000 Reference  - 
$10,000 - $20,000 1.129 0.547 – 332 0.7735 
More than $20,000 0.790 0.272 – 2.294 0.7423 
    
Marital Status    
Single Reference - - 
Married 0.666 0.246 – 1.805 0.4248 
    
Level of Education    
12 years or less Reference -  
More than 12 years 0.631 0.245 – 1.622 0.3393 
    
Child's Insurance Status    
Uninsured Reference - - 
Insured 0.979 0.073 – 13.120 0.9872 
    
Parent's Insurance Status    
Uninsured Reference - - 
Insured 0.185 0.038 – 0.894 0.0358 
    
No. of Dependents 0.959 0.626 – 1.468 0.8463 
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Table 4-14 (Continued) 
 
Variables Emergency room visit 
 Odd ratio 95% CI P value 
    
Health Condition    
Excellent/Good health Reference - - 
Worst/Bad health 1.369 0.556 – 3.374 0.4943 
    
Access to Health Provider    
Not difficult at all Reference - - 
Not too difficult 0.885 0.393 – 1.993 0.7682 
Somewhat or very difficult 0.795 0.267 – 2.263 0.6798 
    
Time to Reach the Provider    
Less than 15 minutes Reference - - 
15 - 30 minutes 1.046 0.493 – 2.220 0.9060 
More than 30 minutes 0.661 0.202 – 2.162 0.4939 
    
Having a Usual Source of 
Care    
No Reference - - 
Yes 2.915 0.280 – 30.397 0.3711 
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable. 
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The Max-rescaled R-square statistics for this model was 11.23% and the Hosmer 
and Lemeshow Goodness-of-fit test was 0.1274, which meant we failed to reject the null 
hypothesis and concluded that the model fits the data. The C statistics was 0.681 which 
means that for 68.10% of all possible pairs of children (one being those who had an 
emergency room visit in the past 12 months and the other with no 
 
 
4.2.2.3.3 Results of Negative Binomial Regression Model 
 
The dispersion parameter for this model was 1.314 (95% CI: 0.846 – 1.964), 
hence the data fits Poisson distribution instead of a negative binomial model (as the 9% 
CI includes 1). 
 
The dependent variable was a count variable consisting of number of times the 
child has made a visit to an emergency room in the past 12 months. The Poisson 
regression model estimated that children living with HIV seropositive parent(s) have 86% 
(p =0.0464) more visits to an emergency room than the children living with HIV 
seronegative parent(s). All other variables in the model were found to be statistically 
insignificant. 
 
Table 4-15 summarizes the results of the negative binomial regression model for 
the number of emergency visits. 
 
 
4.2.3 Results for Aim 3 
 
To determine the healthcare outcomes of the HIV seronegative children living 
with HIV seropositive parent(s) in comparison to HIV seronegative children living with 
HIV seronegative parent(s). 
 
 
4.2.3.1 Hypothesis 9 
 
Children of HIV seropositive parent(s) have higher likelihood to have a 
school/daycare day missed due to ill health compared to children of HIV seronegative 
parent(s). 
 
 
4.2.3.1.1 Results of Bivariate Analysis 
 
Bivariate analysis of the child’s productivity in school/daycare showed that the 
differences in the mean number of school/daycare days missed due to illness in the past 
12 months were statistically insignificant (3.078 versus 2.606, p=0.3734), see Table 4-16. 
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Table 4-15: Rate ratios from the poisson regression of the visit to an emergency 
room as the dependent variable 
 
Variables Emergency room visit 
 Rate ratio P value 
   
Children of HIV Parent 1.8606 0.0464 
   
Child's Age 0.9412 0.1018 
   
Parent's Age 1.0095 0.6388 
   
Child's Gender   
Male 1.5129 0.1180 
   
Parent's Gender   
Male 0.5850 0.3128 
   
Race   
Black 0.5874 0.1175 
   
Annual Family Income   
Less than $10,000 Reference - 
$10,000 - $20,000 1.2903 0.3714 
More than $20,000 1.1002 0.8353 
   
Marital Status   
Single Reference - 
Married 0.5524 0.1514 
   
Level of Education   
12 years or less Reference - 
More than 12 years 0.7263 0.4123 
   
Child's Insurance Status   
Uninsured Reference - 
Insured 0.9878 0.9913 
   
Parent's Insurance Status   
Uninsured Reference - 
Insured 0.4626 0.1269 
   
No. of Dependents 0.8935 0.5025 
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Table 4-15 (Continued) 
 
Variables Emergency room visit 
 Rate ratio P value 
Health Condition   
Excellent/Good health Reference - 
Worst/Bad health 1.6578 0.1065 
   
Access to Health Provider   
Not difficult at all Reference - 
Not too difficult 0.6824 0.2499 
Somewhat or very difficult 0.6544 0.3458 
   
Time to Reach the Provider   
Less than 15 minutes Reference - 
15 - 30 minutes 1.3742 0.2850 
More than 30 minutes 0.7444 0.5680 
   
Having a Usual Source of Care   
No Reference - 
Yes 3.1456 0.2890 
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable. 
 
 
Table 4-16: Bivariate chi-square analysis of the number of school day(s) missed due 
to illness in the past 12 months for the study population (children of HIV 
seropositive versus seronegative parents) 
 
Variable Children of HIV seropositive parent(s) 
Children of HIV 
seronegative parents P value
    
School/Daycare Day(s) 
Missed    
Mean (SD) 3.078 (3.58) 2.606 (4.91) 0.3734 
Minimum 0 0  
Maximum 15 29  
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference is observed. 
* Fisher Exact Test Two-sided Probability 
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4.2.3.1.2 Results of Logistic Regression Model 
 
The dependent variable for analyzing this hypothesis was whether the child had 
missed a school/daycare day visit in the past 12 months. The variable was dichotomized 
as ‘yes’ and ‘no’. Logistic regression estimates showed that children living with a HIV 
seropositive parent were less likely to have missed a school/daycare (OR: 0.938; 95% CI: 
0.425 – 2.069) than the children living with a HIV seronegative parent(s) after adjusting 
for all the child’s and parent’s predisposing, need and enabling factors. However, this 
relationship was statistically insignificant with a p value of 0.8743. Child’s age, parent’s 
age, marital status of the parent and the number of dependents had a significant influence 
on the likelihood of the child missing a school/daycare due to illness. With every one 
year increase in the age of the child the likelihood of having missed school/daycare due 
to illness increases 0.201 times (95% CI: 1.088 – 1.327), however with every increase in 
the age of the parent the likelihood of the child to miss school/daycare is 0.902 times 
(95% CI: 0.857 – 0.950). Children who reported to have a usual source of care were less 
likely to miss school/daycare because of illness (OR: 0.073; 95% CI: 0.007 – 0.734) 
compared to those children who did not had any usual source of care. 
 
For the complete regression results of the logistic model for missed school/day 
care due to illness, please refer to Table 4-17. 
 
 
4.2.3.1.3 Results of Negative Binomial Regression Model 
 
The dispersion parameter for this model was 5.748 (95% CI: 3.567 – 9.233), 
hence the data fits the negative binomial model. 
 
The dependent variable was a count variable consisting of number of day(s) the child 
has missed the school or daycare because of illness in the past 12 months. The regression 
model estimated that children living with HIV seropositive parent(s) missed less number 
of school or daycare day(s) than the children living with HIV seronegative parent(s) and 
this estimate was statistically insignificant (RR: 0.7462; p=0.3114). The regression also 
estimated that with every increase in the age of the child the number of missed day(s) 
increased by 10% (p=0.0039). However, with every one year increase in the parent’s age 
it decreased by 5% (p=0.0011). Children who had a usual source of care missed 85% 
(p=0.0142) less number of school/daycare day(s) compared to children who reported that 
they had no regular source of care.  
 
Table 4-18 summarizes the results of the negative binomial model for the number 
of school/daycare day(s) missed due to illness. 
 
Children who took 15 – 30 minutes to get to a provider missed more 
school/daycare day(s) due to illness compared to those children who take less than 15 
minutes to get to a healthcare provider. However, this estimate was marginally significant 
(RR: 1.5982; p=0.0582). 
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Table 4-17: Odd ratios from the logistic regression using missing a school/daycare 
day(s) due to illness as the dependent variable 
 
Variables Missed school/daycare day(s) due to illness 
 Odd ratio 95% CI P value 
    
Children of HIV Parent 0.938 0.425 - 2.069 0.8743 
    
Child's Age 1.201 1.088 - 1.327 0.0003 
    
Parent's Age 0.902 0.857 - 0.950 <0.0001 
    
Child's Gender    
Male 0.660 0.355 - 1.227 0.1888 
    
Race    
Black 1.569 0.562 - 4.379 0.3894 
    
Annual Family Income    
Less than $10,000 pa Reference  - 
$10,000 - $20,000 pa 0.861 0.340 - 2.180 0.7526 
More than $20,000 pa 0.722 0.308 - 1.691 0.4534 
    
Level of Education    
12 years or less Reference   
More than 12 years 2.134 0.926 - 4.921 0.0753 
    
Health Condition    
Excellent/Good health Reference  - 
Worst/Bad health 0.438 0.127 - 1.505 0.1897 
    
Access to Health Provider    
Not difficult at all Reference  - 
Not too difficult 0.923 0.382 - 2.229 0.8582 
Somewhat or very difficult 0.818 0.270 - 2.479 0.7226 
    
Time to Reach the Provider    
Less than 15 minutes Reference  - 
15 - 30 minutes 1.444 0.722 - 2.889 0.2983 
More than 30 minutes 1.695 0.592 - 4.849 0.3255 
    
Having a Usual Source of 
Care    
No Reference  - 
Yes 0.073 0.007 -0.734 0.0262 
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Table 4-17 (Continued) 
 
Variables Missed school/daycare day(s) due to illness 
 Odd ratio 95% CI P value 
    
Predicted Doctor Visits 1.577 0.926 - 4.921 0.1442 
    
Predicted Hospital Visits 2.213 0.082 - 77.024 0.5977 
    
Predicted ER Visits 2.514 0.286 - 22.076 0.4056 
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable. 
 
 
Table 4-18: Rate ratios from the negative binomial regression using missing a 
school/daycare day(s) due to illness as the dependent variable 
 
Variables School/daycare day(s) missed due to illness 
 Rate Ratio P value 
   
Children of HIV Parent 0.7462 0.3114 
   
Child's Age 1.1037 0.0039 
   
Parent's Age 0.9426 0.0011 
   
Child's Gender   
Male 0.9976 0.9916 
   
Race   
Black 1.2591 0.5591 
   
Annual Family Income   
Less than $10,000 pa Reference - 
$10,000 - $20,000 pa 0.6621 0.2213 
More than $20,000 pa 0.7970 0.4738 
   
Level of Education   
12 years or less Reference - 
More than 12 years 0.9174 0.7795 
   
Health Condition   
Excellent/Good health Reference - 
Worst/Bad health 1.0161 0.9715 
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Table 4-18 (Continued) 
 
Variables School/daycare day(s) missed due to illness 
 Rate Ratio P value 
   
Access to Health Provider   
Not difficult at all Reference - 
Not too difficult 0.8085 0.4779 
Somewhat or very difficult 0.7248 0.4190 
   
Time to Reach the Provider   
Less than 15 minutes Reference - 
15 - 30 minutes 1.5982 0.0582 
More than 30 minutes 1.5893 0.2574 
   
Having a Usual Source of Care   
No Reference - 
Yes 0.1488 0.0142 
   
Predicted Doctor Visits 1.5055 0.0623 
   
Predicted Hospital Visits 1.0959 0.8532 
   
Predicted ER Visits 0.6121 0.4029 
   
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable. 
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4.2.3.2 Hypothesis 10 
 
Children of seropositive parent(s) have a higher likelihood to be overweight 
compared to children of HIV seronegative parent(s). 
 
 
4.2.3.2.1 Results of Bivariate Analysis 
 
Descriptive frequency distribution of the data based on the BMI categorization 
indicated that only 20.22% (n=18) of the children living HIV seropositive parent(s) had a 
normal weight compared to 31.46% (n=56) among children living with their HIV 
seronegative parent(s). Nearly 5.6% (n=5) and 5056% (n=45) of the children living with 
HIV seropositive parent(s) were underweight and overweight, respectively. Whereas, 
among the children living with HIV seronegative parent(s), 2.8% (n=5) and 23.03 (n=41) 
were found to under and overweight, respectively. Chi Square analysis indicated these 
differences to be statistically significant (p=0.0012) (Table 4-19). 
 
 
 4.2.3.2.2 Results of Logistic Regression Model 
 
The dependent variable for analysis this hypothesis was whether the child’s was 
categorized as overweight. The variable was dichotomized as ‘yes’ and ‘no’. Logistic 
regression estimates showed that children living with a HIV seropositive parent(s) were 
4.041 times (95% CI: 1.887 – 13.471) more likely to be an overweight child compared to 
children living with a HIV seronegative parent(s) after adjusting for all the child and 
parental predisposing, need and enabling factors. All the other factors were statistically 
insignificant, although variables ‘having any health condition’ (OR: 4.039; 95% CI: 
0.890 – 18.339) and ‘usual source of care’ (OR: 10.203; 95% CI: 0.913 – 114.030) were 
marginally significant at the 0.10 level. Table 4-20 for the logistic regression estimates 
using overweight as the dependent variable. 
 
The Max-rescaled R-square statistics for this model was 23.74% and the Hosmer 
and Lemeshow Goodness-of-fit test was 0.4501, which meant we failed to reject the null 
hypothesis and concluded that the model fits the data. The C statistics was 0.740 which 
means that for 74.00% of all possible pairs of children (one being those who were over-
weight and the other who were not) the model correctly assigned a higher probability to 
those were overweight. 
 
 
4.2.3.3 Hypothesis 11 
 
Children of seropositive parent(s) have a higher likelihood of being currently on a 
prescription medication for any health condition (physical/behavioral), other than 
vitamins, compared to children of HIV seronegative parent(s). 
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Table 4-19: Children who are overweight among the study population (children of 
HIV seropositive versus seronegative parents) 
 
Variable Children of HIV seropositive parent(s)
Children of HIV 
seronegative parent(s) P value 
 Numbers % Numbers %  
      
BMI Categories     0.0012 
Underweight 
(Below 5th percentile) 5 5.61 5 2.8  
Normal 
(5th to 85th percentile) 18 20.22 56 31.46  
Overweight 
(Above 85th percentile) 45 50.56 41 23.03  
Missing 21 23.59 76 42.96  
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
differences between the two groups. 
 
 
Table 4-20: Odd ratios from the logistic regression of the children who are 
overweight as the dependent variable 
 
Variables Overweight 
 Odd ratio 95% CI P value 
    
Children of HIV Parent 0.938 0.425 - 2.069 0.8743 
    
Child's Age 1.201 1.088 - 1.327 0.0003 
    
Parent's Age 0.902 0.857 - 0.950 <0.0001 
    
Child's Gender    
Male 0.660 0.355 - 1.227 0.1888 
    
Race    
Black 1.569 0.562 - 4.379 0.3894 
    
Annual Family Income    
Less than $10,000 pa Reference  - 
$10,000 - $20,000 pa 0.861 0.340 - 2.180 0.7526 
More than $20,000 pa 0.722 0.308 - 1.691 0.4534 
    
Level of Education    
12 years or less Reference   
More than 12 years 2.134 0.926 - 4.921 0.0753 
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Table 4-20 (Continued) 
 
Variables Overweight 
 Odd ratio 95% CI P value 
    
Health Condition    
Excellent/Good health Reference  - 
Worst/Bad health 0.438 0.127 - 1.505 0.1897 
    
Access to Health Provider    
Not difficult at all Reference  - 
Not too difficult 0.923 0.382 - 2.229 0.8582 
Somewhat or very difficult 0.818 0.270 - 2.479 0.7226 
    
Time to Reach the Provider    
Less than 15 minutes Reference  - 
15 - 30 minutes 1.444 0.722 - 2.889 0.2983 
More than 30 minutes 1.695 0.592 - 4.849 0.3255 
    
Having a Usual Source of 
Care    
No Reference  - 
Yes 0.073 0.007 -0.734 0.0262 
    
Predicted Doctor Visits 1.577 0.926 - 4.921 0.1442 
    
Predicted Hospital Visits 2.213 0.082 - 77.024 0.5977 
    
Predicted ER Visits 2.514 0.286 - 22.076 0.4056 
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable. 
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4.2.3.3.1 Results of Bivariate Analysis 
 
Descriptive frequency distribution of the data based on the current status of 
prescription intake of the children in the study sample population indicated that 32.58% 
(n=29) of the children living HIV seropositive parent(s) were currently on some kind of 
prescription medication prescribed by a doctor, other than vitamins compared to 20.78% 
(n=37) among children living with their HIV seronegative parent(s). Chi Square analysis 
indicated these differences to be statistically significant (p=0.0451) (Table 4-21). 
 
 
4.2.3.3.2 Results of Logistic Regression Model 
 
The dependent variable for analysis this hypothesis was whether the child was 
currently on any prescription medication for any medical/behavioral condition. The 
variable was dichotomized as ‘yes’ and ‘no’. Logistic regression estimates showed that 
children living with a HIV seropositive parent(s) were less likely (95% CI: 0.143 – 2.042) 
to be  prescribed a medication for any health reason than the children living with a HIV 
seronegative parent(s) after adjusting for all the child’s and parent’s predisposing, need 
and enabling factors. However, this relationship was statistically insignificant with a p 
value of 0.8343. All the other factors were statistically insignificant except annual family 
income greater than $20,000. A child of parents with an annual family income of more 
than $20,000 was 2.749 times (95% CI: 1.527 – 9.203) and) more likely to have 
prescription medication for any health reason, other than vitamins, compared to children 
with an annual family income less than $10,000.  
 
Children whose travel time to get a provider is greater than 30 minutes are more 
likely to have a prescription medication (OR: 2.964; 95% CI: 0.983 – 8.941), however 
this relationship was only marginally significant (p=0.0537).   
 
 
Table 4-21: Children who are currently on prescription medication for any health 
condition (children of HIV seropositive versus seronegative parents) 
 
Variable Children of HIV seropositive parent(s)
Children of HIV 
seronegative parent(s) P value
 Numbers % Numbers %  
Currently on 
Prescription Medication     0.0451 
Yes 29 32.58 37 20.78  
No 60 67.42 137 76.96  
Missing 0 0 4 2.24  
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference between the two groups. 
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Table 4-22 summarizes the results of the logistic regression model for responses 
on the currently prescribed medications for a health reason as a dependent variable.  
 
The Max-rescaled R-square statistics for this model was 16.20% and the Hosmer 
and Lemeshow Goodness-of-fit test was 0.1768, which meant we failed to reject the null 
hypothesis and concluded that the model fits the data. The C statistics was 0.702 which 
means that for 70.20% of all possible pairs of children (one being those who are currently 
on prescription medication and the other with are not) the model correctly assigned a 
higher probability to those who are on prescription medication, other than vitamins. 
 
 
4.2.3.4 Hypothesis 12 
 
Children of seropositive parent(s) have a higher likelihood to being currently on a 
prescription medication for mental health condition compared to children of HIV 
seronegative parent(s). 
 
 
4.2.3.4.1 Results of Bivariate Analysis 
 
Descriptive frequency distribution of the data for the reason for the current intake 
of prescription among the children in the study sample population indicated that almost 
62.06% (n=18) of the children living HIV seropositive parent(s) were currently 
prescription medication are due to mental health or behavioral reasons compared to 
18.92% (n=7) among children living with their HIV seronegative parent(s). Whereas, 
only 34.48% (n=10) of the children with HIV seropositive parent(s) indicated that the 
medication was for a physical problem versus 81.08% (n=30) among children with HIV 
seronegative parent(s). Chi Square analysis indicated these differences to be statistically 
significant (p=0.0005) (Table 4-23). 
 
 
4.2.3.4.2 Results of Logistic Regression Model 
 
The dependent variable for analyzing this hypothesis was whether the child was 
currently on a prescription medication for a mental/behavioral health condition. The 
variable was dichotomized as ‘yes’ and ‘no’. Logistic regression estimates showed that 
children living with a HIV seropositive parent(s) were 4.520 times (95% CI: 1.503 – 
20.276) more likely be on a prescription medication for a mental health reason than the 
children living with a HIV seronegative parent(s) after adjusting for all the child and 
parental predisposing, need and enabling factors. And this relationship was statistically 
significant with a p value of 0.0101. Apart from income variable, all other factors were 
statistically insignificant. Children with an annual family income more than $20,000 were 
3.8 times (95% CI: 1.243 – 18.774) more likely to be currently on a prescription for 
mental health condition.   
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Table 4-22: Odd ratios from the logistic regression of the children who are and 
aren’t currently on prescription medication for any health condition as the 
dependent variable 
 
Variables Prescription medication for any health condition 
 Odd ratio 95% CI P value 
    
Children of HIV Parent 0.918 0.413 - 2.042 0.8343 
    
Child's Age 1.068 0.939 - 1.178 0.1858 
    
Parent's Age 0.953 0.905 - 1.003 0.0648 
    
Child's Gender    
Male 0.837 0.444 - 1.580 0.5838 
    
Race    
Black 0.683 0.239 -1.955 0.4775 
    
Annual Family Income    
Less than $10,000 pa Reference  - 
$10,000 - $20,000 pa 1.204 0.454 - 3.192 0.7090 
More than $20,000 pa 3.749 1.527 - 9.203 0.0039 
    
Level of Education    
12 years or less Reference   
More than 12 years 0.721 0.306 - 1.698 0.4548 
    
Health Condition    
Excellent/Good health Reference  - 
Worst/Bad health 2.686 0.792 - 9.106 0.1128 
    
Access to Health Provider    
Not difficult at all Reference  - 
Not too difficult 1.23 0.504 - 3.000 0.6496 
Somewhat or very difficult 1.399 0.452 - 4.333 0.5601 
    
Time to Reach the Provider    
Less than 15 minutes Reference  - 
15 - 30 minutes 1.569 0.749 - 3.287 0.2324 
More than 30 minutes 2.964 0.983 - 8.941 0.0537 
    
Having a Usual Source of 
Care    
No Reference  - 
Yes >999.9 - 0.9756 
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Table 4-22 (Continued) 
 
Variables Prescription medication for any health condition 
 Odd ratio 95% CI P value 
    
Predicted Doctor Visits 1.042 0.306 - 1.698 0.8878 
    
Predicted Hospital Visits 0.428 0.042 - 4.389 0.4751 
    
Predicted ER Visits 1.924 0.175 - 21.138 0.5924 
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable. 
 
 
Table 4-23: Children who are currently on prescription medication for any health 
condition (children of HIV seropositive versus seronegative parents) 
 
Variable Children of HIV seropositive parent(s)
Children of HIV 
seronegative parent(s) P value 
 Numbers % Numbers %  
      
      
Type of Prescribed 
Medication     0.0005 
Physical/Medical 10 34.48 30 81.08  
Behavioral 18 62.06 7 18.92  
Other 1 3.44 0 0  
      
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
difference between the two groups. 
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 Children with a perceived health condition of worst/bad also are more likely to be 
currently on a behavioral medication (OR: 5.649; 95% CI: 0.764 – 41.752) compared to 
those children with a perceived health condition of excellent/good. However, this 
relationship was marginally significant (p=0.0898). 
 
The Max-rescaled R-square statistics for this model was 28.37% and the Hosmer 
and Lemeshow Goodness-of-fit test was 0.30.84, which meant we failed to reject the null 
hypothesis and concluded that the model fits the data. The C statistics was 0.821 which 
means that for 82.10% of all possible pairs of children (one being those who have a 
prescription medication for a mental health condition and the other no mental health 
condition) the model correctly assigned a higher probability to those who were currently 
on a prescription medication by a physician for a mental health reason. 
 
Table 4-24 summarizes the results of the logistic regression obtained from the 
model using the information on the whether the children were prescribed any medication 
for a mental/behavioral health condition as the dependent variable. 
 
 
4.3 Sensitivity Analysis 
 
In total 9 children did not have any paired match during the process of matching 
and were excluded in the above analysis. In the sensitivity analysis these 9 children were 
included and logistic regression of the healthcare utilization and health outcome variables 
were performed. Sensitivity analysis showed no differences in the significance of the 
variables observed earlier except that of the hospital visits. In the sensitivity analysis, 
children of HIV seropositive parent were significantly associated with their likelihood to 
have a hospital visit in the past 12 months. A child living with a seropositive parent(s) is 
6 times more likely (OR: 7.883, 95% CI: 1.641 – 37.878) to have hospital visit in 
comparison to a child living with a seronegative parent. 
 
The comparison of the results from the logistic regression using the matched data 
and the sensitivity analysis has been summarized in Table 4-25. 
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Table 4-24: Odd ratios from the logistic regression of the children who are and 
aren’t currently on prescription medication for any mental condition as the 
dependent variable 
 
Variables Prescription medication for any mental health condition 
 Odd ratio 95% CI P value 
    
Children of HIV Parent 5.520 1.503 - 20.276 0.0101 
    
Child's Age 1.124 0.948 - 1.333 0.1781 
    
Parent's Age 0.947 0.862 - 1.039 0.2494 
    
Child's Gender    
Male 1.753 0.597 - 5.146 0.3073 
    
Race    
Black 0.951 0.102 - 8.823 0.9646 
    
Annual Family Income    
Less than $10,000 pa Reference  - 
$10,000 - $20,000 pa 2.202 0.412 - 11.770 0.3561 
More than $20,000 pa 4.830 1.243 - 18.774 0.0230 
    
Level of Education    
12 years or less Reference   
More than 12 years 1.189 0.331 - 4.273 0.7909 
    
Health Condition    
Excellent/Good health Reference  - 
Worst/Bad health 5.649 0.764 - 41.752 0.0898 
    
Access to Health Provider    
Not difficult at all Reference  - 
Not too difficult 1.715 0.404 - 7.274 0.4645 
Somewhat or very difficult 2.081 0.409 - 10.595 0.3775 
    
Time to Reach the Provider    
Less than 15 minutes Reference  - 
15 - 30 minutes 0.894 0.243 - 3.290 0.8657 
More than 30 minutes 3.018 0.586 - 15.550 0.1867 
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Table 4-24 (Continued) 
 
Variables Prescription medication for any mental health condition 
 Odd ratio 95% CI P value 
    
Having a Usual Source of 
Care    
No Reference - - 
Yes 999.9 - 0.9775 
    
Predicted Doctor Visits 0.675 0.258 - 1.768 0.4235 
    
Predicted Hospital Visits 0.827 0.074 - 9.253 0.8776 
    
Predicted ER Visits 1.924 0.175 - 21.138 0.5924 
    
Note: Level of significance was at 0.05, a p value greater than this means no statistical 
association between the dependent and the independent variable. 
 
 
Table 4-25: Comparison of the results from the logistic regression using the matched 
data and the sensitivity analysis 
 
Variables Original group (N=267) Combined group (N=276)
 OR P value OR P value 
     
Doctor Visit 2.682 0.0276 2.695 0.0236 
Hospital Visit 4.383 0.0844 7.883 0.0099 
ER Visit 2.007 0.0887 2.085 0.0656 
Missed School/Daycare 
Days 0.938 0.8743 0.973 0.9467 
Overweight 5.041 0.0013 4.729 0.0013 
Prescription Status 0.918 0.8343 0.943 0.8840 
Prescription for Mental 
Health 5.520 0.0101 4.952 0.0010 
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CHAPTER 5: DISCUSSION 
 
 
This chapter summarizes the findings of the study along with its limitations and 
conclusion. The discussion on the impact of HIV status of the parent as part of the study 
findings has been divided into three sections – impact on child’s access to healthcare, 
impact on child’s healthcare utilization of resources and impact on the child’s health 
outcomes. Recommendations for future research are discussed at the end of this chapter.  
 
The parent’s role in the development and growth of a child is critical. Parents are 
the ‘gatekeepers’ and hence the decision-makers on issues related to the health of the 
child. Any factor that tends to impact the decision making ability of the parent will surely 
have an impact on the development and growth of the child. This study considered the 
HIV status of the parent as one such factor. In this study the investigators aimed at 
examining the impact of the parent’s HIV status on healthcare access, healthcare 
utilization and health outcomes of their children residing with them. Studies have already 
identified some impacts of parent’s health on the healthcare utilization and the health 
outcomes in children.116,117 However, the current literature is devoid of information on 
the impact of HIV-infected parent’s health status on their uninfected child in the context 
of the child’s access, utilization and outcomes of the resources used. The prime reason for 
the absence of such studies is that this phenomenon of uninfected children living with 
their HIV seropositive parents has been recently experienced. A decade ago, HIV-
infected individuals had a very short life expectancy and limited treatment options. Also, 
their children lived with other caregivers, such as grandparents, or landed up in foster 
care facilities, and even before the demise of their infected parent(s). Recent 
developments in antiretroviral therapy and continuous social awareness of the disease has 
not only improved the life expectancy of the infected individuals, but have also increased 
their quality of life. As a result, more and more HIV-infected parents are seen to opt for 
parenthood despite the knowledge of their HIV infection. This study adds immensely to 
the literature of parental health impacts on the child, especially among the HIV-infected 
population. Also, the findings of this study have provided crucial information that could 
lead to several research questions and thus augment future studies. 
 
 
5.1 Impact of Parent’s HIV Status on the Child’s Access to Healthcare 
 
This study concludes that the child’s access to healthcare resources is severely 
hampered due to the HIV status of their parent(s). Access to healthcare, as defined by the 
Institute of Medicine, is “the timely use of personal health services to achieve the best 
possible health outcomes”.118,119 According to the various theoretical and empirical 
concepts having a health insurance and a regular source of care are key constructs of 
access to healthcare.32,120 Also, the definition of access by IOM emphasizes the 
importance of time as a factor that influences one’s access to healthcare resources. 
Therefore, this study looked at access to healthcare insurance, access to regular source of 
care, travel time to get to a provider and level of difficulty faced to get to a provider as 
the critical variables to analyze the child’s access to healthcare. 
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5.1.1 Impact on Child’s Access to Health Insurance 
 
This study shows that the HIV seropositive status of the parents had no impact on 
access to health insurance for children. In fact, children of HIV seropositive parents were 
found to have higher access to prescription drug coverage in comparison to children of 
HIV seronegative parent(s). Increased emphasis on the awareness of HIV as a chronic 
disease and continuous government initiated programs that provide health insurance 
coverage to certain marginalized sections of the society can be one reason that explain 
this finding. As almost 85% of the study sample population belonged to a low-income 
category, i.e. had an annual family income of less than $20,000, hence they all were 
eligible for state funded health insurance policies. The study also found that a greater 
portion of children living with HIV seropositive parent(s) were covered under publicly 
funded insurance compared to those living with HIV seronegative parents. The fact that 
the HIV population is more exposed to various health related awareness programs than 
non HIV individuals and that all HIV individuals, once diagnosed, are eligible for 
government funded insurance seems to justify the high proportions of children living with 
HIV seropositive parent having a public health insurance and a prescription drug 
coverage. This finding also supports the observations reported in other studies where a 
high degree of association between the parent’s insurance status and the child’s insurance 
status was observed.117,121 A study by Lambrew J M (2001) on the US population found 
that low- income people and people with chronic diseases were less likely to have a 
private insurance.121 The study also highlighted the fact that among low-income parents, 
health insurance was a matter of concern and when parents were insured, there was a 
higher likelihood that their children will also be insured.121 Based on this fact, since most 
HIV seropositive parents have government sponsored prescription drug coverage, it was 
found that their children had prescription drug insurance in place compared to children of 
HIV seronegative parents.  
 
 
5.1.2 Impact on Child’s Access to Regular Source of Care 
 
No difference between the children of HIV seropositive and seronegative parents 
were observed in terms of their access to a regular source of care. Health insurance 
exhibits a critical role in access to health care services in the current healthcare system in 
the US. Hence having healthcare insurance ensures a regular source of care for the 
individual. Since in our study almost everyone had health insurance hence everyone had 
access to a regular source of care. 
 
 
5.1.3 Impact on Child’s Access to a Healthcare Provider 
 
Children of HIV positive parent(s) took more time to get to a provider compared 
to children of HIV seronegative parents. The study concluded that these children also 
experienced greater difficulty in getting to a provider. It was also found that almost a 
quarter of the children of HIV seropositive parents had to rely on public transportation 
systems, or use a hired vehicle and some had to even walk to reach their regular source of 
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care. This problem of transportation to avail healthcare was minimal among children 
living with their HIV seronegative parent as more than 80% of them owned a vehicle. As 
this study was conducted in the city of Memphis where the public transportation system 
is not well developed compared to other metropolitan cities in US the hindrances posed 
by it is understandable. Also the differences in the sources of data for the primary group 
and the comparative group, i.e. the primary group came from Memphis, US, while the 
comparative group came from the southern states in US, could have influenced this result. 
Longer travel time and absence of adequate mode of transportation may explain to a great 
extent why the HIV seropositive parents reported very or somewhat difficulty in getting 
to a healthcare provider in case of any medical need for their children compared to HIV 
seronegative parents.  
 
 
5.2 Impact of Parent’s HIV Status on the Child’s Healthcare Utilization 
 
Three variables measured the child’s healthcare utilization: child’s doctor visits, 
hospital visits and emergency room visits during the last 12 months. This study found 
that children of HIV seropositive parent(s) had significantly higher doctor visits and were 
more likely to make such visits compared to children of HIV seronegative parents. 
However, no difference in their likelihood for hospital visits and emergency rooms visits 
were observed. 
 
 
5.2.1 Impact on Child’s Visit to a Doctor 
 
Being HIV seropositive exposes the infected parent to numerous opportunistic 
infections and health related ailments. Therefore HIV-infected parents themselves utilize 
a greater quantity of healthcare resources. Previous studies indicate that parent’s 
utilization of healthcare resources significantly influences the utilization of resources by 
their children.117,122 One such study documented that children were two to three times 
more likely to see a doctor if their parents had seen a doctor, and that parents having 
health insurance are more likely to seek care.117 In this study similar results were 
observed among children of HIV seropositive parents. This may partly explain the study 
findings. One other possible explanation could be the observed phenomenon of 
‘defensive mothering’ among parents suffering from life threatening chronic illnesses. 
Mothers suffering from serious medical and psychological illnesses have been found to 
make higher referrals to specialists, and expressed less willingness to accept medical 
assurances. Such mothers also tend to perceive the medical condition of their child as less 
healthy.116 This reason could probably explain the high number of doctor visits among 
children living with their HIV seropositive parent(s) observed in this study, compared to 
children living with their HIV seronegative parent. Altman et al. (1987) found that 
children of families with members with disability had higher utilization of doctors visits 
compared to children of families without disability.63 Since the results were adjusted for 
child’s health status, family income and insurance status, the possibility of these variables 
influencing their healthcare utilization was excluded. 
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5.2.2 Impact on Child’s Visit to a Hospital 
 
In regards to hospital visits, no significant association was observed between the 
parent’s HIV status and the child’s likelihood for a hospital visit. However, its 
association with the number of hospital visits in the past 12 months was significant. 
These children had a higher number of hospital visits compared to children of HIV 
negative parents. The suggestive explanation seems to be that parent’s HIV status did not 
influence the parent’s decision to take their child to a hospital although it greatly 
influenced the subsequent visits if an earlier visit was made. Presence of fear and 
uncertainty among the HIV-infected mothers is obvious, and the perception among the 
mothers that their child’s health less than normal may be the underlying reason. This also 
suggest that the initiation of the hospital visits for a child may be the result of the child’s 
actual medical need, while children of HIV seropositive parent(s) were more prone to 
subsequent visits compared to those of HIV seronegative parents. 
 
 
5.2.3 Impact on Child’s Visit to an Emergency Room 
 
This study found no association between the HIV status of the parent and the 
child’s likelihood for an emergency room visits among the children. This result adds to 
the previous work by Lipstein et al. (2009) where similar results were observed among 
children of parents suffering from chronic diseases.123 However, the binomial regression 
of the children having atleast one emergency room visit showed that children of HIV 
seropositive parent(s) had higher number of emergency room visits than the children of 
HIV seronegative parents. This finding is similar to that observed in the hospital 
utilization patterns among children of HIV-infected parents. It seems the perception of 
the parent regarding the health of their children, as explained by the concept of ‘defensive 
mothering’, may influence the child’s utilization of healthcare services. Further research 
is required to understand the exact reasoning of these phenomena. 
 
 
5.3 Impact of Parent’s HIV Status on the Child’s Health Outcomes 
 
The health outcomes variables considered for this study were missed 
school/daycare days in the past 12 months, child’s Body Mass Index (BMI) and the 
current prescription medication status of the child. Productivity of an individual in the 
work force is a variable generally used in economic literature as a measure of the health 
status. However, among children their productivity is measured by their performance in 
the school/daycare. Absenteeism is highly association with performance hence missed 
school/daycare days was considered as an indicator for the child’s productivity. The BMI 
has been considered as one of the good and easily measurable indicators of child’s health 
outcomes hence was a variable of interest in this study.124 Evidence of consumption of 
prescription drugs indicates the presence of the medical condition for which the 
medication has been prescribed. Current intake of prescription medication for either 
physical or mental reason was taken as an indicator of the child’s health outcomes. 
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5.3.1 Impact on Child’s Productivity in School/Daycare 
 
No differences were observed in the likelihood or number of missed 
school/daycare days among children living with HIV seropositive and seronegative 
parents. Thus from this study it was concluded that the HIV status of the parent did not 
impact the overall productivity of their children. Increase in the quality of life among 
HIV patients adhering to the HAART treatment in recent years is well documented.125,126 
Adherence to the HAART treatment is a prime factor for desired treatment outcomes and 
individuals with children have been found to be more serious in their adherence to the 
treatment guidelines. Since our study population was comprised of children in a family 
setting hence it is quite possible that most parents had optimal adherence to treatment 
guidelines. This study did not have adequate information on the parenting skills and 
disease coping skills of parent hence it limited interpretation of this study finding. Length 
of period the individual has been exposed to the disease plays a crucial role in the 
development of adequate coping skills. Since our study inclusion criteria considered 
children born to HIV-infected parent after the detection of the disease it is possible that 
these parents were mentally prepared and were more responsible or over cautious towards 
the health of their children. Another line of thought could be that HIV-infected parents 
prefer to send their kids to school/daycare irrespective of their health status as they are 
unable to provide the adequate attention and time demanded by a child when they stay at 
home.  
 
This particular finding contradicted an earlier study that reported high number of 
school/daycare days missed due to illness among children living with parent suffering 
from chronic disease versus children living with parents with no chronic disease.127 
However, the previous study looked at children suffering from asthma and this criterion 
may have lead to the observed contradiction.  
 
 
5.3.2 Impact on Child’s Body Mass Index 
 
Though the bivariate analysis showed a significant proportion of children living 
with HIV seropositive parent(s) are overweight, the multivariate logistic analysis showed 
no differences in the likelihood of a child of HIV seropositive parent(s) to be overweight 
compared to children of a HIV seronegative parent. Similar results were observed by 
studies done in European setting by Ross et al. (1995) and Newell et al. (2003).19,20 
Therefore, this study concludes that the HIV status of the parent does not impact the 
height and weight of the child residing with them. Agostoni et al. (1998) also reported no 
difference in the BMI of uninfected children in the first 6 months compared to the 
reference group born at the same hospital.128 Growth faltering is dependent on various 
socio-economic and environmental variables and not just on the health status of the 
mother. Since both the groups compared in this study were similar in terms of their socio-
economic variables the difference in their BMI was minimal. This finding was in 
agreement with other studies found in the literature. 
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5.3.3 Impact on Child’s Prescription Drug Status 
 
The information on the prescription drugs administered by the child other than 
vitamins during the study period provided crucial information on the presence of a 
medical or health condition. This information also assisted in understanding whether this 
medical condition was physical or behavioral in nature. This study concluded that the 
HIV status of the infected parent has no impact on the prescription drug status of the 
child. However, further subgroup analysis on the type of prescription drug administered 
by the child revealed that significantly higher proportion of children living with HIV 
seropositive parent(s) were on psychotropic medications compared to children living with 
HIV seronegative parents. This suggests that children of HIV seropositive parent(s) are 
vulnerable to severe mental and behavioral disorders. As this study considered the 
information on administered psychotropic medications as an indicator of mental health 
condition in a child, it is possible that this approach may have missed those children who 
may have mental health needs but currently were not on any kind of prescription 
medication. In this scenario, our study findings could have underestimated the presence 
of mental health needs in this population. The prevalence of mental health problems 
among children of parents with somatic illness has been well documented.11,129-131 
Several studies have reported the presence of emotional and behavioral problems among 
children of cancer patients, especially in their adolescent age.68,132-134 Depression is one 
of the most common symptoms observed in chronically ill parents and an extensive 
personal limitations associated with depression among women is also well established.67 
Families of HIV-infected individuals are further exposed to alterations in daily family 
routines caused by regular hospital and physician visits which can be overwhelming for 
the children.68 Social stigma is one big factor that burdens the infected person 
continuously and the impact of the disclosure of the parents HIV status on the children is 
enormous.  
 
Concurrently, these findings need to be interpreted cautiously as some studies 
looking at the long term impacts of parental HIV status on their mental health of the child 
provide a different picture. A study by Murphy et al. (2006) found significant declines in 
degree of behavioral problems among children living HIV-infected mothers and that it 
was significantly associated with the health status of the parent at the time of entry in to 
the study.135 In a pilot study, Pilowsky et al. (2001) revealed no significant differences in 
the psychopathological symptoms in children of HIV-infected versus non-HIV-infected 
parents.89 This study did not take the severity of the HIV disease of the parent in to 
consideration and this could limit the strength of the conclusions. Also, several antisocial 
behavioral factors such as drug abuse, crime, unwanted sexual orientation, etc, in HIV 
parents, which are prevalent in the HIV-infected population and had the potential to bias 
the study result, were not considered in this study. It has been estimated that 40% of the 
HIV population has been a recent drug user and this could potential bias the results.86 
Numerous such factors prevalent among this population are required to be included to get 
the clear picture. Consequently, this study suggests further research to unearth the long 
term impacts of the parent’s HIV status on their children.  
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5.4 Limitations 
 
The study possesses certain limitations which may induce unobserved bias in to 
the analysis and some of these have been discussed below. 
 
The study used a convenience sampling method to identify the HIV seropositive 
parents visiting the study sites. This method did not reach those HIV seropositive parents 
who were not encountered at the study sites during the period of study or those who are 
not associated with the study sites. Since the study sites address more than 80% of the 
HIV-infected population in and around the city of Memphis, TN, the investigator is 
confident that its impact on the final results was minimal. The findings of this study may 
not be generalized to the complete HIV/AIDS population in the US, but the study result 
represents HIV-infected populations similar to the study population used in this study. 
 
The CDC report, 2008, estimates that almost 25% of the HIV-infected population 
was unaware of their HIV positive status. As the comparative group extracted from the 
MEPS database consisted of individuals having no previous record of an HIV infection 
and was not based on a HIV serological test. There is a possibility that the comparative 
groups may consists of HIV-infected parents who were unaware of their infection. 
Absence of a confirmatory serological test to identify HIV negative parents may limit the 
study results. 
 
The information on the children living with HIV seropositive and seronegative 
parents were parent-reported information. The study assumed that the parents were well 
informed about the health of their child and hence provided the best answers to the 
questions posed to them during the interview process. The questionnaire used for this 
study was derived from the Child Health Questionnaire (CHQ), similar to the one used by 
MEPS in their data collection process.104 The reliability and validity for the use of CHQ 
in HIV patient population has been well established in previous studies hence the effect 
of this limitation on the study finding is negligible.136 Like all self reported studies, this 
study may also be subjected to recall bias as the data collected is based on self-reported 
events. 
 
The information on the children of HIV seropositive was collected through a 
primary data collection procedure and the comparative data, i.e. information on children 
of HIV seronegative data, was obtained from the MEPS 2006 survey data. Since 
information on the groups compared was obtained from two different sources thus may 
induce certain observed and unobserved bias, apparent to observational studies, during 
the analysis of the study. However, the study used a propensity based matching technique 
before the analyses to ensure groups were as similar as possible and this attenuated the 
biases induced due to difference in their source. The use of this technique to reduce the 
observed and unobserved bias, generally experienced in observational studies, has been 
well established.105,107,110 
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5.5 Conclusion 
 
The purpose of this study was to understand the impact of the parent’s HIV 
seropositive status on the access to healthcare services, healthcare service utilizations and 
health outcomes in their uninfected children currently living with them. Upon analysis, 
several conclusions were derived and documented. 
 
One of the main conclusions was that the HIV status of the parent affected their 
child’s access to healthcare services. In traditional theoretical models health insurance is 
significantly linked to access to healthcare. The general thinking within the current health 
system is that if adequate health insurance is available, then the healthcare requirements 
of the children from culturally and traditionally diverse backgrounds can be met with this 
present system.137 This line of thinking delineates the existence of several other 
institutional barriers such as public transportation policies, micro level family based 
barriers, education and ethnic sentiments, etc, that may dictate the child’ access to 
healthcare in conjunction with health insurance. Health insurance is a key element to 
having an access to healthcare services but does not ensure adequate utilization of 
resources. This fact was highlighted from this study which showed that most children had 
health insurance in place, but absence of basic transportation hampered their timely 
utilization of basic healthcare services. 
 
Another conclusion of this study was that these children have an over-utilization 
of health resources, especially with respect to visits to a physician. A high number of 
physician visits were observed among children living with HIV seropositive parent(s) in 
comparison to children of HIV seronegative parent(s). It seems that availability of the 
health insurance allowed accessing physician’s services. However, this utilization could 
not be explained as the results of this study were adjusted for the health of the child. Also, 
no differences in the likelihood of utilization of hospital and emergency room services 
between the children of HIV-infected and non-infected parents negate the possibility of a 
disease induced demand for healthcare services. Presence of fear and apprehension that 
their child is not as healthy as other children or that their children may fall sick may have 
lead to this psychosis driven demand for healthcare resources. Information, education and 
communication have been identified as key drivers of successful public health policies 
and absence of these elements limit the adequate implementation and execution of a 
healthcare program. This study call for education and awareness programs which focus 
on the HIV-infected mothers related to parenting and child development skills. 
 
Finally, this study concluded that the parent’s HIV status did not impact the 
physical development of the child as no differences in the BMI of the child or 
absenteeism in the school/daycare were observed. However, the impact on psychological 
growth of the child was significant. Almost 60% of the children on prescription 
medications were taking them due to mental health reasons. This association needs to be 
seriously looked at as the presence of mental health problems among children of critically 
ill parents has been well documented. Children experiencing mental health problems 
during their childhood have been found to have diminished social, emotional and 
cognitive skills. They are more prone to be school dropouts, develop alcohol and illicit 
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drug use, engage in anti-social activities, are more likely to be involved in juvenile crimes, 
develop suicidal tendencies and may result to an early death.138-140 
 
The presence of mental health problems observed in this study can also be 
explained by the age group of the study population. The mean age of children in this 
study was around 8 years. Children of this age group (6 – 11 years) develop a sense of 
autonomy and have greater emotional independence.141,142 This group of children 
separate easily from their parents and see themselves as autonomous individuals leading 
to initiation of their self-esteem/self-regard, in relationship to others.141 This transition 
from early adolescence to middle adolescence plays a significant role in the degree of 
influence a parent may have on their children.143 Responses of parents toward this 
personality shift among their children is crucial in the further development of the parent-
child relationship. If the parent is unable to provide adequate attention to their child 
during this growth phase, which may arise because of depression, physical illness such as 
HIV/AIDS, or even due to illicit lifestyle behaviors, may have long term detrimental 
effects on the child’s behavior. Some children may internalize these responses of their 
parent(s) as ‘non-motivating’ or ‘disapproval’ resulting in the child developing poor self-
worth.141 Parent(s) in this study were suffering from HIV/AIDS and the related diseases, 
and presence of behavioral and personality related limitation among this population is 
well established.144-146 This limited attention and lack of motivational responses shown by 
HIV-infected parent(s) may turn the behavior of a child inward (depression, poor social 
skills, etc) or outward (bullying fighting, poor academic performance). Attending to the 
mental health needs among HIV patients through adequate interventions has also been 
recommended in various global HIV/AIDS initiatives such as the World Health 
Organization’s ‘3 by 5’ Initiative.147 Further study is recommended to understand the role 
of different child’s age groups and the age-specific psychological dynamics in 
manifesting the impact of parent’s HIV status on their uninfected children. 
 
 
5.6 Policy Implications 
 
As this study was conducted on a restricted population, further research needs to 
be augmented to generalize the result to a larger population. However, certain key lessons 
were learned from this study which can have certain health policy implications. Most 
public sponsored programs targeted for the HIV population are individual centric and 
hence catering to the needs of HIV-infected individuals.148 With the observed impacts of 
the parents HIV status on healthcare access, resource utilization and certain long term 
health outcomes from this study, it is necessary to move the current programs to a more 
family-centric approach. Current programs that facilitate healthcare resources to HIV-
infected populations need to also include children and families affected by HIV. There is 
a need to design and implement interventions focusing on children’s current unmet 
mental health needs among this at risk population. 
 
This study also highlights the need for treatment guidelines especially for 
healthcare professionals providing medical care to children. Since this study showed a 
significant impact of the parent’s HIV status on nutrition and mental health of the child, it 
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becomes necessary for the parents to disclose their HIV status to their child’s physician. 
Consequently, each physician needs to be aware of the parent’s HIV status in order to 
make adequate treatment decisions regarding their child age patients. As a policy, it is 
suggested that each parent should be required to disclose their HIV status as a part of 
their child’s medical history. Policy makers should ensure that this requirement be an 
integral part of the treatment guidelines for every health professional managing 
healthcare needs of the children of HIV patients. 
 
 
5.7 Recommendations for Future Research 
 
This study has brought to our attention issues relating to access to healthcare 
resources, lack of education and fear among HIV-infected parents, and impact of the 
parent’s HIV status on the psychological development of the HIV affected child. In order 
to identify, design and implement adequate policies and programs that will provide 
education and enhance the awareness of the HIV-infected parents, policy makers and the 
healthcare community, a comprehensive research is required. Some of the 
recommendations for future researchers are as follows: 
 
1. A study that has more generalizability to the HIV/AIDS population in the US 
should be augmented. This will help provide a comprehensive picture of the 
actual impact of parent’s HIV status on their children. This will also enable the 
design of policies at the State and Federal level. 
2. Since most of the study participants were African Americans and non-Hispanics, 
this study could not analyze the racial and ethnic disparities in its findings. Future 
research is required to understand the existence of any such variations in the 
impact in order to address it accordingly. 
3. Geographical factors such as zip codes, type of city, state specific policies, etc 
were not considered in this study. Hence future research is recommended to 
understand the variations in results after adjusting for these factors. 
4. Better understanding of the impact of parent’s HIV status on the different age 
groups of children is necessary so that adequate policies can be made more 
specific during implementation. 
5. This study looked into cross sectional or short-term impacts and therefore a study 
focusing on the long term impacts of the parent’s HIV status on their children is 
recommended. 
6. Variation in the impact of HIV status based on parent-specific factors such as 
HIV parents using illicit drugs or disclosure of their status to the children, etc, are 
specific questions a researcher may be interested in investigating in the future. 
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A.1 History of HIV/AIDS 
 
The history of HIV virus has been really fascinating. Serological evidences 
confirm that the virus has been in existence since 1959.149 Zhu et al. (1998) found the 
strains of the HIV/AIDS virus in the blood sample obtained from an adult Bantu male, 
who died of an unexplainable disease in the Leopoldville region of Belgian Congo (now 
Kinshasa, Democratic Republic of Congo).150 The first case of HIV diagnosed in the 
United States was reported among five gay men in the June 5, 1981, in their Morbidity 
and Mortality Weekly Report (MMWR), by the Center for Disease Control and 
Prevention (CDC).151 This report identified this disease as a “cellular-immune 
dysfunction related to a common exposure” and a “disease acquired through sexual 
contact”. Later, this virus was named ‘Human Immunodeficiency Virus, commonly 
known as ‘HIV’. 
 
 
A.2 Human Immunodeficiency Virus Disease (HIV) 
 
Human Immunodeficiency Virus was first isolated in 1983 from a patient with 
lymphadenopathy and was identified as the causative agent of Acquired 
Immunodeficiency Syndrome (AIDS) by 1984.152 HIV represents the subfamily of 
lentiviruses (Lentivirinae) of the human retroviruses family (Retroviridae) and apart from 
human beings it infects mainly the vertebrates. The human retroviruses can be classified 
in to two groups: the human T lymphotropic viruses (HTLV-I and HTLV-II), which are 
transforming retroviruses, and the human immunodeficiency viruses (HIV-1 and HIV-2). 
HIV-1 and its subtypes are the most common cause of the infection seen throughout the 
world, and in the United States, while HIV-2 has been detected in several cases in West 
Africa or in cases with sexual contact with West Africans. Both the types are classified as 
zoonotic infection but HIV-1 is the main cause of the infection among human beings. 
 
 
A.2.1 Morphology of the Virus 
 
The view of the virus observed through an electron microscope reveals the 
icosahedral structure with several spikes on the external surface formed by the two main 
envelop proteins, the external gp120 and the transmembrane gp41 (Figure A-1).  
 
Retroviruses measure 70 – 140 nm in diameter and consists of a lipid-containing 
envelop which surrounds the icosahedral capsid with a dense inner core. Within this core 
are two identical copies of single-strand RNA genome. The RNA genome is fused with 
reverse transcriptase and tRNA, and is 8-10 kb long. The virion particle also consists of 
other viral proteins, such as the integrase. Similar to the mRNA, virion RNA has a cap 
site at the 5’ end of the RNA genome, which is important in the initiation of mRNA 
translation, and a polyadenylation site at the 3’ end, which influences mRNA turnover. 
This feature cases messages with shorter polyA tails turn over faster then messages with 
longer polyA tails. However, there is no translation of the retroviral RNA, instead it is 
transcribed in to DNA, and this DNA form is called a provirus. 
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Figure A-1: Schematic structural representation of the HIV-1 
(Reprinted with permission from McGraw Hill Companies, Inc®. Fauci AS, Lane CH. 
Human Immunodeficiency Virus Disease: AIDS and related disorder. In: Anthony 
S.Fauci, Dennis L.Kasper, Dan L.Longo et al, Eds.  Harrison's Principles of Internal 
Medicine. 17th Edition. The McGraw-Hill Companies, Inc.; 2008:1137-1203.)153  
 
 
A.2.2 Replication Cycle of HIV 
 
The transformation of the genomic RNA to DNA in HIV is brought by the enzyme 
reverse transcriptase. The replication cycle of the HIV starts with the binding of the virus 
to the host cell surface, the CD4 molecule. This is done by the N terminus of the V1 
region of the gp120 protein which has a high affinity for the cell surface. This facilitates 
the penetration of the gp41 in to the plasma membrane of the CD4 cell and then the 
coiling of this protein brings the virion and the target cell together. Once both these cell 
fuse it triggers the release of the protein coated capsid containing the viral RNA and the 
enzymes in to the cytoplasm of the target cell. Through the cytoplasm this complex 
capsid reaches the nucleus, and then the reverse transcriptase enzyme catalyzes the 
reverse transcription of the genomic RNA in to DNA. The protein coats break open 
thereby releasing the double-stranded HIV-DNA in to the host CD4 cell. The HIV 
provirus DNA with the help of the enzyme integrase integrates with the chromosomes of 
the host cell. At this stage the provirus may remain inactive (latent period) or may even 
manifest itself to actively produce more viruses. Further progression of the disease is 
dependent on the interaction of a number of cellular and viral factors. From the 
therapeutic point of view each stage of the replication cycle of the HIV is a potential 
target for pharmacologic intervention (Figure A-2). 
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Figure A-2: The replication cycle of HIV 
(Reprinted with permission from McGraw Hill Companies, Inc®. Fauci AS, Lane CH. 
Human Immunodeficiency Virus Disease: AIDS and related disorder. In: Anthony 
S.Fauci, Dennis L.Kasper, Dan L.Longo et al, Eds.  Harrison's Principles of Internal 
Medicine. 17th Edition. The McGraw-Hill Companies, Inc.; 2008:1137-1203.)153 
 
 
 115
A.2.3 Transmission 
 
HIV is a sexually transmitted disease and transmitted by both homosexual as well 
as heterosexual contact. Additionally, HIV can be transmitted by blood and blood 
products; and from mother to infant, either intrapartum, parentally, or via breast milk.153 
In United States, male-to-male sexual contact resulted in approximately 49% of the 
infection while the heterosexual sexual contact accounted for nearly 32% of new 
infection, rest through other non-sexual routes. Although worldwide, heterosexual contact 
is the most predominant cause for the spread of the disease. Among the non-sexual 
contact route of infection, infection because of sharing of paraphernalia such as needles, 
syringes or cottons is predominant. This is common among intravenous drug users (IDU) 
and individuals with hemophilia or other clotting disorders. In case of mother-to-child 
transmission of HIV infection the likelihood of the transmission is high in the perinatal 
stage. Studies done on the HIV mothers in Rwanda and Zaire showed 23-30% of the 
children were infected before birth (prenatal), 50-65% during birth, and 12-20% via 
breast feeding. Transmission of the HIV infection via saliva is yet to be evident.153 
Studies have shown that the human saliva contains certain antiviral immunoglobulins of 
IgA, IgG, and IgM isotypes that inhibits the growth of HIV. Though rare, transmission of 
the infection via human bite has been reported. The possibility of transmission from the 
exposure to tears, sweat and urine has been negated. Male to male contact has been the 
prime cause of HIV transmission followed by IDU and heterosexual routes in the United 
States (Figure A-3). 
 
 
A.2.4 Pathogenesis 
 
One of the main features of the HIV infection is the prolific immunodeficiency 
resulting because of the weakening or loss of the subset of T lymphocytes called the 
helper T cells. This helper T cell is characterized by the presence of the CD4 molecule on 
its surface and it is this site which serves as a primary target for HIV during cell attack. In 
order for the HIV-1 to enter in to the cell apart from the primary cellular receptor (CD4 
molecule) a co-receptor is also required for efficient fusion. The destruction or depletion 
of this CD4+ T cells upon infection either happen either by the immune clearance of the 
infected cell (direct mechanism), or by immune exhaustion due aberrant cellular 
activation and activation-induced cell death (indirect mechanism). The virus is successful 
in evading the immune clearance system and is never eliminated from the human body, 
and it actually thrives upon the activation of the immune system. In untreated patients the 
HIV can persists in the system for a period of approximately 10 years before any 
significant clinical symptoms appear. This chronic and persistence presence of the 
infection is the traditional characteristic of HIV. This persistence of the virus has been 
attributed to its amazing ability to replicate with diversity via mutation and recombination. 
The progression of the virus results in further depletion of the CD4+ T cells and hence 
CD4+ T cells acts as a clinical measure for the progression of the disease. The 
concentration of these cells fall significantly in infected individuals who are either 
untreated or in whom the treatment is not effective in controlling the viral replication. 
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Figure A-3: AIDS cases among U.S. adults and adolescents by exposure category 
and year of diagnosis 
(Center for Disease Control and Prevention. Epidemiology of HIV/AIDS--United States, 
1981-2005. Morb Mortal Wkly Rep. 2006;55:589-592.)2 
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CD4+  T cells are the integral part of the body’s antigen-specific immune humoral 
as well as cell mediated response. Continuous loss of these viral specific helper T cells 
has a direct impact on the control of the immune system of the other types of infections. 
The fall in the concentration of the CD4+ T cells below a threshold of 200/µL exposes 
the individual to a myriad of opportunities infections. This stage in the progression in the 
HIV infection is termed as Acquired Immunodeficiency Syndrome or ‘AIDS’ (Table     
A-1). Individuals with CD4+ T cells counts as low as 10/µL or even zero has been 
reported. This compromised immune system opens the gates for several bacterial and 
fungal infections. Immunological disorders such as Kaposi’s sarcoma and neurological 
abnormalities are observed as AIDS related diseases. Respiratory infections like 
pneumonia, acute bronchitis, nonspecific interstitial pneumonitis, and tuberculosis are 
commonly seen in individuals with AIDS.  
 
 
A.2.5 Diagnosis and Detection 
 
Development of the screening and diagnostic testing took pace immediately after 
the establishment of HIV as a causative agent of AIDS in 1984. All blood donors were 
screened for the HIV antibodies sin 1985 in the United States. The early screening 
methods like the p24 antigen test had the ability to identify the presence of the disease 
after 3 months of the infection, that the time between infection and the development of 
the disease. But subsequent refinement of this technique shrunk the interval between 
infection and detection (window period) to 22 days antibody testing, later to 16 days with 
advanced p24 antigen testing and then finally to 12 days with the development of the 
nucleic acid testing (NAT). 
 
 
Table A-1: 1993 Revised classification system for HIV-infected and expanded AIDS 
surveillance case definition for adolescents and adults  
 
 Clinical categories 
A B C 
CD4+ T cell 
categories 
Asymptomatic, 
Acute (Primary) 
HIV or PGL* 
Symptomatic, 
not A or C 
conditions 
AIDS-indicator 
conditions 
>500/uL A1 B1 C1 
200-499/uL A2 B2 C2 
<200/uL A3 B3 C3 
* PGL, progressive generalized lymphadenopathy. 
(Reprinted with permission from McGraw Hill Companies, Inc®. Fauci AS, Lane CH. 
Human Immunodeficiency Virus Disease: AIDS and related disorder. In: Anthony 
S.Fauci, Dennis L.Kasper, Dan L.Longo et al, Eds.  Harrison's Principles of Internal 
Medicine. 17th Edition. The McGraw-Hill Companies, Inc.; 2008:1137-1203.) 153 
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One of the most successful screening tests used for HIV detection is the Enzyme 
Immunoassay (EIA), commonly known as the ‘ELISA’ test. The ELISA test is a 
combination of the antibody test and the p24 antigen test. The ELISA kit contains 
antigens of both HIV-1 and HIV-2 genomes from both the natural and recombinant 
antigen types. The ELISA test has a sensitivity of more than 99%, but the specificity of 
this test is highly questionable. Further confirmatory test have shown that only 10% of 
the individuals tested positive by ELISA test actually had the disease. Auto-antibodies 
and class-II antigens from the hepatic disease, recent influenza vaccination, and acute 
viral infection attribute to these false positive results. The Western blot test is used 
mostly as a confirmatory test for HIV infection. The fundamental theory behind this test 
is that the multiple HIV antigen of different with specific molecular weight triggers the 
production of specific antibodies. Each of these antibodies can be identified as discrete 
bands on the Western plot. This technique has high specificity which makes it a 
recommended confirmatory test by the U.S. Food and Drug Administration, however, its 
low sensitivity makes it a poor choice for screening purposes. Apart from these two 
commonly used tests, other test such as the DNA PCR, RNA PCR, the bDNA assay, or 
p24 antigen tests are available for specific information. 
 
The serological testing guidelines for the detection of HIV infection suggest 
ELISA test for screening of suspected individuals. A negative test result confirms 
absence of the disease, unless there is a strong evidence of early infection. In case of a 
positive result, the same test needs to be repeated. If two consecutive repeats show 
negative then the initial positive result is assumed false positive or an error, and patient is 
considered negative for HIV infection. If the repeat test is again positive then the Western 
blot test is recommended as a confirmatory test. An intermediate or positive test in the 
Western blot confirms the infection and the individual is diagnosed as HIV positive. In 
case of a negative Western blot result the initial results from the ELISA test is considered 
as a false positive for HIV-1 and the individual is declared HIV-1 negative. At this 
juncture a serological test specific for HIV-2 is recommended. In case of an intermediate 
Western blot result a repeat test after 4-6 weeks is recommended and further testing with 
p24 antigen capture assay, HIV-1 RNA assay, or HIV-1 DNA PCR assay and a specific 
HIV-1 test is warranted. A negative result from the later tests confirms the absence of the 
disease in the individual. If any of later tests is positive then the individual is tentatively 
diagnosed for an infection which needs to be confirmed later by a positive Western blot 
test. One another point-of-care test available is the OraQuick Rapid HIV-1 antibody test 
generally to detect HIV infection in the blood, plasma, or saliva. This test has a 
sensitivity and specificity of about 99%. A negative result of this test confirms the 
absence of the infection and in case of a positive result the individual is subjected to the 
standard serologic testing mentioned in the guidelines (Figure A-4). 
 
 
A.3 Antiretroviral Therapy 
 
Preserving the immune function and reducing the HIV-associated morbidity and 
mortality are the prime objective of the antiretroviral therapy. Since plasma viral load and 
the CD4+ T cells are the most significant predictors for the progression of HIV  
 119
 
 
 
Figure A-4: Algorithm for the use of serologic tests in the diagnosis of HIV-1 or 
HIV-2 infection  
(Reprinted with permission from McGraw Hill Companies, Inc®. Fauci AS, Lane CH. 
Human Immunodeficiency Virus Disease: AIDS and related disorder. In: Anthony 
S.Fauci, Dennis L.Kasper, Dan L.Longo et al, Eds.  Harrison's Principles of Internal 
Medicine. 17th Edition. The McGraw-Hill Companies, Inc.; 2008:1137-1203.)153 
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infection,5,155 hence constant monitoring of these measures is recommended along with 
the antiretroviral therapy to ensure the desired clinical efficacy and treatment 
effectiveness is achieved.155  
 
According to the Guidelines for the Use of Antiretroviral Agents in HIV-1 
infected Adults and Adolescents, 2008, developed by the Office of AIDS Research 
Advisory Council (OARAC), U.S. Department of Health and Human Services (DHHS), 
antiretroviral therapy needs to be initiated in patients with a history of AIDS-defining 
illness or with a CD4+ T cell count of less than 350 cells/mm3.156 The guidelines also 
suggests that the antiretroviral therapy should be initiated regardless of the CD4+ T cell 
count in pregnant women, and in patients with HIV-associated nephropathy (HIVAN) 
and Hepatitis B virus (HBV) coinfections (Table A-2). The combination antiretroviral 
therapy commonly known as the highly active antiretroviral therapy (HAART), since it 
use in 1995 – 1996, has been highly effective in keeping the AIDS related illness under 
check.157 A recent study published in the Lancet on the patients initiated with 
combination antiretroviral therapy in Europe and North America showed a decrease in 
the mortality rates from 16.3 deaths per 1000 person years in 1996-99 to10.0 deaths per 
1000 person years in 2003-05. The study also reported a decrease in the potential life lost  
per 1000 person years, from 366 to 189 years. And the life expectancy at age 20 years 
increased from 36.1 (SE 0.6) years to 49.4 (SE 0.5) years in the same cohort (Hogg, 
2008).158 
 
The antiretroviral drugs are classified into six different classes based on their 
pharmacological activity: nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), 
nonnucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (FIs), fusion 
inhibitors, CCR5 antogonists, and integrase inhibitors. 
 
? Nucleoside reverse transcriptase inhibitors (NRTI) 
(Zidovudine, Lamivudine, Emtricitabine, Abacavir, Didonosine, Stavudine and 
Tenofovir) 
? Non-nucleoside reverse transcriptase inhibitors (NNRTI) 
(Efavirenz, Etravirine, Nevirapine and Delavirdine) 
? Protease Inhibitors (PI) 
(Lopinavir, Ritonavir, Atazanavir, Indinavir, Nelfinavir, Saquinavir, Tipranavir 
and Darunavir) 
? Integrase inhibitors  
(Raltagravir) 
? Fusion inhibitors  
(Enfuvirtide) 
? CCR5 antagonists  
(Maraviroc) 
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Table A-2: Indications for initiating antiretroviral therapy for the chronically HIV-
1 infected patient  
 
Clinical condition and/or CD4 count Recommendations 
  
? History of AIDS-defining illness 
? CD4 count <200 cells/mm3 
? CD4 count 200-350 cells/mm3 
? Pregnant women 
? Persons with HIV-associated 
nephropathy 
? Persons coinfected with hepatitis B 
virus (HBV), when HBV treatment is 
indicated (Treatment with fully 
suppressive antiviral drugs active 
against both HIV and HBV is 
recommended). 
Antiretroviral therapy should be 
initiated. 
? Patients with CD4 count >350 
cells/mm3 who do not meet any of the 
specific conditions listed above. 
The optimal time to initiate therapy 
in asymptomatic patients with CD4 
count >350 cells/mm3 is not well 
defined. 
(Department of Health and Human Services. Guidelines for the use of antiretroviral 
agents in HIV-1 adults and adolescents. Accessed November 3, 2008, 
www.http://www.aidsinfo.nih.gov/contentfiles/adultandAdolescentGL.pdf, 2007.)157 
 
 
A.4 Epidemiology of HIV/AIDS 
 
 
A.4.1 HIV – A Global Epidemic 
 
So far, virtually every country in the world has reported the presence of HIV 
among their population. According to the UNAIDS (Joint United Nations Program on 
HIV/AIDS) statistics the estimated population of HIV-infected cases in the world at the 
end of 2007 is around 33.0 million cases (30 million to 36 million).159 Among these half 
of them are females and around 2.5 million cases are children less than 15 years of age. 
This infection has mostly affected the lower and middle income families as they account 
for almost 95% of the cases. Among the new cases, estimated to be around 2.5 million 
cases worldwide in 2007, 420,000 were children below the age of 15 years. In the year 
2007, the total loss of life due to HIV or HIV- related diseases around the globe were 
estimated to be 2.1 million in which 330,000 were children below the age of 15 years.159 
The characteristic of the infected individuals differ between countries and is driven by the 
cultural and traditional norms of the country. HIV has mainly hit the poor and 
underdeveloped part of the globe especially the southern African countries of the sub-
Saharan Africa. This part of globe consists of almost 22.5 million HIV-infected people, a 
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two third of the world HIV population, where as their population accounts for only 10-
11% of the global population.159 In some countries in the southern African more than 
15% of population between the age of 15-49 years are HIV seropositive and this 
proportion is more than 50% among high risk population such as commercial sex workers, 
patients attending STD clinics, etc. Many of these highly affected countries are expected 
to have a population life expectancy of less than 40 years, a significant drop from their 
pre-AIDS era.159 
 
Recent development in the HIV prevalence in the Asian and the Central Asian 
countries has been alarming.  Though the prevalence in some of the countries in Central 
Asia are less than the countries in African but the large population in these countries (like 
India and China) put the HIV-infected population ahead in terms of sheer numbers. At 
the end of 2007, the total number of HIV cases in Asia was estimated to be 4.9 million, 
and that in the Central Asia and Eastern Europe to be approximately 1.6 million.159 The 
Russian Federation and Ukraine has been reported to have contributed to nearly 90% of 
the new HIV infection in 2007. This spread has been attributed to be driven by injection 
drug users and an increase in the heterosexual transmission.159 In the Latin America and 
the Caribbean region Brazil has the largest HIV/AIDS-infected population. This region is 
estimated to have 1.8 million HIV/AIDS-infected cases. While North America along with 
Western and Central Europe account for 2.1 million of the HIV/AIDS-infected 
population (Figure A-5).159 
 
 
 
 
 
Figure A-5: Global view of HIV infection  
(Reprinted from the United Nations AIDS Program (UNAIDS). Report on Global AIDS 
Epidemic. UNAIDS/08.27E / JC1511E. 2008. Accessed April 3, 2009, 
www.unaids.org.)160 
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A.4.2 HIV/AIDS in United States 
 
Since 1981 the number of AIDS cases in the United States has increased rapidly 
and reached its peak in 1992. Around 78,000 cases of HIV were diagnosed in 1992.2 
However, this rapid growth stabilized in 1998, mostly because of tremendous public 
awareness and safety drives coupled with the development of HAART guidelines (Figure 
A-6). Trends show a drop of 47% in the number for cases from 1992 to 1998. Although 
males accounted for the majority of the cases a rise in the proportion of females has been 
observed in recent trend analysis. Statistics confirm a rise from 15% (1981-1995) to 27% 
(2001-2004) in the females among the all AIDS cases.2 In the mean time a decrease in the 
proportion of cases aged <13 years has been observed between the periods 1981-1985 to 
2001-2004. 
 
Annually, nearly 56,000 new cases of HIV infection are identified in the United 
States. The MMWR (2008) report estimates put the current population of ‘People Living 
with HIV/AIDS (PLWHA) in the United States to be 1.1 million. This number includes 
all adults and adolescents either diagnosed or undiagnosed at the end of 2006.39 
Compared to the 994,000 HIV cases estimated in 2003, there has been an 11.3% increase 
in the PLWHA population in the United States. Among them 46.1% (1,715.1 per 100,000 
population) were black, 34.6% (224.3 per 100,000) were white, 17.5% (585.3 per 
100,000) were Hispanic, 1.4% (129.6 per 100,000) were Asian/Pacific Islander, and 0.4% 
(231.4 per 100,000) were American Indian/Alaska Native. Gender wise, males made up 
the largest portion accounting 74.8% of prevalent HIV cases (685.7 per 100,000). Among 
males 64.3% of them reported to have male-to-male sexual contact, and thus accounting 
for 48.1% of the total HIV-infected population. Infection resulting from heterosexual 
contact accounted for 27.6% of the prevalent cases (1.6% among men and 72.4% of cases 
among women), 18.5% of the cases was attributed to injection drug use (IDU) and the 
balance 5% accounted to men who reported both male-to-male sexual contact and IDU or 
whose transmission category was classified as other (0.8%; including hemophilia, blood 
transfusion, perinatal exposure, and risk factors nor reported or not identified).39 
 
The MMWR 2006 report also reported that almost 24%-27% of the HIV 
population is unaware of their HIV infection and more than half of the individuals had 
their first diagnosed HIV-positive within 12 months of AIDS diagnosis (MMWR, 
2003).39 
 
In the State of Tennessee, as of 2005 some 11,867 cases of HIV/AIDS were 
identified and out them 6,133 cases are currently living with AIDS.161 Eighty one percent 
of the HIV/AIDS population in the State of Tennessee are females and 51% of the 
reported cases are Black, non-Hispanics. Around 4,449 cases have been reported in the 
Shelby County so far. The number of HIV cases per 100,000 population is Memphis is 
about 313 as of 2007, and 89% of these cases are Black, non-Hispanics.162 
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Figure A-6: Estimated number of AIDS cases and AIDS deaths, United States, 
1985-2005 
(Center for Disease Control and Prevention. Epidemiology of HIV/AIDS--United States, 
1981-2005. Morb Mortal Wkly Rep. 2006;55:589-592.)2 
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 B.4  IRB-Approved Questionnaire for Child 
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847 Monroe Avenue, Room 205, 
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The McGraw-Hill Companies 
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Subject: Permission to reprint book excerpts 
As an introduction, my name is Arijit Ganguli and I am a Graduate PhD 
student in Health Outcomes & Policy Research program in the University of Tennessee, 
Memphis. My dissertation topic deals with analyzing the impact of parent's HIV status 
on the healthcare utilization, access and health outcomes of their children.  
As a part of my dissertation, I have a detailed description on morphology and 
replication of the HIV virus. In order to compliment my text I would also like to provide 
some visual figures/diagrams that illustrate the text. Therefore, I will like to have your 
permission to reprint the figures/tables from the Chapter 182 of Section 14 (Part 7): 
Human Immunodeficiency Virus Disease: AIDS and related disorder, Harrison's 
Principles of Internal Medicine, 17th Edition (2008). This chapter is authored by Antony 
S. Fauci and H. Clifford Lane. The material was accessed from an online version of the 
book available to the students of University of Tennessee Health Science Center on 
http://online.statref.com website. The figures/tables for which the permission is requested 
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1. Figure 182-2B: Structure of HIV-1, including the gp120 outer membrane, gp41 
transmembrane components of the envelope, genomic RNA, enzyme reverse 
transcriptase, p18(17) inner membrane (matrix), and p24 core protein (capsid) 
(copyright by George V. Kelvin). (Adapted from RC Gallo: Sci Am 256:46, 
1987.). 
2. Figure 182-3: The replication cycle of HIV. See text for description. (Adapted 
from Fauci, 1996.) 
3. Figure 182-27: Algorithm for the use of serologic tests in the diagnosis of HIV-
1 or HIV-2 infection. 
4. Table 182-1: 1993 Revised Classification system for HIV infection and 
expanded AIDS surveillance case definition for adolescents and adults. Source: 
MMWR 42(No. RR-17), December 18, 1992. 
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new work will be in MS Word and in Adobe PDF formats and the work will be in 
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